<SEC-DOCUMENT>0001558370-24-014552.txt : 20241106
<SEC-HEADER>0001558370-24-014552.hdr.sgml : 20241106
<ACCEPTANCE-DATETIME>20241106111100
ACCESSION NUMBER:		0001558370-24-014552
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241106
FILED AS OF DATE:		20241106
DATE AS OF CHANGE:		20241106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		241429690

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>gmab-20241106x6k.htm
<DESCRIPTION>6-K
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 11/5/2024 06:58:04 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Washington,&#160;D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">FORM&#160;6-K</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">FOR THE&#160;MONTH OF NOVEMBER 2024</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;white-space:pre-wrap;">COMMISSION FILE NUMBER 001-38976  </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">Genmab A/S</b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><br></b><font style="color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;background:#ffffff;">(Exact name of Registrant as specified in its charter)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Carl Jacobsens Vej 30</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">2500 Valby</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Denmark</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;">+45 70 20 27 28</b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;"><br></b><font style="color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;background:#ffffff;">(Address of principal executive offices)</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Form&#160;20-F&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      Form&#160;40-F&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;"> </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="background:#ffffff;">Exhibit 99.1 to this report on Form&#160;6-K&#160;shall be deemed to be&#160;</font>incorporated by reference<font style="background:#ffffff;">&#160;in Genmab A/S&#8217;s registration statement on&#160;</font><font style="background:#ffffff;">Form&#160;S-8</font><font style="background:#ffffff;">&#160;(File&#160;No. 333-232693, </font>333-253519, 333-262970 and 333-277273<font style="background:#ffffff;">)&#160;and in the outstanding prospectus contained in such registration statement. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">SIGNATURE</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">GENMAB A/S</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">BY:</font></p></td><td style="vertical-align:bottom;width:45.3%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">/s/ Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Name: Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Title: Executive Vice President &amp; Chief Financial Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">DATE: NOVEMBER 6, 2024 </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">EXHIBIT&#160;INDEX</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:96.42%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">A</b></p></div></div></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Description of Exhibit</u></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">99.1</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;">Interim Report Dated November 6, 2024   &#160;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gmab-20241106xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 11/5/2024 06:58:10 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title>Interim Report for the 6 months ended June 30, 2011</title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">November 6, 2024 Copenhagen, Denmark; </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Highlights</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">European Commission (EC) granted conditional marketing authorization for TEPKINLY</b><sup style="font-family:'Arial Bold';font-size:7.5pt;font-style:normal;font-weight:bold;vertical-align:top;">&#174;</sup><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;"> (epcoritamab) as a monotherapy for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Genmab announced that it will assume sole responsibility for the continued development and potential commercialization of acasunlimab</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Genmab revenue increased 29% compared to the first nine months of 2023, to DKK 15,085 million</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Genmab 2024 financial guidance updated</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk12956096"></a>&#8220;The third quarter of 2024 presented Genmab with additional opportunities to progress towards our goal of fundamentally transforming the lives of people with cancer and other serious diseases. The additional approval for TEPKINLY, along with positive data presentations for our promising late-stage assets acasunlimab and rinatabart sesutecan (Rina-S), underscore the potential of our pipeline and our commitment to the development of innovative antibody-based therapeutics,&#8221; said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;">Financial Performance First Nine Months of 2024</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenue was DKK 15,085 million for the first nine months of 2024 compared to DKK 11,715 million for the first nine months of 2023. The increase of DKK 3,370 million, or 29%, was primarily driven by higher DARZALEX</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> (daratumumab) and Kesimpta</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> (ofatumumab) royalties achieved under our collaborations with Janssen Biotech, Inc. (Janssen) and Novartis Pharma AG (Novartis), respectively, and increased EPKINLY</font><sup style="font-family:'Arial Bold';font-size:7.5pt;font-style:normal;font-weight:bold;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> (epcoritamab) net product sales.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Royalty revenue was DKK 12,367 million in the first nine months of 2024 compared to DKK 9,722 million in the first nine months of 2023, an increase of DKK 2,645 million, or 27%. The increase in royalties was driven by higher net sales of DARZALEX and Kesimpta.</font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;"> </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Net sales of DARZALEX, including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;">FASPRO</i><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> in the U.S.), by Janssen were USD 8,586 million in the first nine months of 2024 compared to USD 7,194 million in the first nine months of 2023, an increase of USD 1,392 million or 19%.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_Hlk527456303"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Total costs and operating expenses were DKK 10,542 million in the first nine months of 2024 compared to DKK 8,145 million in the first nine months of 2023. The increase of DKK 2,397 million, or 29%, was driven by the </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">expansion of our product pipeline, including </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">the addition of ProfoundBio related research and development expenses, primarily Rina-S</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">, the continued development of Genmab&#8217;s broader organizational capabilities and related increase in team members to support these activities, as well as profit-sharing amounts payable to AbbVie Inc. (AbbVie) related to EPKINLY sales.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="OLE_LINK13"></a><a name="OLE_LINK14"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Operating profit was DKK 4,543 million in the first nine months of 2024 compared to DKK 3,570 million in the first nine months of 2023</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_Hlk164842825"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Net financial items resulted in income of DKK 1,019 million for the first nine months of 2024 compared to DKK 1,060 million in the first nine months of 2023. </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 1/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is updating the lower end of its revenue range of 2024 financial guidance driven by higher total royalty revenues from DARZALEX. Genmab is also lowering the upper end of its operating expense range to reflect a continued focused and disciplined approach to investments and portfolio prioritization. </p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;width:19.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:19.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous Guidance</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">21,100 - 21,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">20,500 - 21,700</p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Royalties</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">17,000 - 17,400</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">16,600 - 17,400</i></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Net product sales/Collaboration revenue*</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,000 - 2,200</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,000 - 2,200</i></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Milestones/Reimbursement revenue</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,100 - 2,100</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">1,900 - 2,100</i></p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gross profit**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">20,200 - 20,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">19,600 - 20,800</p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(13,700) - (14,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(13,700) - (14,300)</p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Including Acquisition &amp; Integration Related Charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(14,100) - (14,400)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(14,100) - (14,700)</p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">6,200 - 7,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">5,300 - 7,100</p></td></tr><tr><td style="vertical-align:bottom;width:58.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Including Acquisition &amp; Integration Related Charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">5,800 - 6,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4,900 - 6,700</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:10pt;background:#ffff00;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></font><i style="font-style:italic;">*Net Product Sales and Collaboration Revenue consists of EPKINLY Net Product Sales in the U.S. and Japan and Tivdak (Genmab&#8217;s share of net profits) in the U.S.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">**Operating Expenses Range excludes Cost of Product Sales Range, which is included in Gross Profit Range</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:101.44%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:20.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:28.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:4.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Conference Call</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab will hold a conference call to discuss the results for the first nine of 2024 today, November 6, 2024, at 6:00 pm CET, 5:00 pm GMT or 12:00 pm EST. To join the call please use the below registration link. Registered participants will receive an email with a link to access dial-in information as well as a unique personal PIN: <font style="color:#029c93;">https://register.vevent.com/register/BI6db06ed786914762a9dc001f798b7c1b</font>. A live and archived webcast of the call and relevant slides will be available at <font style="color:#029c93;">www.genmab.com/investor-relations</font>.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Contact</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marisol Peron, Senior Vice President, Global Communications &amp; Corporate Affairs</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +1 609 524 0065; E: <font style="color:#029c93;">mmp@genmab.com</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Andrew Carlsen, Vice President, Head of Investor Relations</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +45 3377 9558; E: <font style="color:#029c93;">acn@genmab.com</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 2/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONTENTS</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><b style="color:#029c93;font-weight:bold;">MANAGEMENT&#8217;S REVIEW</b></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#CONSOLIDATEDKEYFIGURES_439617"><font style="font-style:normal;font-weight:normal;">CONSOLIDATED KEY FIGURES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#OUTLOOK_182548"><font style="font-style:normal;font-weight:normal;">OUTLOOK</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">5</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#KEY2019PRIORITIES_328557"><font style="font-style:normal;font-weight:normal;">KEY 2024 PRIORITIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#PRODUCTPIPELINE_603298"><font style="font-style:normal;font-weight:normal;">PRODUCT PIPELINE</font></a> <a href="#PRODUCTPIPELINE_603298"><font style="font-style:normal;font-weight:normal;">AND TECHNOLOGY PROGRESS FIRST NINE MONTHS OF 2024 </font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#_SIGNIFICANT_RISKS_AND"><font style="font-style:normal;font-weight:normal;">SIGNIFICANT RISKS AND UNCERTAINTIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">17</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#FINANCIALREVIEW_601130"><font style="font-style:normal;font-weight:normal;">FINANCIAL REVIEW</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">18</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#CondensedConsolidatedStatementsofCompInc"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">26</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#NOTESTOTHEFINANCIALSTATEMENTS_435403"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">NOTES&#160;TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">30</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#ABOUTGENMAB_556806"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">ABOUT GENMAB</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">44</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">45</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 3/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">CONSOLIDATED KEY FIGURES</b><b style="font-size:16pt;font-weight:bold;"><a name="_MON_1428392831"></a></b><b style="color:#339966;font-weight:bold;white-space:pre-wrap;">   </b><b style="font-size:16pt;font-weight:bold;"><a name="CONSOLIDATEDKEYFIGURES_439617"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:24.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Full Year</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,540</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,712</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,085</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,715</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16,474</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cost of product sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (273)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (79)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (648)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (100)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (226)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,283)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,088)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (7,084)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (5,682)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (7,630)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (865)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (860)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,541)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,363)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,297)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Acquisition and integration related charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (17)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (269)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total costs and operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,438)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,027)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10,542)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8,145)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (11,153)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,102</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,685</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,543</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,570</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,321</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net financial items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (383)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 985</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,019</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,060</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 316</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,266</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,104</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,999</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,649</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,352</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,976</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13,252</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,976</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13,252</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13,268</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,273</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,273</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,867</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,961</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,257</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,961</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,257</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,196</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39,660</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35,005</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39,660</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35,005</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35,335</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31,922</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30,936</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31,922</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30,936</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31,656</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Cash Flow Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,033</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,037</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,059</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,708</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,380</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 224</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,008</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9,989)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (840)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,282)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (276)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,922)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (584)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (606)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Investment in intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (98)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (93)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (299)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (366)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Financial Ratios and Other Information</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Basic net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19.94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 55.88</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66.64</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Diluted net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19.81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31.94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 55.40</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66.02</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Period-end share market price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,620</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,508</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,620</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,508</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,155</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Price / book value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.35</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5.35</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.35</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5.35</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.50</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 483.67</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 468.73</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 483.67</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 468.73</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 478.94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Equity ratio</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 80</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 88</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 80</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 88</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">66,176,831</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66,067,481</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">66,176,831</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66,067,481</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66,074,535</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Average number of employees (FTE*)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,591</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,488</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,953</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,011</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Number of employees (FTE) at the end of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,635</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,132</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,635</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,132</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.44%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,204</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><font style="white-space:pre-wrap;">* Full-time equivalent or team members  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 4/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514641"></a><b style="color:#029c93;font-size:11pt;font-weight:bold;">OUT</b><a name="_Hlk117861578"></a><a name="_Hlk117854937"></a><b style="color:#029c93;font-size:11pt;font-weight:bold;">LOOK</b><b style="color:#029c93;font-size:11pt;font-weight:bold;"> </b><a name="OUTLOOK_182548"></a><a name="_Hlk22722517"></a><a name="_Hlk117861572"></a><a name="_Hlk117854930"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous Guidance</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">21,100 - 21,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">20,500 - 21,700</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Royalties</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">17,000 - 17,400</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">16,600 - 17,400</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Net product sales/Collaboration revenue*</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,000 - 2,200</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,000 - 2,200</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;white-space:pre-wrap;"> Milestones/Reimbursement revenue</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">2,100 - 2,100</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;background:#f2f2f2;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">1,900 - 2,100</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gross profit**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">20,200 - 20,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">19,600 - 20,800</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(13,700) - (14,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(13,700) - (14,300)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Including Acquisition &amp; Integration Related Charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(14,100) - (14,400)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(14,100) - (14,700)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">6,200 - 7,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">5,300 - 7,100</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Including Acquisition &amp; Integration Related Charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">5,800 - 6,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4,900 - 6,700</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-style:italic;visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">*Net Product Sales and Collaboration Revenue consists of EPKINLY Net Product Sales in the U.S. and Japan and Tivdak (Genmab&#8217;s share of net profits) in the U.S.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">**Operating Expenses Range excludes Cost of Product Sales Range, which is included in Gross Profit Range</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is updating the lower end of its revenue range of 2024 financial guidance driven by higher total royalty revenues from DARZALEX and continued focused and disciplined approach to investments and portfolio prioritization. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab expects its 2024 revenue to be in the range of DKK 21.1 &#8211; 21.7 billion, an increase to the </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">previous guidance range of DKK 20.5 &#8211; 21.7 billion, driven by higher total royalty revenues from </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DARZALEX. DARZALEX royalties of DKK 13.7 &#8211; 14.0 billion are based on Genmab&#8217;s estimate of DARZALEX 2024 net sales of USD 11.6 &#8211; 11.8 billion. DARZALEX royalties are partly offset by Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme Therapeutics, Inc. (Halozyme) in connection with SC net sales as well as royalty reduction in countries and territories where there are no Genmab patents. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk117861601"></a><b style="color:#029c93;font-weight:bold;">Operating Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab anticipates its 2024 operating expenses (excluding acquisition and integration related charges) to be in the range of DKK 13.7 &#8211; 14.0 billion, a decrease to the previous guidance range of DKK 13.7 &#8211; 14.3 billion, primarily related to continued focused and disciplined approach to investments and portfolio prioritization. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Including acquisition and integration related charges, Genmab expects operating expenses for 2024 to be in the range of DKK 14.1 &#8211; 14.4 billion.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Profit</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab now expects its 2024 operating profit excluding acquisition and integration related charges to be <a name="_Hlk181110822"></a>in the range of DKK 6.2 &#8211; 7.1 billion, compared to the previous guidance of DKK 5.3 &#8211; 7.1 billion, primarily driven by the items described above. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Including acquisition and integration related charges, Genmab expects operating profit for 2024 to be in the range of DKK 5.8 &#8211; 6.7 billion.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook: Risks and Assumptions</b></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 5/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to factors already mentioned, the estimates above are subject to change due to numerous reasons, including but not limited to, the achievement of certain milestones associated with Genmab&#8217;s collaboration agreements; the timing and variation of development activities (including activities carried out by Genmab&#8217;s collaboration partners) and related income and costs; DARZALEX, DARZALEX <i style="font-style:italic;">FASPRO,</i><sup style="font-size:7.5pt;font-style:italic;vertical-align:top;"> </sup> Kesimpta, TEPEZZA<sup style="font-family:'Arial Bold';font-size:7.5pt;vertical-align:top;">&#174;</sup>, RYBREVANT<sup style="font-family:'Arial Bold';font-size:7.5pt;vertical-align:top;">&#174;</sup>, TECVAYLI<sup style="font-family:'Arial Bold';font-size:7.5pt;vertical-align:top;">&#174;</sup>, TALVEY<sup style="font-family:'Arial Bold';font-size:7.5pt;vertical-align:top;">&#174;</sup> and TEPKINLY net sales and royalties paid to Genmab; changing rates of inflation; and currency exchange rates (the 2024 guidance assumes a USD / DKK exchange rate of 6.8). The financial guidance assumes that no significant new agreements are entered into during the remainder of <a name="_Hlk117861623"></a>2024 that could materially affect the results. Refer to the section &#8220;Significant Risks and Uncertainties&#8221; in this interim report for matters that may cause Genmab&#8217;s actual results to differ materially from 2024 Guidance and Key 2024 Priorities. <a name="_Hlk117854961"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The factors discussed above, as well as other factors that are currently unforeseeable, may result in further and other unforeseen material adverse impacts on Genmab&#8217;s business and financial performance, including on the sales of Tivdak<sup style="font-family:'Arial Bold';font-size:7.5pt;vertical-align:top;">&#174;</sup> and EPKINLY/TEPKINLY, and on the net sales of DARZALEX, Kesimpta, TEPEZZA, RYBREVANT, TECVAYLI and TALVEY by Genmab&#8217;s collaboration partners and on Genmab&#8217;s royalties, collaboration revenue and milestone revenue therefrom.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">KEY 2024 PRIORITIES</b><b style="font-size:16pt;font-weight:bold;"><a name="KEY2019PRIORITIES_328557"></a></b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:26.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:73.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td rowspan="3" style="vertical-align:middle;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Bring Our Own Medicines to Patients</b></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">EPKINLY<sup style="font-size:7.5pt;vertical-align:top;">1</sup></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Initiate three Phase 3 trials</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Expand label to include relapsed/refractory FL&#160;</font></div></div></div></td></tr><tr><td style="display:none;vertical-align:top;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tivdak<sup style="font-size:7.5pt;vertical-align:top;">2</sup></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Initiate Phase 3 study in head and neck cancer</font></div></div></div></td></tr><tr style="height:1pt;"><td style="display:none;vertical-align:top;width:26.92%;background:#bfbfbf;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Execute successful launches and growth in key markets</p></td></tr><tr><td rowspan="3" style="vertical-align:middle;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Build World-class Differentiated Pipeline&#160;&#160;</b><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Acasunlimab (GEN1046, DuoBody<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup>-PD-L1x4-1BB)</p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Initiate Phase 3 study (second line non-small cell lung cancer (NSCLC))</font></div></div></div></td></tr><tr><td style="display:none;vertical-align:top;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1042 (DuoBody-CD40x4-1BB)<sup style="font-size:7.5pt;vertical-align:top;">3</sup></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 2 data and determine next steps </font></div></div></div></td></tr><tr><td style="display:none;vertical-align:top;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Expand and advance&#160;proprietary&#160;clinical&#160;product portfolio</p></td></tr><tr><td style="vertical-align:top;width:26.92%;background:#bfbfbf;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;background:#bfbfbf;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:middle;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Invest in Our People &amp; Culture</b></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Further scale organization aligned&#160;with&#160;differentiated antibody product&#160;portfolio&#160;growth and future&#160;launches</p></td></tr><tr><td style="vertical-align:top;width:26.92%;background:#bfbfbf;border-bottom:1px solid #000000;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:73.07%;background:#bfbfbf;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:27.4pt;"><td style="vertical-align:middle;width:26.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Become a Leading Integrated Biotech</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Innovation&#160;Powerhouse</b></p></td><td style="vertical-align:top;width:73.07%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Use solid financial base to grow and broaden&#160;antibody product and technology portfolio</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1. Co-development w/ AbbVie; 2. Co-development w/ Pfizer Inc. (Pfizer); 3. Co-development w/ BioNTech SE (BioNTech)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">PRODUCT PIPELINE</b><a name="PRODUCTPIPELINE_603298"></a><b style="color:#029c93;font-weight:bold;"> AND TECHNOLOGY PROGRESS FIRST NINE MONTHS OF 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">At the end of the first nine months of 2024, Genmab&#8217;s proprietary pipeline of investigational medicines, where we are responsible for at least 50% of development, consisted of over a dozen antibody products in clinical development. These include Genmab&#8217;s approved medicines, Tivdak, which Genmab is co-developing globally and co-promoting in the U.S. in collaboration with Pfizer, and EPKINLY/TEPKINLY, which Genmab is co-developing and co-commercializing in the U.S. and Japan in collaboration with AbbVie. In addition to our own pipeline, there are multiple investigational medicines in development by global pharmaceutical and biotechnology companies, including six approved medicines powered by Genmab&#8217;s technology and innovations. Beyond the investigational medicines in clinical development, our pipeline includes multiple preclinical programs. An overview of the development status of our approved </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 6/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">medicines and each of our investigational medicines is provided in the following section, including updates for the third quarter of 2024. For events that occurred during the first and second quarters of 2024, please refer to <a href="https://www.sec.gov/Archives/edgar/data/1434265/000155837024006478/gmab-20240502xex99d1.htm"><font style="font-style:normal;font-weight:normal;">Genmab&#8217;s Q1 2024</font></a> and <a href="https://www.sec.gov/Archives/edgar/data/1434265/000155837024006478/gmab-20240502xex99d1.htm"><font style="font-style:normal;font-weight:normal;">Genmab&#8217;s First Half 2024</font></a> reports. Detailed descriptions of dosing, efficacy and safety data from certain clinical trials have been disclosed in company announcements and media releases published via the Nasdaq Copenhagen A/S (Nasdaq Copenhagen) stock exchange and may also be found in Genmab&#8217;s filings with the U.S. Securities and Exchange Commission (U.S. SEC). Additional information is available on Genmab&#8217;s website, <font style="color:#029c93;">www.genmab.com</font>. The information accessible through our website is not part of this report and is not incorporated by reference herein.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="PRODUCTPIPELINEANDTECHNOLOGYPROGRESSFIRS"></a><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Genmab Proprietary Products</b><sup style="color:#029c93;font-size:8.25pt;font-weight:bold;vertical-align:top;">1</sup></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Approved Medicines</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-bottom:2.15pt;padding-top:2.15pt;width:99.03%;"><tr style="height:1pt;"><td style="vertical-align:top;width:25.09%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:13.24%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:18.16%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:43.49%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:25.09%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Approved Product</b></p></td><td style="vertical-align:top;width:13.24%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Target</b></p></td><td style="vertical-align:top;width:18.16%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Developed By</b></p></td><td style="vertical-align:top;width:43.49%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Disease Indication</b></p></td></tr><tr><td style="vertical-align:top;width:25.09%;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">EPKINLY</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(epcoritamab-bysp, epcoritamab)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">TEPKINLY</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(epcoritamab)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:13.24%;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">CD3xCD20</p></td><td style="vertical-align:top;width:18.16%;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Co-development</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab/AbbVie </p></td><td style="vertical-align:top;width:43.49%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Approved in multiple territories including in the U.S. and Europe for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy and in Japan for adult patients with certain types of relapsed or refractory large B-cell lymphoma (LBCL) after two or more lines of systemic therapy<sup style="font-size:7.5pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:25.09%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:13.24%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:18.16%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.49%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Approved in the U.S. and Europe for adult patients with relapsed or refractory FL after two or more lines of systemic therapy<sup style="font-size:7.5pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:25.09%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Tivdak</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(tisotumab vedotin-tftv)</p></td><td style="vertical-align:top;width:13.24%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tissue factor (TF)</p></td><td style="vertical-align:top;width:18.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Co-development Genmab/Pfizer </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:43.49%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Approved in the U.S. for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy<sup style="font-size:7.5pt;vertical-align:top;">2</sup></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup>Approved and investigational medicines where Genmab has &#8805;50% ownership, in co-development with partners as indicated.<br><sup style="font-size:6pt;vertical-align:top;">2</sup>Refer to relevant local prescribing information for precise indication and safety information.<br><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 7/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pipeline, Including Further Development for Approved Medicines</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;"><img src="gmab-20241106xex99d1005.jpg" alt="Graphic" style="display:inline-block;height:251.6pt;left:0%;padding-bottom:0.4pt;position:relative;top:0pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">*Genmab is developing HexaBody-CD38 in an exclusive worldwide license and option agreement with Janssen.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">EPKINLY/TEPKINLY (epcoritamab) &#8211; First and only bispecific antibody approved in the U.S. and Europe to treat both relapsed or refractory FL and DLBCL after two or more lines of systemic therapy</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">SC bispecific antibody targeting CD3 and CD20, created using Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Epcoritamab (approved as EPKINLY and TEPKINLY) has received regulatory approvals in multiple territories including in the U.S. and Europe for adult patients with relapsed or refractory DLBCL after two or more lines of systemic therapy, and in Japan for adult patients with certain types of relapsed or refractory LBCL after two or more lines of systemic therapy. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">EPKINLY/TEPKINLY have also been approved in the U.S. and Europe for the treatment of adults with relapsed or refractory FL after two or more lines of systemic therapy. Regulatory submission for epcoritamab for this indication is currently under review in Japan. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Multiple clinical trials are ongoing across different settings and histologies, including five Phase 3 trials, with more trials in planning</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed and co-commercialized in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab is a proprietary bispecific antibody created using Genmab&#8217;s DuoBody technology platform. Epcoritamab targets CD3, which is expressed on T-cells, and CD20, a clinically validated target on malignant B-cells. Genmab used technology licensed from Medarex Inc. (Medarex) to generate the CD20 antibody forming part of epcoritamab. Epcoritamab is marketed as EPKINLY in the U.S., Japan, and other regions, and as TEPKINLY in Europe and other regions. See local prescribing information for specific indications and safety information. In 2020, Genmab entered into a collaboration agreement with AbbVie to jointly develop and commercialize epcoritamab. The companies share commercialization responsibilities in the U.S. and Japan, with AbbVie responsible for further global commercialization. </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 8/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab records sales in the U.S. and Japan and receives tiered royalties between 22% and 26% on remaining global sales outside of these territories, subject to certain royalty reductions. The companies have a broad clinical development program for epcoritamab including five ongoing Phase 3 trials and additional trials in planning. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font><font style="color:#029c93;"> </font>for EPKINLY and the <font style="color:#029c93;">European Summary of Product Characteristics</font><font style="color:#029c93;"> </font>for TEPKINLY for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2024 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">September: The U.S. Food and Drug Administration (U.S. FDA) granted a Breakthrough Therapy Designation (BTD) for EPKINLY (epcoritamab) in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory FL after at least one line of systemic therapy. This is the second BTD granted for EPKINLY. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">August: The </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">EC granted conditional marketing authorization for TEPKINLY (epcoritamab) as a monotherapy for the treatment of adult patients with relapsed or refractory FL after two or more lines of systemic therapy. The conditional marketing authorization was supported by data from the FL cohort of the EPCORE</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> NHL-1 trial (NCT03625037)</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Tivdak (tisotumab vedotin-tftv) &#8211; First and only U.S. FDA approved ADC for recurrent or metastatic cervical cancer</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">An ADC directed to TF, a protein highly prevalent in solid tumors, including cervical cancer, which is associated with poor prognosis</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Full approval granted by the U.S. FDA for tisotumab vedotin-tftv, marketed as </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Tivdak</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">, for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy; Tivdak is the first ADC with demonstrated overall survival data to be granted full U.S. FDA approval in this patient population</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Regulatory submissions for tisotumab vedotin for the treatment of recurrent or metastatic cervical cancer are currently under review in both Japan and Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed globally and co-promoted in the U.S. in collaboration with Pfizer</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 4.5pt 11pt 0pt;">Tisotumab vedotin is an ADC composed of Genmab&#8217;s human monoclonal antibody directed to TF and Pfizer&#8217;s ADC technology that utilizes a protease-cleavable linker that covalently attaches the microtubule-disrupting agent monomethyl auristatin E to the antibody. Genmab used technology licensed from Medarex to generate the TF antibody forming part of tisotumab vedotin. Tisotumab vedotin-tftv, marketed as Tivdak, is the first and only U.S. FDA approved ADC for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Tisotumab vedotin is being co-developed by Genmab and Pfizer. Under a joint commercialization agreement, Genmab is co-promoting Tivdak in the U.S. and will lead commercial operational activities in Japan. Pfizer is leading commercial operational activities in the U.S. and will lead commercial operational activities in Europe and China. In these four markets there will be a 50:50 profit split. In other markets, Pfizer will commercialize Tivdak and Genmab will receive royalties based on a percentage of aggregate net sales ranging from the mid-teens to the mid-twenties. The companies have joint decision-making power on the worldwide development and commercialization strategy for Tivdak. Upon strategic evaluation we have decided to discontinue preparation for a Phase 3 study in second / third line squamous cell carcinoma of the head and neck. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> for Tivdak for the labeled indication and safety information, including the boxed warning.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2024 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">July: Data from innovaTV 301 clinical trial (NCT04697628) published in New England Journal of Medicine, </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;">Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.</i></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 9/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Acasunlimab (GEN1046) &#8211; Bispecific next-generation immunotherapy</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting PD-L1 and 4-1BB, created using Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Clinical trials in solid tumors ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">In August 2024, BioNTech opted not to participate in the further development of the acasunlimab program under the parties&#8217; existing License and Collaboration Agreement </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Genmab is assuming sole responsible for the continued development and potential commercialization of acasunlimab</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Acasunlimab (GEN1046, DuoBody-PD-L1x4-1BB) is a proprietary bispecific antibody, created using Genmab&#8217;s DuoBody technology platform. In August 2024, BioNTech opted not to participate in the further development of the acasunlimab program under the parties&#8217; existing License and Collaboration Agreement for reasons related to BioNTech&#8217;s portfolio strategy. Genmab is assuming sole responsibility for the continued development and potential commercialization of acasunlimab and the program will be subject to payment of certain milestones and a tiered single-digit royalty on net sales by Genmab to BioNTech. Acasunlimab is designed to induce an antitumor immune response by simultaneous and complementary PD-L1 blockade and conditional 4-1BB stimulation using an inert DuoBody format. Acasunlimab is currently in Phase 2 clinical development. Based on encouraging data from the Phase 2 trial in NSCLC (NCT05117242), a Phase 3 trial is expected to start before the end of 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Third Quarter 2024 Update</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">September: Translational and pharmacokinetic/pharmacodynamic data supporting the Phase 3 dosing regimen for acasunlimab in combination with pembrolizumab in patients with relapsed/refractory metastatic NSCLC was presented as a poster at the 2024 World Conference on Lung Cancer (WCLC).</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Rinatabart Sesutecan (Rina-S, GEN1184) &#8211; Potential best-in-class folate receptor alpha (FR&#945;)-targeted topoisomerase I (TOPO1) ADC</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">FR&#945;-targeted TOPO1 ADC being evaluated for potential treatment of FR&#945;-expressing cancers</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">(NCT05579366) </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">in advanced solid tumors ongoing</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rina-S is a novel FR&#945;-targeted TOPO1 ADC being evaluated for the potential treatment of ovarian cancer and other FR&#945;-expressing cancers. Dose escalation data suggests that Rina-S has robust single agent activity in various cancers across a broad range of FR&#945; expression levels. In January 2024, Rina-S was granted Fast Track Designation by the U.S. FDA for the treatment of FR&#945;-expressing high-grade serous or endometrioid platinum-resistant ovarian cancer. A Phase 1/2 trial of Rina-S in advanced solid tumors is ongoing. Based on encouraging data from this trial, a Phase 3 trial in second line plus platinum resistant ovarian cancer is expected to start before the end of 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Third Quarter 2024 Update</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">September: Data from the Phase 1/2 study of Rina-S were presented as a mini-oral presentation at the European Society of Medical Oncology Congress 2024 (ESMO) in Barcelona, Spain. Rina-S demonstrated a confirmed objective response rate (ORR) of 50.0% (95% CI, 26.0 &#8211; 74.0) in ovarian cancer patients treated with Rina-S 120 mg/m</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">2</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> once every 3 weeks (Q3W), regardless of FR&#945; expression levels. Rina-S was well tolerated in these patients with no signals of ocular toxicities, neuropathy, or interstitial lung disease (ILD) observed.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 10/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1042 (BNT312) &#8211; Potential first-in-class bispecific agonistic antibody</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting CD40 and 4-1BB, created using Genmab&#8217;s DuoBody technology platform </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Multiple Phase 1/2 clinical trials in solid tumors ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1042 (DuoBody-CD40x4-1BB, BNT312) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology platform. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and future potential profits for GEN1042 on a 50:50 basis. CD40 and 4-1BB were selected as targets to enhance activation of both dendritic cells and antigen-dependent T-cells. Three clinical trials of GEN1042 in solid tumors are ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN3014 &#8211; HexaBody-based investigational medicine with potential in hematological malignancies</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Antibody targeting CD38, created using Genmab&#8217;s HexaBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial (NCT04824794) in relapsed/refractory multiple myeloma and other hematological malignancies ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed in an exclusive worldwide license and option agreement with Janssen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN3014 (HexaBody-CD38) is a human CD38 monoclonal antibody-based investigational medicine created using Genmab&#8217;s HexaBody technology platform. GEN3014 is a second generation CD38-targeting lgG1 antibody with a hexamerization-enhancing modification. GEN3014 is designed to induce antitumor activity through highly potent complement-dependent cytotoxicity (CDC) and antitumor activity, which is enhanced compared to daratumumab as demonstrated in previously presented preclinical data and is effective at a wider range of target expression levels. In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen to develop and commercialize GEN3014. A Phase 1/2 clinical trial in hematologic malignancies is ongoing and includes a cohort comparing GEN3014 to daratumumab in CD38 monoclonal antibody-na&#239;ve relapsed or refractory multiple myeloma patients.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1047 &#8211; Bispecific antibody with potential in solid tumors</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting CD3 and B7H4, created using Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">(NCT05180474) </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">in malignant solid tumors recruiting </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1047 (DuoBody-CD3xB7H4) is a bispecific antibody-based investigational medicine created using Genmab&#8217;s DuoBody technology platform. B7H4 is a tumor-associated antigen expressed on malignant cells in various solid cancers including breast, ovarian and lung cancer. In preclinical studies, GEN1047 induced T-cell mediated cytotoxicity of B7H4-positive tumor cells. GEN1047 is being developed for the potential treatment of solid cancer indications known to express B7H4. A Phase 1/2 clinical trial of GEN1047 in malignant solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN3017 &#8211; DuoBody-based investigational therapy in the clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting CD3 and CD30, created using Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1 clinical trial (NCT06018129) in relapsed or refractory classical Hodgkin lymphoma and NHL ongoing </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffffff;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 11/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN3017 (DuoBody-CD3xCD30) is a bispecific antibody-based investigational medicine created using Genmab&#8217;s DuoBody technology platform. CD30 is highly expressed in multiple hematologic malignancies, including classical Hodgkin lymphoma and anaplastic large cell lymphoma. In preclinical studies, GEN3017 induced potent T-cell mediated cytotoxicity of CD30-expressing tumor cells, which was associated with induction of CD4+ and CD8+ T-cell activation, proliferation, and cytokine production. GEN3017 is being developed for the potential treatment of certain hematological malignancies. A Phase 1/2 clinical trial of GEN3017 in relapsed or refractory classical Hodgkin lymphoma and NHL is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1059 (BNT314) &#8211; Bispecific antibody with potential in solid tumors</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting EpCAM and 4-1BB, created using Genmab&#8217;s DuoBody technology platform </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial (NCT06150183) in solid tumors recruiting </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1059 (DuoBody-EpCAMx4-1BB, BNT314), jointly owned by Genmab and BioNTech and created using Genmab&#8217;s DuoBody technology platform, is a bispecific antibody aimed at boosting antitumor immune responses through EpCAM-dependent 4-1BB agonistic activity. GEN1059 is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and future potential profits for GEN1059 on a 50:50 basis. A Phase 1/2 clinical trial of GEN1059 in solid tumors is recruiting.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1055 (BNT315) &#8211; HexaBody-based antibody with potential in solid tumors</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Antibody targeting OX40, created using Genmab&#8217;s HexaBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial (NCT06391775) in malignant solid tumors recruiting</font><font style="display:inline-block;width:31.51pt;"></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1055 (HexaBody-OX40, BNT315), jointly owned by Genmab and BioNTech and created using Genmab&#8217;s HexaBody technology platform, is an immune-modulating OX40 agonist antibody designed to promote immunity by enhancing T-cell responses through Fc&#947;R-independent OX40 clustering on T cells. GEN1055 is being co-developed by Genmab and BioNTech under an agreement in which the companies</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">share all costs and future potential profits for GEN1055 on a 50:50 basis. A Phase 1/2 clinical trial of GEN1055 in solid tumors is recruiting.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1160 &#8211; ADC with potential in both solid tumors and hematological malignancies</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">CD70-targeted ADC being evaluated in advanced solid and liquid tumors</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">(NCT05721222) </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">in advanced solid and liquid tumors </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1160 is a CD70-targeted ADC. CD70 is a protein expressed on both solid tumors and hematological malignancies. A Phase 1/2 clinical study of GEN1160 in advanced renal cell carcinoma, nasopharyngeal carcinoma and NHL is recruiting.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1107 &#8211; ADC with potential in solid tumors</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">PTK7-targeted ADC being evaluated in advanced solid tumors</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial (NCT06171789) in advanced solid tumors recruiting </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1107 is a PTK7-targeted ADC. PTK7 is a clinically validated ADC target with broad solid tumor expression, particularly in tumor-initiating cells. A Phase 1/2 clinical study of GEN1107 in advanced solid tumors is recruiting.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 12/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1057 &#8211; Bispecific antibody with potential in solid tumors</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody targeting FAP&#945; and death receptor 4 (DR4), created using Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical trial </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">(NCT06573294) </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">in malignant solid tumors recruiting  </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1057 (DuoBody-FAP&#945;xDR4) is a bispecific antibody-based investigational medicine created using Genmab&#8217;s DuoBody technology platform. GEN1057 is designed for the conditional transactivation of DR4 and thereby induction of apoptosis. A Phase 1/2 clinical trial of GEN1057 in malignant solid tumors is recruiting.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Third Quarter 2024 Update</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">September: The first patient was dosed in the first-in-human Phase 1/2 clinical trial of GEN1057 in solid tumors.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">GEN1056 (BNT322)</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1 clinical trial (NCT05586321) in solid tumors ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffffff;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GEN1056 (BNT322) is an antibody product co-developed by Genmab and BioNTech for the treatment of solid tumors. A first-in-human Phase 1 clinical study of GEN1056 in patients with advanced solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Preclinical Programs</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Broad preclinical pipeline that includes both partnered products and in-house programs based on our proprietary technologies and/or antibodies</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Multiple new Investigational New Drug (IND) applications expected to be submitted over the coming years</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Genmab has entered multiple strategic collaborations to support the expansion of our innovative pipeline</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Our preclinical pipeline includes immune effector function enhanced antibodies developed with our HexaBody technology platform, bispecific antibodies created with our DuoBody technology platform and ADCs created with our ADC technology platforms. We are also collaborating with our partners to generate additional new antibody-based product concepts. A number of the preclinical programs are conducted in cooperation with our collaboration partners.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Third Quarter 2024 Update</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">September: Clinical Trial Application (CTA) submitted in Europe for GEN1078.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Programs Incorporating Genmab&#8217;s Innovation and Technology</b><sup style="font-size:7.5pt;vertical-align:top;">1</sup></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to Genmab&#8217;s own pipeline of investigational medicines, our innovations and proprietary technology platforms are applied in the pipelines of global pharmaceutical and biotechnology companies. These companies are running clinical development programs with antibodies created by Genmab or created using Genmab&#8217;s proprietary DuoBody bispecific antibody technology platform. The programs run from Phase 1 development to approved medicines. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:10pt;">The information in this section includes those therapies that have been approved by regulatory agencies in certain territories. Under the agreements for these medicines Genmab is entitled to certain potential milestones and royalties.</font> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 13/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Approved Medicines</b><sup style="font-size:8.25pt;font-weight:bold;vertical-align:top;">1</sup></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-bottom:2.15pt;padding-top:2.15pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.16%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9.5pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:35.06%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9.5pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:30.76%;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9.5pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">Approved Product</b></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">Discovered and/or Developed &amp; Marketed By</b></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">Disease Indication(s)</b></p></td></tr><tr style="height:20.6pt;"><td rowspan="2" style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">DARZALEX</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(daratumumab)/</font><b style="font-size:9.5pt;font-weight:bold;">DARZALEX </b><font style="font-size:9.5pt;font-style:italic;font-weight:bold;">FASPRO</font><font style="font-size:9.5pt;"> (daratumumab and hyaluronidase-fihj) </font></p></td><td rowspan="2" style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Janssen (Royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Multiple myeloma</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr style="height:20.6pt;"><td style="display:none;vertical-align:middle;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"></td><td style="display:none;vertical-align:middle;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Light-chain (AL) Amyloidosis</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">Kesimpta</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(ofatumumab)</font></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Novartis (Royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;"><font style="font-size:9.5pt;">Relapsing multiple sclerosis (RMS)</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">TEPEZZA</b><font style="font-size:9.5pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(teprotumumab-trbw)</font></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Amgen Inc. (Amgen) (under sublicense from Roche, royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Thyroid eye disease (TED)</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">RYBREVANT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(amivantamab/amivantamab-vmjw)</font></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Janssen (Royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">NSCLC</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">TECVAYLI</b><font style="font-size:9.5pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(teclistamab/teclistamab-cqyv)</font></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Janssen (Royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Relapsed and refractory multiple myeloma</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr><tr><td style="vertical-align:top;width:34.16%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-size:9.5pt;font-weight:bold;">TALVEY </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">(talquetamab/talquetamab-tgvs)</font></p></td><td style="vertical-align:top;width:35.06%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Janssen (Royalties to Genmab on net global sales)</font></p></td><td style="vertical-align:top;width:30.76%;border-bottom:1.0pt solid #029c93;border-top:1.0pt solid #029c93;margin:0pt;padding:2.15pt 5.4pt 2.15pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="font-size:9.5pt;">Relapsed and refractory multiple myeloma</font><sup style="font-size:7.12pt;vertical-align:top;">2</sup></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;margin:0pt;"><sup style="font-family:'Times New Roman','Times','serif';font-size:6pt;vertical-align:top;">1</sup>Approved and investigational medicines created by Genmab or created by collaboration partners leveraging Genmab&#8217;s DuoBody technology platform, under development, and where relevant, commercialized by a third party.<br><sup style="font-size:6pt;vertical-align:top;">2</sup>See local prescribing information for precise indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt;"><font style="font-size:8pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pipeline, Including Further Development for Approved Medicines, &#8805; Phase 2 Development</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#029c93;font-weight:bold;"><img src="gmab-20241106xex99d1006.jpg" alt="Graphic" style="display:inline-block;height:196.9pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;vertical-align:super;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:super;">*</sup><font style="vertical-align:super;">UltiMAb</font><sup style="font-size:6pt;vertical-align:super;"> </sup><font style="vertical-align:super;">transgenic mouse technology licensed from Medarex, a wholly owned subsidiary of Bristol-Myers Squibb.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;vertical-align:super;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 14/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DARZALEX (daratumumab) &#8211; Redefining the treatment of multiple myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First-in-class human CD38 monoclonal antibody</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed and commercialized by Janssen under an exclusive worldwide license from Genmab </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Intravenous (IV) formulation approved in combination with other therapies and as monotherapy for certain multiple myeloma indications </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First and only SC CD38-directed antibody approved for the treatment of certain multiple myeloma indications, known as DARZALEX </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;">FASPRO</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> in the U.S., and DARZALEX SC in Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">SC daratumumab is the first and only approved therapy for AL amyloidosis in the U.S., Europe, and Japan</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Net sales of DARZALEX by Janssen were USD 8,586 million in the first nine months of 2024</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Daratumumab is a human monoclonal antibody that binds with high affinity to the CD38 molecule, which is highly expressed on the surface of multiple myeloma cells and is also expressed by AL amyloidosis plasma cells. Genmab used technology licensed from Medarex to generate the CD38 antibody. Daratumumab is being developed and commercialized by Janssen under an exclusive worldwide license from Genmab. Under the terms of the agreement, Genmab receives royalties between 12% and 20% with Janssen reducing such royalty payments for Genmab&#8217;s share of Janssen&#8217;s royalty payments made to Halozyme; payments are further reduced in countries and territories where there are no relevant patents. Daratumumab (marketed as DARZALEX for IV administration and as DARZALEX <i style="font-style:italic;">FASPRO </i>in the U.S. and as DARZALEX SC in Europe for SC administration) is approved in a large number of territories for the treatment of adult patients with certain multiple myeloma indications and is the only<i style="font-style:italic;"> </i>approved therapy in the U.S., Europe and Japan for the treatment of adult patients with AL amyloidosis. Please consult the <font style="color:#029c93;">European Summary of Product Characteristics</font><font style="color:#029c93;"> </font>for DARZALEX and DARZALEX SC and the U.S. Prescribing Information for <font style="color:#029c93;">DARZALEX</font> and <font style="color:#029c93;">DARZALEX </font><i style="color:#029c93;font-style:italic;">FASPRO</i><b style="color:#0070c0;font-size:13pt;font-weight:bold;"> </b>for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Kesimpta (ofatumumab) &#8211; Approved for the treatment of RMS</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Human CD20 monoclonal antibody developed and commercialized by Novartis under a license agreement with Genmab</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Approved in multiple territories including the U.S., Europe and Japan for the treatment of RMS in adults</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First B-cell therapy that can be self-administered by patients at home using the Sensoready</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> autoinjector pen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Ofatumumab is a human monoclonal antibody that targets an epitope on the CD20 molecule encompassing parts of the small and large extracellular loops. Genmab used technology licensed from Medarex to generate the CD20 antibody. Ofatumumab, marketed as Kesimpta, is approved in territories including the U.S., Europe, and Japan for the treatment of certain adult patients with RMS. Kesimpta is the first B-cell therapy that can be self-administered by patients at home using the Sensoready autoinjector pen, once monthly after starting therapy. Ofatumumab is being developed and marketed worldwide by Novartis under a license agreement between Genmab and Novartis. Under the terms of the agreement, Genmab receives a 10% royalty on net sales of Kesimpta, and Genmab pays a low-single digit royalty to Medarex based on Kesimpta sales. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the <font style="color:#029c93;">European Summary of Product Characteristics</font> for the labeled indication and safety information for Kesimpta. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TEPEZZA (teprotumumab) &#8211; First U.S. FDA-approved medicine for the treatment of TED</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed and commercialized by Amgen for the treatment of TED</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First and only approved medicine for the treatment of TED in the U.S. and Japan</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 15/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Regulatory approval pending in Europe </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Teprotumumab, approved by the U.S. FDA and by Japan&#8217;s Ministry of Health, Labour and Welfare (MHLW) under the trade name TEPEZZA, is a human monoclonal antibody that targets the Insulin-like Growth Factor 1 Receptor (IGF-1R), a validated target. It is the first and only medicine approved in the U.S. and in Japan for the treatment of TED. Genmab used technology licensed from Medarex to generate the IGF-1R antibody. The antibody was created by Genmab under a collaboration with Roche. Development and commercialization of the product was subsequently conducted by Horizon Therapeutics plc (Horizon) under a sublicense from Roche. In October 2023, Amgen completed its acquisition of Horizon, including the rights to all commercialization and development of teprotumumab. Under the terms of Genmab&#8217;s agreement with Roche, Genmab receives a mid-single digit royalty on net sales (as defined) of TEPEZZA. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> for the labeled indication and safety information for TEPEZZA.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">RYBREVANT (amivantamab) &#8211; First regulatory approvals for a DuoBody-based medicine</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Part of Genmab and Janssen DuoBody research and license agreement</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First approved medicine created using Genmab&#8217;s proprietary DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Under the agreement with Janssen, Genmab is eligible to receive milestones and receives royalties on net sales of RYBREVANT</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 4.5pt 11pt 0pt;">In July 2012, and as amended in December 2013, Genmab entered into a collaboration with Janssen to create and develop bispecific antibodies using Genmab&#8217;s DuoBody technology platform. One of these, Janssen&#8217;s amivantamab, is a fully human bispecific antibody that targets epidermal growth factor receptor (EGFR) and cMet, two validated cancer targets. The two antibody libraries used to produce amivantamab were both generated by Genmab. In collaboration with Janssen, the antibody pair used to create amivantamab was co-discovered. Amivantamab, marketed as RYBREVANT, is approved in certain territories for the treatment of certain adult patients with NSCLC. Janssen is responsible for the development and commercialization of amivantamab. Under the agreement with Janssen, Genmab is eligible to receive milestones and receives royalties between 8% and 10% on net sales of RYBREVANT subject to a reduction of such royalty payments in countries and territories where there are no relevant patents, among other reductions. Genmab pays a royalty to Medarex based on RYBREVANT net sales. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the<font style="color:#029c93;"> European Summary of Product Characteristics</font> for RYBREVANT for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TECVAYLI (teclistamab) &#8211; Bispecific antibody approved for the treatment of relapsed and refractory multiple myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Part of Genmab and Janssen DuoBody research and license agreement</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Second approved medicine created using Genmab&#8217;s proprietary DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Under the agreement with Janssen, Genmab is eligible to receive milestones and receives royalties on net sales of TECVAYLI</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In July 2012, and as amended in December 2013, Genmab entered into a collaboration with Janssen to create and develop bispecific antibodies using Genmab&#8217;s DuoBody technology platform. One of the products subsequently discovered and developed by Janssen is teclistamab, a bispecific antibody that targets CD3, which is expressed on T-cells, and B-cell maturation antigen (BCMA), which is expressed in mature B lymphocytes. Teclistamab, marketed as TECVAYLI, is approved in certain territories for the treatment of certain adult patients with relapsed or refractory multiple myeloma. Janssen is responsible for the development and commercialization of TECVAYLI. Under our agreement with Janssen, Genmab is eligible to receive milestones and receives a mid-single digit royalty on net sales of TECVAYLI subject </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 16/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">to a reduction of such royalty payments in countries and territories where there are no relevant patents, among other reductions. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the <font style="color:#029c93;">European Summary of Product Characteristics </font>for TECVAYLI for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TALVEY (talquetamab) &#8211; Bispecific antibody approved for the treatment of relapsed and refractory multiple myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Part of Genmab and Janssen DuoBody research and license agreement</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Fourth approved medicine created using Genmab&#8217;s proprietary DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Under the agreement with Janssen, Genmab is eligible to receive milestones and royalties on net sales of TALVEY</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In July 2012, and as amended in December 2013, Genmab entered into a collaboration with Janssen to create and develop bispecific antibodies using Genmab&#8217;s DuoBody technology platform. One of the products subsequently discovered and developed by Janssen is talquetamab, a bispecific antibody that targets CD3, which is expressed on T-cells, and G protein-coupled receptor, family C, group 5, member D (GPRC5D), an orphan receptor expressed in malignant plasma cells. Talquetamab, marketed as TALVEY, is approved in certain territories for the treatment of certain adult patients with relapsed or refractory multiple myeloma. Janssen is responsible for the development and commercialization of TALVEY. Under our agreement with Janssen, Genmab is eligible to receive milestones and receives a mid-single digit royalty on net sales of TALVEY subject to a reduction of such royalty payments in countries and territories where there are no relevant patents, among other reductions. Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the <font style="color:#029c93;">European Summary of Product Characteristics </font>for TALVEY for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_SIGNIFICANT_RISKS_AND"></a></b><b style="color:#029c93;font-weight:bold;">SIGNIFICANT RISKS AND UNCERTAINTIES</b><b style="font-size:16pt;font-weight:bold;"><a name="SIGNIFICANTRISKSANDUNCERTAINTIES_402181"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As a biotech company, Genmab faces a number of risks and uncertainties. These are common for the industry and relate to operations, intellectual property, research and development, commercialization, and financial activities. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">With the acquisition of ProfoundBio, Genmab has an increased operating presence in China. This increased presence subjects Genmab to risks specific to conducting business in China such as being subject to changes in the political, economic and tax policies of the Chinese government or in relationships between China and Denmark, the United States or other governments. In addition, the Chinese government has discretion and oversight over the conduct of the business operations of Genmab&#8217;s Chinese subsidiaries. Genmab mitigates these risks through the monitoring of the activities of our Chinese subsidiaries as well as geopolitical activities as they pertain to our global operations.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For further information about risks and uncertainties that Genmab faces, refer to the 2023 Annual Report filed with the Nasdaq Copenhagen and the Form 20-F filed with the U.S. SEC, both of which were filed in February 2024. At the date of this interim report, there have been no significant changes to Genmab&#8217;s overall risk profile since the publication of these reports, other than those additional risks in regard to our Chinese subsidiaries stated above. See Genmab&#8217;s Form 20-F for a detailed summary of risks related to our collaborations. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 17/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="OLE_LINK15"></a><a name="OLE_LINK16"></a></b><b style="color:#029c93;font-weight:bold;">FINANCIAL REVIEW</b><b style="font-size:16pt;font-weight:bold;"><a name="FINANCIALREVIEW_601130"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK6"></a><a name="OLE_LINK7"></a>The interim report is prepared on a consolidated basis for Genmab A/S (parent company) and its subsidiaries. The Genmab financial statements are published in Danish Kroner (DKK). The Genmab consolidated Group is referenced herein as &#8220;Genmab&#8221; or the &#8220;Company&#8221;. On May 21, 2024 (Acquisition Date), Genmab completed the previously announced acquisition of all of the outstanding shares of ProfoundBio, resulting in ProfoundBio becoming a wholly-owned subsidiary of Genmab. From the Acquisition Date through the third quarter of 2024, ProfoundBio&#8217;s financial results have been incorporated into Genmab&#8217;s Condensed Consolidated Financial Statements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s revenue was DKK 15,085 million for the first nine months of 2024 compared to DKK 11,715 million for the first nine months of 2023. The increase of DKK 3,370 million, or 29%, was primarily <a name="_Hlk117601415"></a>driven by higher DARZALEX and Kesimpta royalties achieved under our collaborations with Janssen and Novartis, respectively, and increased EPKINLY net product sales, partly offset by milestones achieved under our collaboration with Janssen in the first nine months of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:5.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;width:26.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:26.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:26.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:26.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,694</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,836</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,367</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,722</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 267</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 306</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 835</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 789</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 347</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 797</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Collaboration revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 105</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 78</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 311</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 218</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net product sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 471</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 150</font></p></td><td style="vertical-align:bottom;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,225</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 189</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,540</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,712</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15,085</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,715</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Royalties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue amounted to DKK 12,367 million in the first nine months of 2024 compared to DKK 9,722 million in the first nine months of 2023. The increase of DKK 2,645 million, or 27%, was <a name="_Hlk117601480"></a>primarily driven by higher DARZALEX and Kesimpta royalties achieved under our daratumumab collaboration with Janssen and ofatumumab collaboration with Novartis. The table below summarizes Genmab&#8217;s royalty revenue by product.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:13.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:13.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:5.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:13.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:13.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:27.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:27.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:27.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:27.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:13.05%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:13.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:13.05%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:13.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">DARZALEX </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,787</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,145</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,899</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,000</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Kesimpta </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 569</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 449</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,559</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,049</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">TEPEZZA </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 198</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 180</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 539</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 516</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 140</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 370</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 157</font></p></td></tr><tr><td style="vertical-align:bottom;width:38.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total royalties</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,694</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,836</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.05%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,367</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,722</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk164328790"></a>Net sales of DARZALEX by Janssen were USD 8,586 million in the first nine months of 2024 compared to USD 7,194 million in the first nine months of 2023. The increase of USD 1,392 million, or 19%, was driven by market share gains in all regions. Royalty revenue on net sales of DARZALEX<sup style="font-size:7.5pt;vertical-align:top;"> </sup>was DKK 9,899 million in the first nine months of 2024 compared to DKK 8,000 million in the first nine months of 2023, an increase of DKK 1,899 million. The percentage increase in royalties of 24% is higher than the percentage increase in the underlying net sales primarily due to a higher effective royalty rate.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 18/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of Kesimpta by Novartis were USD 2,274 million in the first nine months of 2024 compared to USD 1,530 million in the first nine months of 2023. The increase of USD 744 million, or 49%, was primarily driven by increased demand and strong access. Royalty revenue on net sales of Kesimpta was DKK 1,559 million in the first nine months of 2024 compared to DKK 1,049 million in the first nine months of 2023, an increase of DKK 510 million, or 49%. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of TEPEZZA by Amgen were USD 1,391 million in the first nine months of 2024 compared to USD 1,304 million in the first nine months of 2023. Royalty revenue on net sales of TEPEZZA was DKK 539 million in the first nine months of 2024 compared to DKK 516 million in the first nine months of 2023, an increase of DKK 23 million, or 4%.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other royalties consist of royalties from net sales of RYBREVANT, TECVAYLI, TALVEY and TEPKINLY. These royalties were not material for the first nine months of 2024 or 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk109307336"></a>Royalty revenue fluctuations from period to period are driven by the level of product net sales, foreign currency exchange rate movements and more specifically to DARZALEX, the contractual arrangement related to annual Currency Hedge Rate, Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with SC product net sales and the level of royalty deductions on net sales in countries and territories where there is no patent protection.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reimbursement Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Reimbursement revenue amounted to DKK 835 million in the nine months of 2024 compared to DKK 789 million in the first nine months of 2023. The increase of DKK 46 million, or 6%, was <a name="_Hlk117601660"></a>primarily driven by higher activities under our collaboration agreement with Pfizer for the global development of Tivdak.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Milestone Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk14190762"></a>Milestone revenue was DKK 347 million in the first nine months of 2024 compared to DKK 797 million in the first nine months of 2023, a decrease of DKK 450 million, or 56%, primarily driven by milestones of DKK 446 million achieved under our Janssen DuoBody collaboration in 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Milestone revenue may fluctuate significantly from period to period due to both the timing of achievements and the varying amount of each individual milestone under our license and collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Collaboration Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Collaboration revenue was DKK 311 million in the first nine months of 2024 compared to DKK 218 million in the first nine months of 2023, an increase of DKK 93 million, or 43%, primarily driven by an increase in net sales of Tivdak. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net Product Sales</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background:#ffffff;">Global net sales of EPKINLY/TEPKINLY were USD 203 million in the first nine months of 2024. </font>Net product sales in the U.S. and Japan by Genmab were DKK 1,225 million in the first nine months of 2024 compared to DKK 189 million in the first nine months of 2023. EPKINLY was approved in the U.S. in May 2023 and in Japan in September 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of TEPKINLY in territories where Genmab receives royalty revenue were USD 24 million in the first nine months of 2024, with no net sales in the first nine months of 2023 due to regulatory approvals in such territories not occurring until late 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 19/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 3 in this interim report for further details about revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Revenue &#8211; Third Quarter of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background:#ffffff;">Global net sales of EPKINLY/TEPKINLY were USD 82 million in the third quarter of 2024. </font>Genmab&#8217;s revenue was DKK 5,540 million for the third quarter of 2024 compared to DKK 4,712 million for the third quarter of 2023. The increase of DKK 828 million, or 18%, was primarily driven by higher DARZALEX and Kesimpta royalties achieved under our collaborations with Janssen and Novartis, respectively, and increased EPKINLY net product sales, partly offset by milestones achieved under our collaboration with Janssen in the third quarter of 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Cost of Product Sales</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab recognized cost of product sales of DKK 648 million in the first nine months of 2024 compared to DKK 100 million in the first nine months of 2023. <a name="_Hlk149042760"></a>Cost of product sales related to EPKINLY sales is primarily comprised of profit-sharing amounts payable to AbbVie of DKK 580 million as well as product costs. EPKINLY was approved in the U.S. in May 2023 and in Japan in September 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Cost of Product Sales &#8211; Third Quarter of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Cost of product sales were DKK 273 million for the third quarter of 2024 compared to DKK 79 million for the third quarter of 2023. Cost of product sales related to EPKINLY sales is primarily comprised of profit-sharing amounts payable to AbbVie of DKK 228 million for the quarter, as well as product costs. EPKINLY was approved in the U.S. in May 2023 and in Japan in September 2023.  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Research and Development Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses amounted to DKK 7,084 million in the first nine months of 2024 compared to DKK 5,682 million in the first nine months of 2023. The increase of DKK 1,402 million, or 25%, <a name="_Hlk148641127"></a>was driven by the increased and accelerated advancement of Epcoritamab under our collaboration with AbbVie, the addition of ProfoundBio related research and development expenses, primarily Rina-S, and the increase in team members to support the continued expansion of our product portfolio.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses accounted for 74% of total research and development expenses &amp; selling, general and administrative expenses in the first nine months of 2024 compared to 71% in the first nine months of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Research and Development Expenses &#8211; Third Quarter of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses were DKK 2,283 million for the third quarter of 2024 compared to DKK 2,088 million for the third quarter of 2023. The increase of DKK 195 million, or 9%, was primarily driven by the addition of ProfoundBio related research and development expenses, primarily Rina-S, further progression of pipeline products, and the increase in team members to support the continued expansion of our product portfolio.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Selling, General and Administrative Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses were DKK 2,541 million in the first nine months of 2024 compared to DKK 2,363 million in the first nine months of 2023. The increase of DKK 178 million, or 8%, was <a name="_Hlk117601923"></a>driven by the expansion of Genmab&#8217;s commercialization capabilities. Selling, General and Administration expense growth has been moderating during 2024 reflecting a focus on driving efficiency. We continue to increase team members and commercial support in a strategic manner.&#160;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses accounted for 26% of total research and development expenses &amp; selling, general and administrative expenses in the first nine months of 2024 compared to 29% for the first nine months of 2023.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 20/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Selling, General and Administrative Expenses &#8211; Third Quarter of 2024</b> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses were DKK 865 million for the third quarter of 2024 compared to DKK 860 million for the third quarter of 2023. The increase of DKK 5 million, or 1%, was driven by Genmab&#8217;s increasing commercialization capabilities, which slowed during 2024 as commercial capabilities have now been scaled commensurate with current operations. We continue to increase team members and commercial support in a strategic manner.&#160;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Acquisition and Integration Related Charges</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Acquisition and integration related charges for the acquisition of ProfoundBio were DKK 269 million in the first nine months of 2024.  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Acquisition and Integration Related Charges &#8211; Third Quarter of 2024</b> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Acquisition and integration related charges for the acquisition of ProfoundBio were DKK 17 million for the third quarter of 2024. There were no acquisition and integration related charges for the third quarter of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Profit </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Operating profit was DKK 4,543 million in the first nine months of 2024 compared to DKK 3,570 million in the first nine months of 2023. Operating profit was DKK 2,102 million for the third quarter of 2024 compared to DKK 1,685 million for the third quarter of 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Financial Items</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net financial items include the following:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 162</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 244</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 771</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 672</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gain on marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 144</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 109</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 352</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 357</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gain on other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 130</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 68</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign exchange rate gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 850</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 968</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 850</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 315</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,209</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,221</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,947</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (18)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (66)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (49)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss on marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (40)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (119)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (199)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss on other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (39)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (108)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (64)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign exchange rate loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (670)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (136)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (909)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (575)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (698)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (224)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,202)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (887)</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.91%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (383)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 985</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,060</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interest Income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Interest income was DKK 771 million in the first nine months of 2024 compared to DKK 672 million in the first nine months of 2023. The increase of DKK 99 million was primarily driven by higher average cash and cash equivalents and marketable securities, as well as higher interest rates on USD denominated marketable securities in the first nine months of 2024 compared to the first nine months of 2023.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 21/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Foreign Exchange Rate Gains and Losses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Foreign exchange rate gain, net was DKK 59 million, comprised of DKK 968 million foreign exchange rate gains, offset by DKK 909 million foreign exchange rate losses in the first nine months of 2024 compared to foreign exchange rate gain, net of DKK 275 million in the first nine months of 2023. The USD weakened against the DKK in the first nine months of 2024, negatively impacting our USD denominated securities and cash holdings. The USD strengthened against the DKK in the first nine months of 2023, positively impacting our USD denominated securities and cash holdings.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:12.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">USD/DKK Foreign Exchange Rates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.6595</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.7447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7.0390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.9722</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">% (Decrease)/increase from prior year-end</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">(1.3)%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1.0%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 6 in this interim report for further details about the net financial items.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Net Financial Items &#8211; Third Quarter of 2024 </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Foreign Exchange Rate Gains and Losses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Foreign exchange rate loss was DKK 670 million in the third quarter of 2024 compared to the foreign exchange rate gain, net of DKK 714 million in the third quarter of 2023. The USD weakened against the DKK in the third quarter of 2024, negatively impacting our USD denominated securities and cash holdings. The USD strengthened against the DKK in the third quarter of 2023, positively impacting our USD denominated securities and cash holdings.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interest Income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest Income was DKK 162 million for the third quarter of 2024 compared to DKK 244 million for the third quarter of 2023. The decrease of DKK 82 million was primarily driven by lower cash and cash equivalents and marketable securities in the third quarter of 2024 as a result of the ProfoundBio acquisition, compared to the third quarter of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk180146370"></a><b style="color:#029c93;font-weight:bold;">Corporate Tax</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax expense for the first nine months of 2024 was DKK 1,563 million compared to DKK 981 million for the first nine months of 2023. The increase in corporate tax expense is primarily the result of Genmab&#8217;s higher net profit before tax and an increase in the estimated annual effective tax rate in the first nine months of 2024 to 28.1% from 21.2% in the first nine months of 2023. The increase in Genmab&#8217;s effective tax rate was mainly driven by the increase in the deferred provision attributable to losses in relation to EPKINLY commercial expenses in the U.S. and ProfoundBio operational losses in the U.S. for which tax benefit cannot be recognized. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">With the acquisition of ProfoundBio, Genmab is currently evaluating the integration of ProfoundBio operations from a tax perspective. As a result,&#160;Genmab&#8217;s effective tax rate may experience some volatility as integration activities progress, but is anticipated to normalize within the next 12-18 months.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Developments to Corporate Tax &#8211; Third Quarter of 2024 </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax expense for the third quarter of 2024 was DKK 453 million compared to DKK 566 million for the third quarter of 2023. The decrease in corporate tax expense is primarily the result of Genmab&#8217;s lower net profit before tax and an increase in the estimated annual effective tax rate, driven by an increase in </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 22/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">the deferred provision attributable to nondeductible losses in relation to EPKINLY commercial expenses in the U.S. and ProfoundBio operational losses in the U.S.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Profit </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net profit for the first nine months of 2024 was DKK 3,999 million compared to DKK 3,649 million in the first nine months of 2023. The increase was driven by the items described above. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Liquidity and Capital Resources</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,976</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13,268</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,867</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31,922</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31,656</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:10.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:9.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:14.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;width:40.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;width:40.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash Flow (DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:10.25%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,059</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,708</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (649)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9,989)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (840)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9,149)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,922)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (584)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,338)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Increase (decrease) in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (8,852)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,284</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (13,136)</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exchange Rate adjustments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.25%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 327</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 96</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 231</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk117601987"></a>Net cash provided by operating activities is primarily related to our operating profit, changes in operating assets and liabilities, reversal of net financial items, and adjustments related to non-cash transactions<font style="white-space:pre-wrap;">. The DKK 649 million decrease in net cash provided by operating activities is primarily driven by  </font>significant AbbVie milestones achieved in 2022 with related cash received during the first nine months of 2023. This impact was offset by an increase in net profit before tax of DKK 932 million, an increase in non-cash transactions of DKK 243 million and an increase in interest received of DKK 145 million in the first nine months of 2024 compared to the first nine months of 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in investing activities primarily reflects cash used in making acquisitions, differences between the proceeds received from the sale and maturity of our investments and amounts invested, and the cash paid for investments in tangible and intangible assets. The DKK 9,149 million increase in net cash used in investing activities is primarily driven by the acquisition of ProfoundBio, partly offset by the sales and maturities of marketable securities exceeding purchases in the first nine months of 2024, compared to purchases exceeding sales and maturities in the first nine months of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in financing activities is primarily related to the purchase of treasury shares, exercise of warrants, lease payments, and payment of withholding taxes on behalf of employees on net settled Restricted Stock Units (RSUs). The DKK 3,338 million increase in net cash used in financing activities between the periods is primarily driven by higher purchases of treasury shares of DKK 3,879 million in the first nine months of 2024 related to the share buy-back programs initiated in March 2024 and completed in June 2024 compared to DKK 564 million in the first nine months of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s USD denominated marketable securities represented 76% of Genmab&#8217;s total marketable securities as of September 30, 2024, compared to 81% as of December 31, 2023. The decrease was </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 23/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">primarily attributable to the liquidation of USD denominated marketable securities to fund the acquisition of ProfoundBio and the purchase of treasury shares.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cash and cash equivalents included short-term marketable securities of DKK 285 million as of September 30, 2024, compared to DKK 1,353 million as of December 31, 2023. In accordance with our accounting policy, securities purchased with a maturity of less than ninety days at the date of acquisition are classified as cash and cash equivalents. Refer to Financial Statement Note 5 in this interim report for further details about our marketable securities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Balance Sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2024, total assets were DKK 39,660 million compared to DKK 35,335 million on December 31, 2023. As of September 30, 2024, assets were mainly comprised of intangible assets of DKK 11,504 million, primarily made up of intangible assets acquired in the ProfoundBio acquisition, marketable securities of DKK 10,976 million, current receivables of DKK 6,310 million, cash and cash equivalents of DKK 6,342 million and DKK 2,407 million of goodwill related to the acquisition of ProfoundBio. The current receivables consist primarily of amounts related to royalties from our collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2024, total liabilities were DKK 7,738 million compared to DKK 3,679 million on December 31, 2023. The increase in total liabilities of DKK 4,059 million <a name="_Hlk117602057"></a>was <font style="background:#ffffff;">primarily driven by the DKK 1,994 million deferred tax liability assumed in the acquisition of ProfoundBio,</font> <font style="background:#ffffff;">an increase of DKK 1,219 million in corporate taxes payable due to Genmab&#8217;s net profit before tax and increase in Genmab&#8217;s effective tax rate, an increase of approximately DKK 500 million in accruals related to the expansion of our product pipeline, and </font>an increase in lease liabilities of DKK 217 million driven by the commencement of a lease in the U.S. with respect to office and laboratory space.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Shareholders&#8217; equity as of September 30, 2024, was DKK 31,922 million compared to DKK 31,656 million on December 31, 2023. The increase of DKK 266 million, or 1%, was primarily driven by Genmab&#8217;s net profit for the period and share-based compensation expenses, partly offset by the purchase of treasury shares. The decrease in Genmab&#8217;s equity ratio, which was 80% as of September 30, 2024, compared to 90% as of December 31, 2023, <font style="background:#ffffff;">was primarily attributable to assets acquired in the acquisition of ProfoundBio, net of cash paid, in addition to the share buy-back completed in June 2024 that offset Genmab&#8217;s net profit for the period.</font><font style="background:#ffffff;">&#160;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:126.1pt;"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Team Members</b></font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2024, the total number of team members was 2,635 compared to 2,132 as of September 30, 2023. The increase was primarily driven by the expansion and acceleration of our pipeline, as well as the investment in the expansion of Genmab&#8217;s commercialization capabilities, including support for EPKINLY in the U.S. and Japan post launch activities, and broader organizational capabilities and the acquisition of ProfoundBio.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:21.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:20.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:45.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:51.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:45.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Team Members</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:21.72%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:20.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development team members</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,853</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,484</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative team members</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 782</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 648</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total team members</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,635</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,132</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Legal Matters </b></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 24/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Janssen Binding Arbitrations </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk117603397"></a><a name="_Hlk117601217"></a>In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen relating to daratumumab. In April 2022, the arbitral tribunal issued an award in the binding arbitration of the two matters in favor of Janssen. Genmab did not seek a review of the award, and the award is final.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On June 9, 2022, Genmab announced the commencement of a second arbitration under the daratumumab license agreement with Janssen with claims for milestone payments for daratumumab SC of USD 405 million and a separate 13-year royalty term for daratumumab SC on a country-by-country basis, from the date of the first commercial sale of daratumumab SC in each such country. This second arbitration followed from the award in the prior arbitration, where the tribunal ruled in favor of Janssen on the question as to whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme for its technology used in the daratumumab SC product. The tribunal based its ruling on the finding that DARZALEX <i style="font-style:italic;">FASPRO</i> constitutes a new licensed product under the license agreement. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On April 21, 2023, the arbitral tribunal dismissed Genmab&#8217;s claims regarding the second arbitration, on the basis that these claims should have been brought in the first arbitration. One arbitrator dissented. Genmab filed a request for review of the award, which was denied on January 23, 2024.  As a result, the dismissal of Genmab&#8217;s claims in the second arbitration is now final.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Chugai Patent Infringement Complaint  </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">In June 2024, Chugai Pharmaceutical Co., Ltd. filed a lawsuit in the Tokyo District Court, Japan against AbbVie&#8217;s and Genmab&#8217;s subsidiaries in Japan asserting that their activities with EPKINLY (epcoritamab) in Japan infringe two Japanese patents held by Chugai, JP6278598 and JP6773929. Chugai is claiming damages and injunctive relief.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab<font style="font-size:11pt;"> </font>and AbbVie believe that the two Japanese patents are invalid and not infringed and intend to vigorously defend against the lawsuit, and thus no provision has been recorded related to this matter.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 25/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="CondensedConsolidatedStatementsofCompInc"></a><b style="color:#029c93;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,540</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,712</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,085</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,715</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cost of product sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (273)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (79)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (648)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (100)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,283)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,088)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (7,084)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (5,682)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (865)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (860)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,541)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,363)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Acquisition and integration related charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (17)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (269)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total costs and operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (3,438)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (3,027)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (10,542)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (8,145)</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Operating profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,102</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,685</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,543</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,570</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 315</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,209</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,221</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,947</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (698)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (224)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,202)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (887)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net profit before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,719</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,670</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,562</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,630</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Corporate tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (453)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (566)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,563)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (981)</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net profit</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,266</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,104</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,999</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,649</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Other comprehensive income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Amounts which may be re-classified to the income statement:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Exchange differences on translation of foreign operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (580)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (406)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 44</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 686</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,134</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,593</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,693</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Basic net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19.94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 55.88</font></p></td></tr><tr><td style="vertical-align:bottom;width:41.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Diluted net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19.81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31.94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 55.40</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514648"></a><a name="_MON_1411968110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 26/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="FIRSTNINEMONTHSOF2019_377366"></a><b style="color:#029c93;font-weight:bold;">CONDENSED </b><b style="color:#029c93;font-weight:bold;">CONSOLIDATED BALANCE SHEET</b><a name="BALANCESHEET_757698"></a><b style="color:#029c93;font-weight:bold;">S</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,504</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 147</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,407</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 911</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 955</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 890</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 686</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 60</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 212</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 189</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 134</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15,961</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,196</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 57</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,310</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,947</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,976</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13,268</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,867</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 23,699</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 33,139</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 39,660</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 35,335</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">SHAREHOLDERS&#8217; EQUITY AND LIABILITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,579</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,461</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (346)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 60</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19,623</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19,069</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 31,922</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 31,656</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 896</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 680</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 466</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 480</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,762</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 29</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,153</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,195</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,273</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;background:#00ff00;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 54</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 91</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 33</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,182</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,307</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,585</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,484</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,738</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,679</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 39,660</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 35,335</b></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Contingency</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:45.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Subsequent events to the balance sheet date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1411968448"></a><a name="_MON_1428926110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 27/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:16.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:36.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:36.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net profit before tax</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,562</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,630</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Financial income</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,221)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,947)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Financial expenses</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,202</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 887</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Adjustments for non-cash transactions</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Share-based compensation expense</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 535</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 433</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Depreciation</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 247</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 196</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Amortization</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 51</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Impairment charges</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 80</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Change in operating assets and liabilities, excluding the effect of acquisitions:</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Receivables</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,334)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 730</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Inventories</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (13)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (70)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Other payables</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 553</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 625</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flows from operating activities before financial items</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,662</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,525</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest received</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 757</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 612</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest elements of lease payments</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">9</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (25)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (18)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Corporate taxes paid</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (335)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (411)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash provided by operating activities</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,059</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,708</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Acquisition of business, net of cash acquired</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (12,246)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> &#8212;</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Investment in intangible assets</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (93)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (299)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities bought</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (7,128)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8,382)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities sold</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,524</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,868</font></p></td></tr><tr><td style="vertical-align:middle;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments bought</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (36)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (17)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash (used in) investing activities</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (9,989)</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (840)</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Warrants exercised</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 118</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 143</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Principal elements of lease payments</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (60)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (66)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,879)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (564)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Payment of withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (101)</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (97)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash (used in) financing activities</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (3,922)</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (584)</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Change in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (8,852)</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,284</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,867</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,893</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Exchange rate adjustments</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 327</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 96</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 6,342</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,273</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents include:</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Bank deposits</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,057</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,273</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Short-term marketable securities</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 285</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:16.88%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 6,342</b></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,273</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:3pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 28/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCHANGESINEQUITY_43137"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shareholders&#39;</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">reserves</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equity</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 98</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,855</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 27,328</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,649</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,649</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 44</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 44</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 44</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,649</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,693</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 143</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 143</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (564)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (564)</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 433</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 433</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (97)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (97)</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at September 30, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,452</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 142</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 18,276</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 30,936</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,461</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 60</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,069</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 31,656</b></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,999</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,999</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (406)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (406)</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (406)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,999</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,593</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 118</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 118</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,879)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,879)</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 535</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 535</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (101)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (101)</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:30.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at September 30, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:3.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,579</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (346)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,623</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 31,922</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 29/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b><b style="font-size:16pt;font-weight:bold;"><a name="NOTESTOTHEFINANCIALSTATEMENTS_435403"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 1 &#8211; Basis of Presentation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Accounting Policies</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">These interim statements of the Genmab Group (Genmab or the Company) have been prepared in accordance with IAS 34 (Interim Financial Reporting) as issued by the International Accounting Standards Board (IASB) and in accordance with IAS 34 as endorsed by the EU and additional Danish disclosure requirements for interim reports of listed companies. The interim report has not been audited by Genmab&#8217;s external auditors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The interim report has been prepared using the same accounting policies as outlined in Section 1 &#8211; Basis of Presentation in the financial statements in the Genmab 2023 Annual Report (Annual Report). A number of amended standards became applicable for the current reporting period. There was no impact to Genmab&#8217;s financial statements as a result of adopting these amended standards. These interim financial statements should be read in conjunction with the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The below accounting policies have been implemented upon Genmab completing the acquisition of ProfoundBio, Inc. (ProfoundBio) on May 21, 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_heading=h.1fob9te"></a><b style="color:#029c93;font-weight:bold;">Business Combinations</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The acquisition method of accounting is used to account for all acquisitions where the target company meets the definition of a business in accordance with IFRS&#160; 3 (Business Combinations). The purchase price for a business is comprised of the fair value of the assets transferred and liabilities owned to the former owners, including option holders, of the acquired business and the fair value of any asset or liability resulting from a contingent consideration arrangement. Any amount of the purchase price which effectively comprises a settlement of a pre-existing relationship is not part of the exchange for the acquiree and is therefore not included in the consideration for the purpose of applying the acquisition method. Settlements of pre-existing relationships are accounted for as separate transactions in accordance with the relevant IFRS standards. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Identifiable assets and liabilities and contingent liabilities assumed are measured at fair value on the date of acquisition by applying relevant valuation methods. Goodwill is recognized as the excess of purchase price over the fair value of net identifiable assets acquired and liabilities assumed. Acquisition-related charges are expensed as incurred and included in Acquisition and integration related charges.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Other Intangible Assets</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Definite-Lived and IPR&amp;D Intangible Assets</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Intangible assets acquired in a business combination are recognized at fair value at the acquisition date. Intangible assets with definite useful lives are amortized based on the straight-line method over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Amortization commences for in-process research and development (IPR&amp;D) intangible assets after regulatory approval has been obtained or when assets are put in use. IPR&amp;D intangible assets are tested for impairment at least annually or when a triggering event occurs that could indicate a potential impairment. Impairments of intangible assets are reviewed at each reporting date for possible reversal.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 30/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Goodwill</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Goodwill represents the excess of purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing. Goodwill is allocated to each of the group&#8217;s cash-generating units (or groups of cash-generating units) expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that the fair value of net assets in a cash-generating unit are below their carrying amounts. Quantitative goodwill impairment tests are based on management&#8217;s projections and the anticipated net present value of estimated future cash flows from marketable products. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">If the carrying amount of goodwill exceeds the recoverable amount, which is determined based on discounted projected cash flows, any impairment is measured as the difference between those discounted projected cash flows and the carrying amount. Impairments of goodwill are prohibited from future reversals.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Management Judgements and Estimates under IFRS Accounting Standards</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In preparing interim reports, certain provisions under IFRS Accounting Standards (IFRS) require management to make judgements (various accounting estimates and assumptions), which may significantly impact Genmab&#8217;s financial statements. The interim report has been prepared using the same judgments and estimates as outlined in Section 1 &#8211; Basis of Presentation in the financial statements in the Annual Report. For a description of significant judgements and estimates, refer to Note 1.3 in the Annual Report. Additionally, upon Genmab completing the acquisition of ProfoundBio on May 21, 2024, management has determined that the below estimates related to intangible assets are an area that require significant judgement. Refer below for further information on the key accounting estimates related to the valuation of intangible assets utilized in preparation of the condensed consolidated financial statements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Fair Value of Intangible Assets in a Business Combination</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The application of the acquisition method involves the use of significant estimates because the identifiable net assets of the acquiree are recognized at their fair values for which observable market prices are typically not available. This is particularly relevant for intangible assets which require use of valuation techniques typically based on estimates of present value of future uncertain cash flows. The significant assumptions used to estimate the value of the acquired intangible assets include discount rates and certain assumptions that form the basis of future cash flows (such as probabilities of technical and commercial success, revenue growth rates, operating margins, and royalty rates).&#160;<font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Impairment Assessment of Intangible Assets and Goodwill</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">If circumstances or changes in Genmab&#8217;s operations indicate that the carrying amount of intangible assets, including goodwill, may not be recoverable, management reviews the asset for impairment. The basis for the review is the recoverable amount of the intangible asset, determined as the greater of the fair value less cost to sell or its value in use. Value in use is calculated as the net present value of future cash inflow estimated to be generated from the intangible asset. If the carrying amount of an intangible asset is greater than the recoverable amount, the intangible asset is written down to the recoverable amount. An impairment loss is recognized in the income statement when the impairment is identified. Impairments on intangible assets (excluding goodwill) are reviewed at each reporting date for possible reversal.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 31/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Factors considered material that could trigger an impairment test include the following:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Development of a competing drug </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Realized sales trending below predicted sales </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Inconsistent or unfavorable clinical readouts </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Changes in the legal framework covering patents, rights and licenses </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Advances in medicine and/or technology that affect the medical treatments </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Adverse impact on reputation and/or brand names </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8226; Relationship to other intangible assets or property, plant and equipment </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Impairments of intangible assets are recognized in the Condensed Consolidated Income Statements as research and development expenses.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Information about Geographical Areas</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is managed and operated as one business unit, which is reflected in the organizational structure and internal reporting. No separate lines of business or separate business entities have been identified with respect to any licensed products, product candidates, product sales or geographical markets and no segment information is currently prepared for internal reporting. Refer to Note 2.2 in the Annual Report for further details.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reclassifications and Revisions</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">To facilitate comparison of information across periods, certain immaterial reclassifications and revisions have been made to prior period amounts to conform to the current period&#8217;s presentation. Refer to Note 1.4 in the Annual Report for further details.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 2 &#8211; Acquisition of Businesses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On May 21, 2024 (Acquisition Date), Genmab completed the previously announced acquisition of all of the outstanding shares of ProfoundBio, resulting in ProfoundBio becoming a wholly-owned subsidiary of Genmab. The acquisition of ProfoundBio gave Genmab worldwide rights to three candidates in clinical development, including ProfoundBio&#8217;s lead drug candidate, rinatabart sesutecan (Rina-S). In addition, Genmab acquired ProfoundBio&#8217;s novel ADC technology platforms. Rina-S is a clinical-stage, FR&#945;-targeted, TOPO1 ADC, currently in Phase 2 of a Phase 1/2 clinical trial, for the treatment of ovarian cancer and other FR&#945;-expressing solid tumors. Based on the data from the ongoing Phase 1/2 clinical trial Genmab intends to broaden the development plans for Rina-S within ovarian cancer and other FR&#945;-expressing solid tumors. In January 2024, the U.S. FDA granted Fast Track designation to Rina-S for the treatment of patients with FR&#945;-expressing high-grade serous or endometrioid platinum-resistant ovarian cancer.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to payment of USD 1.72 billion (DKK 11.80 billion) for all of the outstanding shares of ProfoundBio, Genmab also made a USD 199 million (DKK 1,368 million) payment to holders of outstanding ProfoundBio equity awards for settlement of such vested and non-vested awards. Of the USD 199 million (DKK 1,368 million) payment, USD 187 million (DKK 1,289 million) related to the portion of awards where the vesting period was completed prior to the Acquisition Date. This portion of the payment was therefore determined to be attributable to the pre-combination period and included in purchase consideration. The remaining USD 11 million (DKK 79 million) payment related to the portion of awards with future vesting conditions, and therefore is attributable to post-combination services. The amount attributable to the post-combination service does not form part of the consideration and was therefore instead recognized as Acquisition and integration related charges in Genmab&#8217;s Condensed Consolidated Statements of Comprehensive Income during the second quarter of 2024.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 32/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The acquisition has been accounted for using the acquisition method of accounting which requires that assets acquired and liabilities assumed be recognized at their fair values as of the Acquisition Date and consolidated into Genmab&#8217;s Condensed Consolidated Balance Sheets. The results of operations for ProfoundBio have been included in Genmab&#8217;s condensed consolidated financial statements from the Acquisition Date. A fair value measurement has been performed and the purchase price has been allocated to intangible assets, associated deferred tax liabilities, other assets and liabilities, as well as goodwill being the excess value of the purchase price over the fair value of assets acquired and liabilities assumed (the purchase price allocation). The purchase price allocation is considered provisional due to uncertainty on key assumptions which require detailed analysis which has not been possible to conclude as of September 30, 2024. Adjustments may be applied to the purchase price allocation for a period of up to 12 months from the Acquisition Date. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The total consideration for the acquisition of ProfoundBio is summarized as follows:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:25.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:middle;width:53.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Consideration</b>&#160;&#160;</p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amounts in USD millions</b></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amounts in DKK millions</b></p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash paid for outstanding shares</p></td><td style="vertical-align:middle;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,718</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,798</font></p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash for equity compensation attributable to pre-combination service</p></td><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 187</font></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,289</font></p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total consideration</b></p></td><td style="vertical-align:middle;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,905</b></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 13,087</b></p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash acquired</p></td><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (122)</font></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (841)</font></p></td></tr><tr><td style="vertical-align:middle;width:46.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash used for acquisition of business</b></p></td><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,783</b></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,246</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the Acquisition Date based upon their respective fair values summarized below:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:middle;width:53.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amounts Recognized as of the Acquisition Date</b></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:25.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amounts in USD millions</b></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amounts in DKK millions</b>&#160;</p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 122</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 841</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Other current assets*</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 29</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Property and equipment&#160;&#160;</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">IPR&amp;D</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,540</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,577</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Technology platform intangible asset</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 181</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,243</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Other non-current assets**</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Non-current deferred tax liability</p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (297)</font></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,039)</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Other current liabilities***</p></td><td style="vertical-align:middle;width:25.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (15)</font></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (108)</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">   </b><b style="font-weight:bold;">Total identifiable net assets</b></p></td><td style="vertical-align:middle;width:25.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,544</b></p></td><td style="vertical-align:middle;width:27.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,605</b></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Goodwill</p></td><td style="vertical-align:middle;width:25.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 361</font></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,482</font></p></td></tr><tr><td style="vertical-align:middle;width:46.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">   </b><b style="font-weight:bold;">Total consideration</b></p></td><td style="vertical-align:middle;width:25.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,905</b></p></td><td style="vertical-align:middle;width:27.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 13,087</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">*Includes receivables and other investments</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">**Includes other investments and right-of-use assets</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">***Includes other payables, deferred revenue, current deferred tax liability and lease liabilities</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The carrying values of other current assets, property and equipment, other non-current assets and other current liabilities were determined to approximate their fair values.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The fair value assigned to acquired IPR&amp;D, which was calculated using the multi-period excess earnings method of the income approach, was based on the present value of expected after-tax cash flows attributable to Rina-S, which is in Phase 1/2 testing. The present value of expected after-tax cash flows </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 33/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">obtainable from Rina-S and assigned to IPR&amp;D was determined by estimating the after-tax costs to complete development of Rina-S into a commercially viable product, estimating future revenue and ongoing expenses to produce, support and sell Rina-S, on an after-tax basis, and discounting the resulting net cash flows to present value. The revenue and costs projections used were reduced based on the probability that compounds at similar stages of development will become commercially viable products. The rate utilized to discount the net cash flows to their present value reflects the risk associated with the future earnings attributable to the intangible asset. Acquired IPR&amp;D will be accounted for as an intangible asset not yet available for use until regulatory approval in a major market is received or development is discontinued.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk167098154"></a>The fair value of the technology platform intangible asset was calculated using the relief from royalty method of the income approach. This method includes assigning value based on the economic savings from owning, rather than in-licensing, the technology platform intangible asset supported by observable market data for peer companies, then discounting the resulting probability adjusted net post-tax cash flows using a discount rate commensurate with the risk associated with the future income or cost savings attributable to the intangible asset.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The significant assumptions used to estimate the value of the acquired intangible assets include discount rates and certain assumptions that form the basis of future cash flows (such as probabilities of technical and commercial success, revenue growth rates, operating margins, and royalty rates).&#160;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The excess of purchase price over the fair value amounts assigned to identifiable assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition. The goodwill recorded as part of the acquisition is attributable to the intangible assets that do not qualify for separate recognition at the time of the acquisition, assembled workforce and deferred tax consequences of the IPR&amp;D and technology platform intangible asset recorded for financial statement purposes. Genmab does not expect any portion of this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition has been recorded as a non-current asset in Genmab&#8217;s Condensed Consolidated Balance Sheets and is not amortized, but is subject to review for impairment annually.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">From the Acquisition Date through September 30, 2024, Genmab&#8217;s Condensed Consolidated Statements of Comprehensive Income include no revenue and the following expenses associated with the acquisition and operations of ProfoundBio (in DKK millions):</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Consolidated Statements of Comprehensive Income (DKK million):</b></p></td><td style="vertical-align:middle;width:35.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Acquisition Date through September 30, 2024</b></p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">204 </p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">11 </p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Acquisition and integration related charges*</p></td><td style="vertical-align:middle;width:35.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">156 </p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:middle;width:35.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">371 </b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">*Acquisition related charges incurred from the Acquisition Date through September 30, 2024, are comprised of payments to holders of outstanding ProfoundBio equity awards related to post-combination services (DKK 79 million). The remaining expenses are integration related charges incurred from the Acquisition Date through September 30, 2024, which are comprised of professional fees incurred to assist with the integration of ProfoundBio into Genmab&#8217;s operations post-acquisition. Additionally, prior to the Acquisition Date, Genmab recorded DKK 113 million in Acquisition and integration related charges in <a name="x__Hlk172662599"></a>Genmab&#8217;s Condensed Consolidated Statements of Comprehensive Income related to professional due diligence procedures in connection with the acquisition of ProfoundBio.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 34/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides Genmab&#8217;s consolidated revenue and net profit for the first nine months of 2024 as if the acquisition of ProfoundBio had occurred on January 1, 2024 (in DKK millions):</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:middle;width:35.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Month Period Ended September 30, 2024</b></p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Revenue</p></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,085</font></p></td></tr><tr><td style="vertical-align:middle;width:64.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:justify;margin:0pt;">Net Profit</p></td><td style="vertical-align:middle;width:35.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,792</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The unaudited pro forma information does not necessarily reflect the actual results of operations of the combined entities that would have been achieved, nor are they necessarily indicative of future results of operations. The unaudited pro forma information reflects certain adjustments that were directly attributable to the acquisition of ProfoundBio, including additional amortization adjustments for the fair value of the technology platform intangible asset acquired.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September&#160;30, 2024, Cash and cash equivalents in Genmab&#8217;s Condensed Consolidated Balance Sheets includes USD 30 million (DKK 200 million) of restricted cash balances for funds held in escrow related to the acquisition of ProfoundBio.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 35/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1428393242"></a><a name="_MON_1428926213"></a><b style="color:#029c93;font-weight:bold;">Note 3 &#8211; Revenue </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below summarizes Genmab&#8217;s revenue by type and collaboration partner, and royalties by product, under Genmab&#8217;s agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Revenue by type:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,694</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,836</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,367</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,722</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 267</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 306</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 835</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 789</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 347</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 797</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Collaboration revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 105</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 78</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 311</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 218</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Net product sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 471</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 150</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,225</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 189</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,540</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,712</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15,085</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,715</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Revenue by collaboration partner:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,909</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,549</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,232</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,603</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Roche</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 201</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 180</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 543</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 516</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Novartis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 573</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 455</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,572</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,061</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">BioNTech</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 230</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 286</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 739</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 732</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Pfizer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 130</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 92</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 386</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 266</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">AbbVie</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 348</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total*</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,069</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,562</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 13,860</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,526</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Royalties by product:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">DARZALEX </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,787</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,145</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,899</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,000</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Kesimpta </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 569</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 449</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,559</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,049</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">TEPEZZA </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 198</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 180</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 539</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 516</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other**</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 140</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 370</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 157</font></p></td></tr><tr><td style="vertical-align:bottom;width:35.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,694</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,836</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.45%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,367</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,722</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">* Excludes Genmab&#8217;s Net product sales</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">** Other consist of royalties from net sales of RYBREVANT, TECVAYLI, TALVEY and TEPKINLY. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net Product Sales</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab recognized net product sales of DKK 1,225 million during the first nine months of 2024 compared to DKK 189 million in the first nine months of 2023. Genmab recognized net product sales of DKK 471 million for the third quarter of 2024 compared to DKK 150 million for the third quarter of 2023. EPKINLY was approved in the U.S. in May 2023 and Japan in September 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Deferred Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As part of the continued evaluation of deferred revenue related to the AbbVie Agreement, during the first nine months of 2024, Genmab&#8217;s classification of deferred revenue reflects the current estimate of co-development activities as of September 30, 2024. Deferred revenue has been recognized as reimbursement revenue during the third quarter of 2024. These co-development activities are related to a performance obligation in connection with the product concepts under a research option agreement.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 2.1 in the Annual Report for further details regarding revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 36/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 4 &#8211; Intangible Assets &amp; Goodwill</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross Carrying Value</b></p></td><td style="vertical-align:bottom;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated Amortization</b></p></td><td style="vertical-align:bottom;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Impairment</b></p></td><td style="vertical-align:bottom;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exchange Rate Adjustments</b></p></td><td style="vertical-align:bottom;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intangible Assets, Net</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">September 30, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Amortizable Intangible Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Licenses &amp; Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 958</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (822)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (64)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 72</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Technology Platform</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,261</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (29)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (56)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,176</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,219</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (851)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (64)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (56)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,248</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Non-amortized Intangible Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Acquired IPR&amp;D Rights</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,728</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (472)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,256</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total Intangible Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,947</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (851)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (64)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (528)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,504</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Amortizable Intangible Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt 0pt 0pt 6pt;">Licenses &amp; Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 947</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (800)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 147</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-size:9pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:29.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total Intangible Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 947</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (800)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> -</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 147</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Intangible Assets</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The increase in the gross carrying value of intangible assets during the first nine months of 2024 was primarily due to the addition of approximately DKK 10,728 million of IPR&amp;D and DKK 1,261 million of a technology platform asset from the ProfoundBio acquisition. The technology platform asset is being amortized over its estimated useful life of 15 years.<font style="color:#ff0000;"> </font>The difference between the Acquisition Date fair value of these acquired intangibles assets and the carrying value as of September 30, 2024 is attributable to net exchange rate differences. Refer to Note 2 for additional details.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Amortization expense was DKK 51 million and DKK 41 million for the first nine months of 2024 and 2023, respectively, which was recorded in Research and development expenses in the Condensed Consolidated Statements of Comprehensive Income. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Goodwill</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The carrying amount of goodwill was DKK 2,407 million as of September 30, 2024 due to the acquisition of ProfoundBio (refer to Note 2)<b style="font-weight:bold;">. </b>The difference between the Acquisition Date fair value of DKK 2,482 million and the carrying value as of September 30, 2024 is attributable to net exchange rate differences. There was no goodwill balance as of December 31, 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk148453111"></a><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 37/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 5 &#8211; </b><a name="_Hlk148453130"></a><b style="color:#029c93;font-weight:bold;">Financial Instruments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s portfolio is spread over a number of different securities with a focus on liquidity and the preservation of capital. Genmab&#8217;s marketable securities in USD, DKK, EUR, and GBP as a percentage of total marketable securities were as follows: </p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.07%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.07%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Percent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 76</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DKK</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GBP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.23%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2024, 70% of Genmab&#8217;s marketable securities were long-term A rated or higher, or short-term A-1 / P-1 rated compared to 72% as of December 31, 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below shows the fair value measurements by level for Genmab&#8217;s financial assets measured at fair value through profit or loss:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:26.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:26.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:39.58%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2024</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:30.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:middle;width:26.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Assets Measured at Fair Value</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.23%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:5.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:middle;width:26.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.8%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.23%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26.28%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.8%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,976</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.8%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.23%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,976</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:5.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">13,268</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;">13,268</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.8%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.8%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 144</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.23%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 189</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:5.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">47</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;">87</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;">134</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Marketable Securities</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">All fair values are determined by reference to external sources using unadjusted quoted prices in established markets for Genmab&#8217;s marketable securities (Level 1). </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Investments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments primarily consist of investments in certain strategic investment funds. Genmab&#8217;s share of the fair value of these fund investments is determined based on the valuation of the underlying investments included in the fund. Investments in publicly traded equity securities included in these strategic investment funds are valued based at the most recent sale price or official closing price reported on the exchange or over-the-counter market on which they trade, while investments in non-publicly traded equity securities are based on other factors, including but not limited to, type of the security, the size of the holding, the initial cost of the security, the price and extent of public trading in similar securities of the comparable companies, an analysis of the company&#39;s or issuer&#39;s financial statements and with respect to debt securities, the maturity and creditworthiness. As such, these fund investments have been characterized as Level 3 investments as fair values are not entirely based on observable market data. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.3 and Note 4.4 in the Annual Report for further details regarding Genmab&#8217;s marketable securities and other investments.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 38/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 6 &#8211; Financial Income and Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#ff0000;font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:25.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Financial income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 162</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 244</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 771</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 672</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Gain on marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 144</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 109</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 352</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 357</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Gain on other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 130</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 68</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Foreign exchange rate gain</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 850</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 968</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 850</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 315</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,209</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,221</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,947</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Financial expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (18)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (66)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (49)</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Loss on marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (40)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (119)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (199)</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Loss on other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (39)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (108)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (64)</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Foreign exchange rate loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (670)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (136)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (909)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (575)</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (698)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (224)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,202)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (887)</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (383)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 985</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.46%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,060</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interest Income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Interest income was DKK 771 million in the first nine months of 2024 compared to DKK 672 million in the first nine months of 2023. The increase of DKK 99 million was driven by higher average cash and cash equivalents and marketable securities, as well as higher interest rates on USD denominated marketable securities in the first nine months of 2024 compared to the first nine months of 2023.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Foreign Exchange Rate Gains and Losses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Foreign exchange rate gain, net was DKK 59 million, comprised of DKK 968 million foreign exchange rate gains, offset by DKK 909 million foreign exchange rate losses in the first nine months of 2024 compared to foreign exchange rate gain, net of DKK 275 million in the first nine months of 2023. The USD weakened against the DKK in the first nine months of 2024, negatively impacting our USD denominated securities and cash holdings. The USD strengthened against the DKK in the first nine months of 2023, positively impacting our USD denominated securities and cash holdings.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:12.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">USD/DKK Foreign Exchange Rates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.6595</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.7447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7.0390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.9722</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">% (Decrease)/increase from prior year-end</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.32%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">(1.3)%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1.0%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 39/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 7 &#8211; Share-Based Payments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restricted Stock Unit Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has established an RSU program (equity-settled share-based payment transactions)<font style="letter-spacing:-0.2pt;"> </font>as an incentive for Genmab&#8217;s employees, members of the Executive Management, and members of the Board of Directors. RSUs granted to Executive Management are performance-based.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:35.96%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:35.96%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">RSUs granted</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 476,439</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 288,670</font></p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average fair value per RSU granted (DKK) </i></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 1,989.31</i></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:16.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,636.71</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">RSUs vested</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 142,263</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 91,514</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.6 in the Annual Report for details on the RSU program.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Warrant Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has established a warrant program (equity-settled share-based payment transactions) as an incentive for all Genmab employees. Following Genmab&#8217;s Annual General Meeting on March 29, 2023, members of the registered Executive Management and members of the Board of Directors may only be granted RSUs.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-size:8.5pt;font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">Warrants granted</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 358,994</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 201,726</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average exercise price per warrant granted (DKK) </i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 1,990.64</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,650.53</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average Black-Scholes fair value per warrant granted (DKK) </i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 645.20</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 932.20</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">Warrants exercised</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 102,296</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 105,908</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average exercise price on date of grant per warrant exercised (DKK)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 1,151.81</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 1,347.69</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">% change in share capital - warrants exercised</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.28%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;">0.15%</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;">0.16%</i></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.6 in the Annual Report for details on the warrant program.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share-Based Compensation Expense</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Share-based compensation expenses related to Genmab&#8217;s RSU and warrant programs for the first nine months of 2024 were DKK 535 million compared to DKK 433 million for the first nine months of 2023. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 40/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share Repurchases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2024, Genmab&#8217;s 2021 and 2023 authorizations have shares available for repurchase, whereas Genmab&#8217;s 2019 authorization has expired. In addition, at Genmab&#8217;s Annual General Meeting on March 13, 2024, a new authorization to acquire treasury shares up to a nominal amount of DKK 3,500,000 was granted.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:54.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:0.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.17%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024 </b><b style="font-weight:bold;"><br></b><b style="font-weight:bold;">Authorization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.68%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023 </b><b style="font-weight:bold;"><br></b><b style="font-weight:bold;">Authorization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.68%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021 </b><b style="font-weight:bold;"><br></b><b style="font-weight:bold;">Authorization</b></p></td><td style="vertical-align:bottom;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Number of shares authorized for repurchase<sup style="font-size:6.75pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.17%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Actual shares repurchased under authorization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.17%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,821,853</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 450,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Shares available for repurchase as of September 30, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.17%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,678,147</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 50,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:72.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup> Nominal value of DKK 3,500,000 for 2024, and DKK 500,000 for 2023 and 2021 Authorizations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 4.5pt 0pt 0pt;">As announced on February 14, 2024, and March 15, 2024, Genmab initiated two share buy-back programs. The purpose of the share buy-back program announced on February 14, 2024, was to honor Genmab&#8217;s commitments under the RSU program. The share buy-back program announced on March 15, 2024, was in support of Genmab&#8217;s capital allocation strategy. During the first nine months of 2024, Genmab acquired 2,011,853 of its own shares <font style="background:#ffffff;">under both programs</font>, representing approximately 3.0% of share capital as of December 31, 2023. The total amount incurred to acquire the shares, including directly attributable costs, was DKK 3,879 million and was recognized as a deduction to shareholders&#8217; equity. These shares are classified as treasury shares and are presented within retained earnings on the Condensed Consolidated Balance Sheets as of September 30, 2024. During the first nine months of 2023, Genmab acquired 220,000 of its own shares, representing approximately 0.3% of share capital as of December 31, 2022. The total amount incurred to acquire the shares, including directly attributable costs, was DKK 564 million and was recognized as a deduction to shareholders&#8217; equity.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">As of September 30, 2024, 2,663,209 treasury shares were held by Genmab. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk148676828"></a><b style="color:#029c93;font-weight:bold;">Note 8 &#8211; Related Parties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s related parties are its Board of Directors, Executive Management, and close members of the family of these persons. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has not granted any loans, guarantees or other commitments to or on behalf of any of the members of the Board of Directors or members of the Executive Management.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other than the similar remuneration relating to the Board of Directors and the Executive Management described in Note&#160;5.1 in the Annual Report, there were no material related party transactions during the first nine months of 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Changes to the Executive Management and the Board of Directors</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Mancini stepped down as Chief Operating Officer in August 2024. Brad Bailey and Rayne Waller were appointed as Executive Vice President and Chief Commercial Officer, and as Executive Vice President and Chief Technical Operations Officer, respectively, and members of the Executive Management in August 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk117757759"></a>Following Genmab&#8217;s Annual General Meeting on March 13, 2024, the Board of Directors is comprised of five independent board members, one non-independent board member, and three employee-elected board members. Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Elizabeth </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 41/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">O&#8217;Farrell, Paolo Paoletti and Anders Gersel Pedersen were re-elected to the Board of Directors for a one-year period. Mijke Zachariasse, Martin Schultz and Takahiro Hamatani continue to serve as employee-elected board members for a three-year period expiring in 2025. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 9 &#8211; Leases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the Condensed Consolidated Balance Sheets</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The Condensed Consolidated Balance Sheets show the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 890</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 686</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 890</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 686</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 91</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 896</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 680</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 987</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 770</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2024, there were additions to Genmab&#8217;s right-of-use assets and lease liabilities related to the commencement of leases in the U.S. with respect to office and laboratory space and in Japan with respect to office space. During the first nine months of 2023, there were additions to Genmab&#8217;s right-of-use assets and lease liabilities related to the commencement of a lease for the new headquarters in Denmark. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the Condensed Consolidated Statements of Comprehensive Income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The Condensed Consolidated Statements of Comprehensive Income show the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 75</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 27</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 75</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:48.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Variable lease payments, short-term lease expense, lease interest expense and low-value leases are not material.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 42/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 10 &#8211; Contingency</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">In 2024, Chugai filed a lawsuit in the Tokyo District Court, Japan against AbbVie&#8217;s and Genmab&#8217;s subsidiaries in Japan asserting that their activities with EPKINLY (epcoritamab) in Japan infringe two Japanese patents held by Chugai, JP6278598 and JP6773929. Chugai is claiming damages and injunctive relief. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">&#160;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab and AbbVie believe that the two Japanese patents are invalid and not infringed and intend to vigorously defend against the lawsuit, and thus no provision has been recorded related to this matter.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 11 &#8211; </b><b style="color:#029c93;font-weight:bold;">Subsequent Events</b><b style="color:#029c93;font-weight:bold;"> to the Balance Sheet Date</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">No events have occurred subsequent to the balance sheet date that could significantly affect the financial statements as of September 30, 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 43/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">ABOUT GENMAB</b><b style="font-size:16pt;font-weight:bold;"><a name="ABOUTGENMAB_556806"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><i style="font-style:italic;font-weight:normal;">Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab&#8217;s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;font-weight:normal;">) antibody medicines.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;"> </i><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit </i><i style="color:#029c93;font-style:italic;">Genmab.com</i><i style="font-style:italic;"> and follow us on </i><i style="color:#029c93;font-style:italic;">LinkedIn</i><i style="font-style:italic;"> and </i><i style="color:#029c93;font-style:italic;">X</i><i style="font-style:italic;">.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">This Interim Report contains forward looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on </i><i style="color:#029c93;font-style:italic;">www.genmab.com</i><i style="font-style:italic;"> and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at </i><i style="color:#029c93;font-style:italic;">www.sec.gov</i><i style="font-style:italic;">. Genmab does not undertake any obligation to update or revise forward looking statements in this Interim Report nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Genmab A/S and/or its subsidiaries own the following trademarks: Genmab</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; the Y-shaped Genmab logo</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; Genmab in combination with the </i><i style="font-style:italic;">Y-shaped Genmab logo</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; HuMax</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; DuoBody</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; HexaBody</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; DuoHexaBody</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; HexElect</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174; </sup><i style="font-style:italic;">and KYSO</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">; Tivdak</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> is a trademark of Seagen Inc.;</i> <i style="font-style:italic;">EPCORE</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">, EPKINLY</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">, TEPKINLY</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> and their designs are trademarks of AbbVie Biotechnology Ltd.; Kesimpta</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> and Sensoready</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> are trademarks of Novartis AG or its affiliates; DARZALEX</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">, DARZALEX FASPRO</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">, RYBREVANT</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;">, TECVAYLI</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> and TALVEY</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> </i><sup style="font-size:6pt;font-style:italic;vertical-align:top;"> </sup><i style="font-style:italic;">are trademarks of Johnson &amp; Johnson; TEPEZZA</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-style:italic;"> is a trademark of Horizon Therapeutics Ireland DAC. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 44/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="gmab-20241106xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months of 2024</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514654"></a></b><b style="color:#029c93;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b><b style="font-size:16pt;font-weight:bold;"><a name="DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The Board of Directors and the registered members of Executive Management have today considered and adopted the unaudited interim report of the Genmab Group for the nine months ended September 30, 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The interim report is prepared in accordance with IAS 34, &#8220;Interim Financial Reporting,&#8221; as issued by the IASB and in accordance with IAS 34 as endorsed by the EU, and additional Danish disclosure requirements for interim reports of listed companies.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">We consider the applied accounting policies to be appropriate and, in our opinion, the interim report gives a true and fair view of the assets and liabilities, financial position, results of operation and cash flows of the Group.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Furthermore, we consider the Management&#8217;s Review to give a true and fair account of the development in the Group&#8217;s activities and financial affairs, results of operations and the Group&#8217;s financial position as a whole as well as a description of the significant risks and uncertainties which the Group faces, as further described in this report, our 2023 Annual Report and the Form 20-F filed with the U.S. Securities and Exchange Commission in February 2024.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Copenhagen, November 6, 2024</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Registered Members of Executive Management</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1.25pt;"><td style="vertical-align:bottom;width:27.38%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:27.38%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1007.jpg" alt="Graphic" style="display:inline-block;height:36.5pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:77.41pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1008.jpg" alt="Graphic" style="display:inline-block;height:32.17pt;width:84.2pt;"></p></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jan van de Winkel</p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Pagano</p></td></tr><tr style="height:13.95pt;"><td colspan="2" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(President &amp; CEO) </p></td><td colspan="2" style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CFO)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;padding-left:28.8pt;text-indent:-28.8pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Board of Directors</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:3.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr style="height:27.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1009.jpg" alt="Graphic" style="display:inline-block;height:26.35pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:39pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1010.jpg" alt="Graphic" style="display:inline-block;height:20pt;width:69pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1011.jpg" alt="Graphic" style="display:inline-block;height:21pt;width:102pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Deirdre P. Connelly</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pernille Erenbjerg </p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anders Gersel Pedersen</p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Chair)<font style="white-space:pre-wrap;">  </font></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Deputy Chair) </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1012.jpg" alt="Graphic" style="display:inline-block;height:23.07pt;width:80pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1013.jpg" alt="Graphic" style="display:inline-block;height:28pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:58pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1014.jpg" alt="Graphic" style="display:inline-block;height:27.35pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:100.37pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rolf Hoffmann</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Paolo Paoletti</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Elizabeth O&#8217;Farrell</p></td></tr><tr style="height:16.15pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1015.jpg" alt="Graphic" style="display:inline-block;height:26.95pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:58pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1016.jpg" alt="Graphic" style="display:inline-block;height:21.51pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:113.39pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="gmab-20241106xex99d1017.jpg" alt="Graphic" style="display:inline-block;height:38.81pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:29.44pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Mijke Zachariasse</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Takahiro Hamatani</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Martin Schultz</p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected) </p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected) </p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 60</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Carl Jacobsens Vej 30</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 45/45</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">2500 Valby, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gmab-20241106xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ ,H# 2(  A$! Q$!_\0
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M;')RHZ9S\[_L\ZYXCL?C+X7CT*[NS<7=]''<PK(S)- 3F7S!T(";CD]" >M
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4I5JU,PQ5N:I9)+5**\W:[?4__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gmab-20241106xex99d1005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'X Z@# 2(  A$! Q$!_\0
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M5U;Q)#8SZO;ZW:62:HWV?3+J*\-X&M8RI6,-.2S AN/E&    >R YI:0<4M
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M^2AC$C(PY#JI0CG=CFM]?VGOAB=0U6R_X2N!9=,ADN+IWMIUA1$"L^)2FQR
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ML[F9V8(TFY%2,M(A2-V$B HP1L$X-9D?[&WP^B,@5=5$;KL,7VWY-O\ :?\
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MS_(_XT?\*A\'_P#0OV?Y'_&CW0YJ_P#*OO?_ ,B=AYB^M'F+ZUQ__"H?!_\
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M/Q#X;^.WCK2]+U_5-/TZTU:>&WM;>]E2.) Q 50&X KSK_A9_C#_ *&K6O\
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M;_&KAE[FK\WX&>(XWCAW%.A>ZO\ %_P#Z.WCU_2C>/7]*^<?^$(T+_H'1?\
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M<7:VTMH'B=#)$S12#)W;&& =CO@YX/<>'+2;2] TVSNC";FWMHHI3;@B/>J
M-M!YVY!QGG%>;V?PS\+O=PJVBVS*6 (.[_&NI_X5!X._Z%^S_(_XUA4IQINS
M9Z^"QU7&Q<XP2M_>_P#M3L/,7UH\Q?6N/_X5#X/_ .A?L_R/^-'_  J'P?\
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M)=X(*F8Y';G=5P?%OXK?:(;.ZBU;39KNYD^Q*?#SRSS[82_E,IB4*H; + ,
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M3 ]!0&I>;1KM#\T:#_MJG^-"Z1=.>$0_]M4']:HX'H*,>U :_P!?\.7CI%T
M/D3G_IJOM[^XI(](NI,;43G'65!Z>I]Q5.DZ]A0&O<O-HUVN,HG/_35/;W]Q
M35TJY?&$3G_IJOM[^]4\#T%+^ HL&I[YK,3M\(OAC& -\%C>H_(P#]NF/![\
M$<BN2^RRY^Z/^^A_C75:W_R1SX5?]@Z^_P#2^>N0KII?"?/YC?ZS*_E^2)FL
MYEZJ/^^U_P ?:D^S2?W1_P!]#W]_:HJ,5J>:3FRF'55_[[7W]_:FFVD!QM'_
M 'T/\:BQ1BD!.+.4C[J_]]K_ (TGV63/0?\ ?0_Q]ZAP/2C%,-286<Q'"K_W
MVOM[^])]FDX^4<_[0]O?W%18HH#4G6SE;& O/^VO^/O2&UE'\(_[Z'^-0T8]
MJ /KK]BO6K/1_"7BZWNG=)9-1M'4)"\@QY;KU4$#GU^O2OHNW\3Z==%1')*=
MV,9MI%Z[,=5_VU_,^AQX%^PL3_PA/C/DC_B9VO\ Z)>OI/\ $_G5T=GZG-F-
M^:G?^5?FS&?Q=I:!<RS?-MQBUE/79C^'_IHGYGT.%MO%FEW>SRI93OP5W6TJ
M]=F.J_\ 31?S/H<;'XG\Z/Q/YUT'D&3)XHTV,*6DE&0"/]'D/4*1_#_M#_(-
M1Q^,-*E&4EF/&>;64=L]UK:_$_G1^)_.@#(F\4Z; A9Y90 "3BVD/0,>R_[+
M?Y(IH\6Z62P$LN5SG_19>V_/\/\ TS;\AZC.S^)_.C\3^= S+N/$FGVH<R22
M#9NW;;>1NF_/1?\ IFWY#U&8/^$RTG>R^;-N7(/^B3=MV?X/]AOR'J,[?XG\
MZ/Q/YT",MO$>GH"3))Q_TPD]_P#9]C4(\7Z47V>;-NZ?\>LOJ!_=]Q6U^)_.
MC\3^= %?1?$^G"_@8RR[3P"+>3OM _A_VU_7T.-^/QYHTC(JSSY;&,V4XZ[,
M?P?]-$_,^AQ6T3_D)1<GOW]JZK)]3^=>?B+<Q]SD:?U9V?5]/)>9CP^*]-G5
M&264JVTC-M*.NS'5?^FB_F?0XK-X\T5"H,]Q\V,?Z'.>NW'\'^VOZ^AQT.3Z
MG\Z,GU/YURZ'T5I=_P /^"8D/C'2IT#I-,5(!!-K,/YI[U'+XXT>%BKS3@@9
MXLYSV)[)[&M_)]3^=&3ZG\Z- M+O^'_!,S3_ !AI9N(Y!+-MC;+?Z++VW9XV
M_P"PWY#U&>FNOB/H-D6$UQ<@IG.VQN&Z;\](S_SS?\AZC-2P)^VP<G[X[UV6
M*X,3;F1]ID2J.C.S6_;_ ()SL?C_ $67=MGG.W=G-E..F_/5/]AOR'J,EUX_
MT6SSYL\XQG.+.=NFX'HG^R?\D5T6/K^=&/K^=<FA]-RU/YE]W_!.;A^(&B7!
MPD\Y.<<V4X[X[I3I?'^BV^T//.-V,8LYSUQZ)_M#_(-=%CZ_G1C_ #FC0+5/
MYE]W_!.=LO'NC:C+''!/.SN5"[K.=>NW')08^^OYGT."NBQ]?SHI:#49]7^'
M_!%HHHI&H4444 %%%% !1110 4444 %%%% !2%0:6B@!,"C%+10 F**6B@!,
M48%+10 F* ,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5G:CKUCI4@2YE*,1N $;-QT[ UHUY!\7= \2^(_'GA.UTA[A-,5
M9Y+W%_>V</ &W+VK*2W7 8XIKS)E>WNG?IXWT21MJW1)_P"N$G_Q-2/X@T>1
MXYV=6:/.QS Q*YZX.WC-?.Y\8_%/2[/Q/<I-?6=E8WZ6]I:RZ-/<231ECEUE
M996)P !E=O/)&<U;B\0?$"^^$^MW$LOB%_$:ZVK);O8/;S16[ $(HC'S)USA
MFQTS3T(M4[K[O^">\GQOH@?:;H[CV\B3_P")JP/%6ED;A.2,=?)?_P")KYKM
M_B5\8],\(S7D]E<W$LL*D(=&D5[%1,$9A\KM(VSYOF5O7;78>+]=\0ZG\-/
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MH\#THQ0!+]FD_N_J*3[/(<?+^HJ/ ]*,#TH E%K*?X?U'^>])]G?CY>ON/\
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MZ/*([RY$+E=P!5CQG&> :U*\=^,/ASQ#XJ\>>$K'2Y[N#3%6>6\\K4;RRC.
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MM=[KN2<$E1<J/(A8 $@2'G%.\1Z/\,M>U==1U?6O"MY>V,43K+-:*Q15QY6
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M11^F[Z_G3)=+UUF)CUN)!C@&R4XZ_P"U]/R]Z+>8O:/^5_A_F;I-&:QET[6
MC@ZM&6.=K?9%&/O8XW>Z_P#?/OQ%<:5KTA;RM<BA!S@&Q5L?>Q_%[K_WR?7A
MV\Q\\OY7^'^9O9HS6)'INMKG=K$;=<8LU&/O8_B[97_OGWX6XTW6GSY6L11=
M<9LPWK_M>X_+WHMYASO^5_A_F;6?:C-8<6F:XN=^LQ/]+)1_[-3I=-UIB-FL
M1H.,_P"AJ<]/]KV/Y^U%O,7/+^5_A_F;6:*Q;73=:B=#/K$<Z@@LHLU7/W<_
MQ<9PW_?7MR4K%*;?1FW17&CXM>'3TGO?_!9=?_&Z/^%L^'?^>][_ ."NZ_\
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MN/\ XW1[*I_*_N#^U,!_S_A_X$O\SO:*X-/C=X0D8*FI3,Q["PN2?_1=2?\
M"Y?"O_/[<_\ @NN?_C='LJG\K*68X.6L:T7_ -O+_,[BBN'_ .%R^%?^?VZ_
M\%UU_P#&Z/\ A<OA7_G]NO\ P777_P ;I>RG_*RO[0PG_/V/_@2.XHKA_P#A
M<OA7_G]NO_!==?\ QNC_ (7+X5_Y_;K_ ,%UU_\ &Z/93_E8?VAA/^?L?O1W
M%%</_P +E\*_\_MU_P""ZZ_^-T?\+E\*_P#/[=?^"ZZ_^-T>RG_*Q?VAA/\
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M3=*2NX!1G+$CD =15#2/B/X:UK3H[RWUNS$36Z792:X6.2.)L;7=&(*@Y')
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M8P8SYD4PBD:5CW41R8]%KZ@R!1D4 >8?!35/'.O6NIW_ (T8VKF18[;3ULC
MD:A1EPS .^X^H7'3%>G[?<_G1D"C- !M]S^=&WW/YT9HR* #;[G\Z-ON?SHS
M1F@ V^Y_.C;[G\Z-PHW"@ V^Y_.C;[G\Z,T;A0 ;?<_G1M]S^=&11N% !M]S
M^=&WW/YT;A1N% !M]S^=&WW/YT;A1N% !M]S^=(1QU-+FD+#% 'X>?M3C_C(
MSXB_]AJX_P#0S7EE>I_M3_\ )Q?Q%_[#5Q_Z&:\LKVX?"C\@Q'\:?JPS1FBB
MJ.?4,T9HHH ,T9HHH ,T9HHH ,T \T4#K0![SK8'_"G/A5_V#K[_ -+YZY#
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MT,VK?]\V_P#\:K>HH"Q!X6\"W&M:J+:X\3ZP(_+9OD%N#D8_Z8UV/_"EH_\
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M%Q;B!D-T;3S/];N \X 8*AMK;L8!Q7/Y(P^KR_Y^R_#_ ".H_M/XG?\ 0O\
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MR7X?Y'3R^/?&T'B*WT"2R\&KK<\+7$6GG7I_.>)>&<+]FSM!(&33M7\<>.=
MGT^'4=.\(6<VH7"VMI'+KEP&GE/(1!]FY. 3^%6Y_ ^M3^(]$\67(TLZ]86%
MS;SP6J,$G=_N!9&^8*,=&]:R_'?P7U#Q_P"+?"GB<^);S1KW29(96L8X;>:%
M<'=)Y;/&65S]W=NQ@=.31S^2%]7E_P _9?A_D-UKXG>+/#NHQV&I0>"[.^EM
MY;I+637I_-:&,9DD"BV)VJ.IKF;?]I6_NM-2^A'A:6)V1%CCN]2:8[T+HWDB
MQ\S:R*S!MNT@$YXKL/$_P7FUH:<4UN6[N;6UO;9[[5(TDN91/&RJ"Z*@VJ6'
M&.@'?FO*=(_92\5Z7I5FC:SIEQ<VOV5! ;[4U1UB@DB+^>)O/4G?D1JWEC!&
M.:.;R0_J\O\ GY+\/\CUW1_%GC_Q#I=MJ6F:3X1OK"Y020W$&N3LDBGH0?LU
M7/[3^)W_ $+WA;_P<W'_ ,C5K_#+PE=^!_ VDZ'>WL>H7-HC*\\47EIR[,%4
M$DX4$+EB6.,DDDUU%'/Y(7U>7_/V7X?Y' ?VG\3O^A>\+?\ @YN/_D:C^T_B
M=_T+WA;_ ,'-Q_\ (U=_11S^2#ZO+_G[+\/\CRCQ9\0O&_@?1WU36]*\+65B
MKK'YG]JW<I+L<*H5+1F8D\  &G>%OB#XV\:Z4-2T/3_".I6>]HC)%K-R"CJ<
M,CJUJ&1AW5@"/2NA^+G@W4_''A2.QTBYM+74(+RWO(GO4=H28G#;6V$-@XQD
M5Y;JW[/GC'4;S5-2B\1Z5;ZEKOF+J:QV\R0P!C'M:W"N"6 CQF3.<^V*.;R0
M?5Y?\_)?A_D=7XN^)7C3P+817FMZ5X8LX9I1#%LU*]G=W/0*D5HS'\!5_1/%
M_C[Q+I-KJFE:5X1U#3[I/,AN8-;N&1U]O]&_#'4$8->8']EGQ##:R>1JFD^>
MEVDZF-[RU-WB5G,L\L,BR"7#;<H<=>W =!^ROXD\B"*;Q-8?:!$H&J0VTR7=
MD%9R88&\S_5OOPY8[FQDY)HYO)!]7E_S]E^'^1Z9I_C'Q]JM[?V=II'A2>ZL
M'$=S$NLW.8F(R <VO<>E7O[3^)W_ $+WA?\ \'-Q_P#(U>+Z3^S;XA\.ZWI%
MM:MI]G;7VH"35GT6&2&W^QK$ Z$O(6\R1E4Y (]?4_4R+L0 8P*.?R0?5Y?\
M_9?A_D<%_:?Q._Z%_P +_P#@YN/_ )&I/[3^)W_0O>%O_!S<?_(U=_11S^2#
MZO+_ )^R_#_(X#^T_B=_T+WA;_P<W'_R-6-JWQ'\8Z%J]EI>HV?@ZSU&]CEE
MMK:;7+@/,L:[I"H^S<[1R>]>L5Y9\7O@NWQ/U6QODU-=-GL;2>.UG2,F6"=Q
M\DJG/0=".X)%'/Y(/J\O^?LOP_R,"V^/.L7>K6^G1-X,:ZN%#1YUB[6,Y!8*
M9#:! Q )"%@Q SBFZ9\?-7UB8Q6;^#)I/-2%!_:]XOFLY*H8RUH/,4D$;URN
M1C-8=O\ LT>(DN[*+_A(;&TM'MHX=1O+!;F*:Y C9'0P>88'!W?*[J74< ]Z
MV;[X2?$&]T?3+%M:\-"'0VM?[-A%C,/.\EN&FDW;ERN!M3C/.>U'/Y(?U>7_
M #\E^'^1HZY\8?$GAK6X-(U2+P=97\NT".36;K:A8X0.XM2L>X\+O*Y[9KI_
M[4^)W_0O^%O_  <W'_R-6!;?#[QS8^(M0U"TU?0;>+7&MY=4#VLLSPO&,,(-
MS;65ATWCY3ZUZZ&XHY_)"^KR_P"?LOP_R.!_M/XG?]"]X6_\'-Q_\C4?VG\3
MO^A>\+?^#FX_^1J[[=[T;J.==D'U>7_/V7X?Y' _VG\3O^A>\+?^#FX_^1J/
M[3^)W_0O^%__  <W'_R-7?;J-U'.NR#ZO+_G[+\/\C@?[3^)W_0O^%__  <W
M'_R-1_:?Q._Z%[PM_P"#FX_^1J[[=[T;J.?R0?5Y?\_9?A_D<#_:?Q._Z%[P
MM_X.;C_Y&H_M/XG?]"]X6_\ !S<?_(U=]NHW4<Z[(/J\O^?LOP_R.!_M/XG?
M]"]X6_\ !S<?_(U']I_$[_H7O"W_ (.;C_Y&KOMP]:-P]:.==D'U>7_/V7X?
MY' _VG\3O^A>\+?^#FX_^1J/[3^)W_0O>%O_  <W'_R-7?;J-P]:.==D'U>7
M_/V7X?Y' _VG\3O^A>\+?^#FX_\ D:C^T_B=_P!"]X6_\'-Q_P#(U=]N]Z-U
M'.NR#ZO+_G[+\/\ (X'^T_B=_P!"]X6_\'-Q_P#(U']I_$[_ *%[PM_X.;C_
M .1J[[=1N'K1SKL@^KR_Y^R_#_(X'^T_B=_T+WA;_P '-Q_\C4?VG\3O^A>\
M+?\ @YN/_D:N^W4;J.?R0?5Y?\_9?A_D<#_:?Q._Z%[PM_X.;C_Y&H_M/XF]
M_#_A?_P<W'_R-7?;J0L*.?R0?5Y?\_9?A_D?B/\ M')9R_';QT^K33VNI-JT
MYN(;.,2PH^XY".Q4L/<@?2O./L^A?\_VH?\ @*G_ ,77>_M3\_M&?$7_ +#5
MS_Z&:\LKV8OW5H?D^(IM5I^\]WV[^AK>1H7_ #_:A_X"I_\ %T>1H7_/]J'_
M ("I_P#%UE8]J3\*JYS\C_F?X?Y&MY&A?\_VH?\ @*G_ ,71Y&A?\_VH?^ J
M?_%UE8]J/PHOY!R/^9_A_D:OD:%_S_:A_P" J?\ Q='D:%_S_:A_X"I_\765
MCVHQ[47\@]F_YG^'^1J^1H7_ #_:A_X"I_\ %T>1H7_/]J'_ ("I_P#%UE8]
MJ,>U%P]F_P"9_A_D:OD:%_S_ &H?^ J?_%THM]"S_P ?U_\ ^ J?_%UDX]J!
MUHN'(_YG^'^1[WJ_E'X6?#=9'<62V-Y]ED509)%^VS;BZ]%(;( !.0 >,XKF
M/+L?^>UQ_P!^A_C72:T/^+._"K_L'7W_ *7SUR-=--^Z>#F,6L3)7?3\EY%K
MR['_ )[7'_?H?_%4>78_\]KC_OT/_BJJXHK2YYO*^Y:\NQ_Y[7'_ 'Z'_P 5
M1Y=C_P ]KC_OT/\ XJJM)1<.5]V6_+L?^>UQ_P!^A_\ %4>78_\ /:X_[]#_
M .*JKBBBX<K[EKR['_GM<?\ ?H?_ !5'EV/_ #VN/^_0_P#BJJT47#E?<M>7
M8_\ /:X_[]#_ .*HV6/_ #VN/^_0_P :J]Z.U%PY7W/K3]CJ;68/"/BL:#:6
M5[ =0MC,VH7#P,K>4^T*%1\C&<DD?2O?/MOC7_H#Z%_X,YO_ (S7BW[#'_(D
M^,_^PG:_^B9*^DLCUK2EL_4Y\QBU*GK]E?FSEOMOC7_H#Z%_X,YO_C-'VWQK
M_P! ?0O_  9S?_&:ZG(HR*W/(L<M]M\:_P#0'T+_ ,&<W_QFC[;XU_Z ^A?^
M#.;_ .,UU)(%&10%O,J>"K_QZNM@VVB^'WE\MN)=4F48X[B UW_]I_$[_H7_
M  O_ .#FX_\ D:J'P_('B!>?^63_ -*]-#>]?.XZ5JVW0_>.#J+GE::FU[SV
MMY>1P/\ :?Q._P"A>\+?^#FX_P#D:C^T_B=_T+WA;_P<W'_R-7?;J-U>=SKL
MC[?ZO+_G[+\/\C@?[3^)W_0O>%O_  <W'_R-1_:?Q._Z%[PM_P"#FX_^1J[[
M=1N]Z.?R0?5Y?\_9?A_D<#_:?Q._Z%[PM_X.;C_Y&H_M/XG?]"]X6_\ !S<?
M_(U=]NHW#UHYUV0?5Y?\_9?A_D<#_:?Q._Z%[PM_X.;C_P"1J/[3^)W_ $+W
MA;_P<W'_ ,C5WVX>M&\>M'/Y(/J\O^?LOP_R.!_M/XG?]"_X7_\ !S<?_(U'
M]I_$[_H7_"__ (.;C_Y&KOMWO1N]Z.==D'U>7_/V7X?Y' _VG\3O^A>\+?\
M@YN/_D:C^T_B=_T+WA;_ ,'-Q_\ (U=]NHW4<_D@^KR_Y^R_#_(X'^T_B=_T
M+WA;_P '-Q_\C4?VG\3O^A>\+?\ @YN/_D:N^W4;J.==D'U>7_/V7X?Y' _V
MG\3O^A>\+?\ @YN/_D:C^T_B=_T+WA;_ ,'-Q_\ (U=]O%&[WHYUV0?5Y?\
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M78V_[-W@^SU'7[V!;Z&77/#\?AR^"77RR0(FP2XQQ,4VJ7'4(F1Q5G6?V?\
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M*&>*/P_:F.:*6W<2;G_=2 *\0W,<)M50$&% &  *LM\*?"+8SH%D<8QF//\
MRW\__P!&_/\ 6NK_ "H_*@#SN#]GKX>6[0,OA:S9X2"C2-(YP%VA268Y3;\N
MPY7;\N,<5Z(!CI1^5'Y4 +12?E1^5 "T4GY49^E "T4GY4F: '44W.?2ES]*
M %I,8H_*C\J %HI/RH_*@!:*3\J/RH 6BD_*C/TH 6BD_*C\J %HI/RH_*@
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MI?B_\SYL\#?%ZR\3>%8==O\ Q5K$-M<LBV\&A:I'K$^?+\R02I%:*8RB\MU
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MO",$W #6XS#@C]X..1ZUG7GQA\,PK9R6WB_QI=PW%W';><;=84$;2&,W ,D
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M>?\ 0X>(?^_\/_QJC_A7]Y_T.'B'_O\ P_\ QJNQHHYY!]5I=G][_P SCO\
MA7]Y_P!#AXA_[_P__&J/^%?WG_0X>(?^_P##_P#&J[&BCGD'U6EV?WO_ #..
M_P"%?WG_ $.'B'_O_#_\:H_X5_>?]#AXA_[_ ,/_ ,:KL:*.>0?5:79_>_\
M,X[_ (5_>?\ 0X>(?^_\/_QJC_A7]Y_T.'B'_O\ P_\ QJNQHHYY!]5I=G][
M_P SCO\ A7]Y_P!#AXA_[_P__&J/^%?WG_0X>(?^_P##_P#&J[&BCGD'U6EV
M?WO_ #.._P"%?WG_ $.'B'_O_#_\:H/P_O/^AP\1?]_X?_C5=C2'I1SR#ZK2
M[/[W_F?B)^TI=IIWQ[\>VKVT%\\6KW"&YN@6ED(8_,Q! )^@%>:G6(O^@78_
M]\/_ /%5Z%^U/_R<9\1?^PU<?^AFO*Z]B+=D?D^(IQ5::\V:7]L1?] NQ_[X
M;_XJC^V(O^@78_\ ?#?_ !59M%7<Y^2)I?VQ%_T"['_OAO\ XJC^V(O^@78_
M]\-_\56;11<.2)I?VQ%_T"['_OAO_BJ/[8B_Z!=C_P!\-_\ %5FT47#DB:7]
ML1?] NQ_[X;_ .*H_MB+_H%V/_?#?_%5FT47#DB:7]L1?] NQ_[X;_XJ@:Q%
MG_D%V/\ WPW_ ,56;0.M%V')$]\U>0)\*/AI/Y:,L]A>,L)'R0XO9AA!U .,
MG)/)-<M]K3_GUA_(_P"-=-K0Q\'/A5_V#[[_ -+YZY"NFF_=/ S&$5B9)>7Y
M(L_:T_Y]8/R/^-'VM/\ GU@_(_XU6HK0\SE19^UI_P ^L'Y'_&C[6G_/K!^1
M_P :K44!RHL_:T_Y]8/R/^-'VM/^?6#\C_C5:B@.5%G[6G_/K!^1_P :/M:?
M\^L'Y'_&JU%%PY46?M:?\^L'Y'_&C[6A_P"76#\C_C5:BBX<J/L/]B(7LGA7
MQ?<6.JWNC,M_;1LM@R*'!B<Y;>K<C';%?2'F:_\ ]#?K?_?<'_QJOG3]A?GP
M5XS_ .PG:?\ HEZ^D\44Z<)IN44]>QMB\;BL-[.%&K**Y5HI-+=D'F:__P!#
M?K?_ 'W!_P#&J/,U_P#Z&_6_^^X/_C53XHQ6OL:?\J^X\_\ M7'_ //^?_@3
M_P R#S-?_P"AOUO_ +[@_P#C5'F:_P#]#?K?_?<'_P :J?%&*/8T_P"5?<']
MJX__ )_S_P# G_F:'A73M8UG51;7'B_7MA1F^26 'C'_ $RKLAX O/\ H</$
M7_?^'_XU6#\/_P#D85_ZY/\ TKTX5X&-]RK:*LK'[5PFGB\M57$2<I<SU;?^
M9Q__  K^\_Z'#Q#_ -_X?_C5'_"O[S_H</$/_?\ A_\ C5=C17#SR/LOJM+L
M_O?^9QW_  K^\_Z'#Q#_ -_X?_C5'_"O[S_H</$/_?\ A_\ C5=C11SR#ZK2
M[/[W_F<=_P *_O/^AP\0_P#?^'_XU1_PK^\_Z'#Q#_W_ (?_ (U78T4<\@^J
MTNS^]_YG'?\ "O[S_H</$/\ W_A_^-4?\*_O/^AP\0_]_P"'_P"-5V-%'/(/
MJM+L_O?^9QW_  K^\_Z'#Q#_ -_X?_C5'_"O[S_H</$/_?\ A_\ C5=C11SR
M#ZK2[/[W_F<=_P *_O/^AP\0_P#?^'_XU1_PK^\_Z'#Q#_W_ (?_ (U78T4<
M\@^JTNS^]_YG'?\ "O[S_H</$/\ W_A_^-4?\*_O/^AP\0_]_P"'_P"-5V-%
M'/(/JM+L_O?^9QW_  K^\_Z'#Q#_ -_X?_C5'_"O[S_H</$/_?\ A_\ C5=C
M11SR#ZK2[/[W_F<A%X$NX9D<^+?$$@5@=CS0[6]C^ZZ45U]%+F92P]..R_%_
MYGQ=XC\??$_Q5IMSK6E/J^Z#0;S4I;73[YK46$JZA-"-L0@;[2T,4:DPLR,^
MPCEG%>@Z%\:_&3:M?%+&"]T&PU&&.21[&YDN+V&XO[JW$D# X4(D,4H7:V0^
MW(!4UW=A\4]/TIKHV?@+QC;?:IFN9A%H$BAY6 #.1GJ<#)[GD\YJV/C3'_T)
M?C;_ ,$4G^-/DEV,_KE#^;\SS/P?\>O&'CWX?>+[K^Q+BT:WBE%KK^EVB2BS
MW6<<R.UJ9F>9D>0KLCW-^[(95;*UU'[/GQ &IVM_INIZQ)?3M?\ DZ?<37YO
M8+K_ $9)9$MKAXHI)0GSE@Z90Y&2!QT@^-,0'_(E>-OQT*3_ !J-OC%;/+'(
MW@?QFTD>=CMH,A*YZX.>*?)+L/ZY0_F_,\5FN/BO-H7Q \1VVJ:G!:6UYKEI
M;K)J):255N)(K58+;[-^XV80B4.Y*J3M;=Q/9^*/%VB:AJ6A>,-;UGPUHEOK
M:1WMU%>/>RVMLUJS0.+\P(1#/,N,A/D,90D%Z]G_ .%TQ_\ 0E^-?_!%)_C1
M_P +IBY_XHKQK_X(I/\ &CDEV#ZY0_F_,XSP;KGC/49/AQ>S:U>RZ)=:UJ5D
MR3V*B74;)8KQK2YN'*!E!6*$C"IN)5B3NVUYY\3_ !S\1O#FBW:1^);XWMMK
MVII'>2V_V2&94M8WMX%,<,A)#N?+A(Q-L8-(".?=O^%TQ_\ 0E^-?_!%)_C0
M?C3&?^9+\;?^"*3_ !I<DNPOKE#^;\SR;4_BOX^77_B!?W>G:[X?M-.T2#4-
M+L+RRB2W#17+<&16;?).N-RY&%PHP06/U"H!'05Y=?\ Q7L-4A6*[\!>,;F)
M9$F"2Z!(RAT8,C8SU# $>X%6_P#A=<?_ $)7C7_P12?XT^278/KE#^;\ST?:
M/2EKS?\ X77'_P!"5XU_\$4G^- ^-4;$#_A"_&@SW.A2?XTN278?URA_-^9Z
M/FC SG'-1PR^;$DFUDW*&VN,,,]B/6N#O_C EA?7-J?!_B^<PR-'YMOHLCQO
M@XW*V>5/8]ZE1;V-JE:%))S=KGH&T>E&T>E><?\ "ZX_^A*\:_\ @BD_QH_X
M77'_ -"5XU_\$4G^-5R2[&'URA_-^9Z/M'H*6O-_^%UQ_P#0E>-?_!%)_C1_
MPNN/_H2O&O\ X(I/\:?)+L'URA_-^9Z117F__"ZX_P#H2O&O_@BD_P :/^%U
MQ_\ 0E>-?_!%)_C1R2[!]<H?S?F>D45YO_PNN/\ Z$KQK_X(I/\ &C_A=<?_
M $)7C7_P12?XT<DNP?7*'\WYGH]4-?T\ZOHE_8K(T37,#Q!T;!7<I&<_C7#'
MXUQG_F2O&O\ X(I/\:V] ^(*Z]8:A=+X?\06 LUWF+4--:&2;@\1J3\YXZ#V
MI.$D7'%4INT9?F>=>"OV>ELK2ZU'5&$&OW&CV^E1F.>4QVXB@: L463RY P.
MX97(!QG(K"E_9)>PLK&#2];@DCM[:S#P:O#->)-/ NSYB\I;R&!9O*SA75"N
M.<^C#XV1$ _\(7XT'UT*3C]>*7_A=D9Z>"O&O_@BD_QI^SEV(^N4/YOS,_X.
M?">_^'FH2?:I8#;VNE6NDVYM(Q%'.(V=FD\L$[!\R@ DX^;MBO6:\V_X79'_
M -"5XU_\$4G^-'_"[(_^A*\:_P#@BD_QHY)=A_7*'\WYGI-%>;?\+LB'_,E>
M- /?0I!_6@_&R(''_"%^-,^G]A29_G1R2["^N4/YOS/2:*\W_P"%UQ_]"5XU
M_P#!%)_C1_PNN/\ Z$KQK_X(I/\ &CDEV']<H?S?F>D45YO_ ,+KC_Z$KQK_
M ."*3_&C_A=<?_0E>-?_  12?XT<DNPOKE#^;\STBBO-_P#A=D8_YDKQI^.A
M2?XTG_"[(_\ H2O&I_[@4G^-'LY=A_7*'\WYGI-%>;_\+LB Y\%^-!]="D_Q
MH_X79'_T)7C7_P $4G^-')+L+ZY0_F_,](HKS;_A=D?_ $)7C7_P12?XTO\
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M !HY)=@^N4/YOS/2**\W_P"%UQ_]"5XU_P#!%)_C1_PNN/\ Z$KQK_X(I/\
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MZ%\'G4W\+Z6VM0-;ZJ;=/M,<DB2,LF/F!9 %//< "MFB@!,#T%&!Z"EHH 3
M]!1@>@I:* $P/048'H*6B@!,#T%&!Z"EHH 3 ]!1@>@I:* $P/048'H*6B@!
M,#T%&!Z"EHH 3 ]!1@>@I:* $P/04A QTIU(>E 'X>?M3\?M&?$7_L-7'_H9
MKRLFO5/VI_\ DXSXB_\ 8:N/_0S7E9KVX?"C\@Q/\:?JPS1FBBJ.8,T9HHH
M,T9HHH ,T9HHH ,T \T4#K3 ]YUL8^#GPJ_[!]]_Z7SUR%=AK?\ R1SX5?\
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MQ"S,"0!K$AR <$_@2/SH_P"%>6@3?_PD?B#;NV[O[8DQG.,?GQ1:/</:5_\
MGVOO_P" 1>#?A_<>'O%,^J75Q!*D6CV>C6JV\2P@I"7=W** J99P B\*$XZX
M'=9KBQ\.K5I#&/$7B'S  Q3^UY,@'H<?@?RI_P#PK2'_ *&#Q'_X-I:+1[A[
M2O\ \^U]_P#P#L<T9KCO^%:0_P#0P>(__!M+1_PK2'_H8/$?_@VEHM'N'M*_
M_/M??_P#L<T9KCO^%:0_]#!XC_\ !M+1_P *TA_Z&#Q'_P"#:6BT>X>TK_\
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M]DU>[CN'D90^(1M\ME16!<ELC-%H]P]I7_Y]K[_^ ?3&:,UQW_"M(?\ H/\
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M#Q'_ .#:6C_A6D/_ $,'B/\ \&TM%H]P]I7_ .?:^_\ X!V.:,UQW_"M(?\
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MX(>.PC;1V>.U9W*O=S,+DLP=C<9<^?EU5OWF>5'88KT//-'- '+>#OAEX?\
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M6LPTG4;*WFDW"16\\)/&40&%_F.$9E8G _BS@G-',NR#V$O^?DOP_P CU?\
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M $*>@?\ @^D_^1J/[=^)'_0IZ!_X/I/_ )&KT"BCF79!["7_ #\E^'^1Y_\
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MAL@#)R #QG%<QY5E_P _$W_?D?\ Q5=)K7_)'/A5_P!@^^_]+YZY"NBF_=/
MS&+6)EJ^GY(M^59?\_$W_?D?_%4>59?\_$W_ 'Y'_P 552BM#S+/N6_*LO\
MGXF_[\C_ .*H\JR_Y^)O^_(_^*JI10%GW+?E67_/Q-_WY'_Q5'E67_/Q-_WY
M'_Q55** L^Y;\JR_Y^)O^_(_^*H\JR_Y^)O^_(_^*JI10%GW+?E67_/Q-_WY
M'_Q5'E67_/Q+_P!^1_\ %54HH"S[GUK^QU<:O:^$O%8T.PM=1@;4+8RO>W36
MQ1O*?  "/N!&><BO??[3\8?] #2?_!L__P 8KQ7]A?\ Y$GQG_V$[7_T2]?2
M=:4GH_4Y\QC:=/7[*_-G+?VGXQ_Z &D_^#9__C%']I^,?^@!I/\ X-G_ /C%
M=316YY)RW]I^,?\ H :3_P"#9_\ XQ1_:?C'_H :3_X-G_\ C%=310!4\%:K
MXX36PUMX<T:67RV^5]9D48X[^0:[[^W/B0/^93T#_P 'TG_R-5#X?_\ (Q+_
M -<G_I7IPZ5\YCI+VVW0_>.#J4I96FIM>\]K>7D<!_;OQ(_Z%/0/_!])_P#(
MU']N_$C_ *%/0/\ P?2?_(U>@45Y_,NR/N/82_Y^2_#_ "//_P"W?B1_T*>@
M?^#Z3_Y&H_MWXD?]"GH'_@^D_P#D:O0**.9=D'L)?\_)?A_D>?\ ]N_$C_H4
M] _\'TG_ ,C4?V[\2/\ H4] _P#!])_\C5Z!11S+L@]A+_GY+\/\CS_^W?B1
M_P!"GH'_ (/I/_D:C^W?B1_T*>@?^#Z3_P"1J] HHYEV0>PE_P _)?A_D>?_
M -N_$C_H4] _\'TG_P C4?V[\2/^A3T#_P 'TG_R-7H%%',NR#V$O^?DOP_R
M//\ ^W?B1_T*>@?^#Z3_ .1J/[=^)'_0IZ!_X/I/_D:O0**.9=D'L)?\_)?A
M_D>?_P!N_$C_ *%/0/\ P?2?_(U']N_$C_H4] _\'TG_ ,C5Z!11S+L@]A+_
M )^2_#_(\_\ [=^)'_0IZ!_X/I/_ )&H_MWXD?\ 0IZ!_P"#Z3_Y&KT"BCF7
M9!["7_/R7X?Y'!V^M?$-[B-9O"VAQPE@'=-<D8J.Y ^SC)]LT5WE%+F78I49
M+[;_  _R,5O!V@OK,^KMH>G-JUQ#]GFOS9QF>2+D>6TFW<5Y/!..:BT?P'X;
M\/3&72O#^E:9*6#E[.QBA;< R@Y51SAF&?1B.YKBSH_PQ&LW>D'6K,:M:(TE
MQ8GQ%+Y\**H9F>/SMR@*022!@$&H=)M/A3KS1+IGB'3]1:69;>-;3Q*\I>5E
M9E0;9SEBJL0.I"D]J=H]_P !<U?^1?\ @3_^1/2(- TVT2T2#3K2%;3=]G$=
MNJB'=D-LP/ESDYQC.:CL_"^CZ?I?]F6NE65MIN\R?8X;9$AW%MQ;8!MSN^;.
M.O-<);:#\-;W4K73[?5K:>_NHWE@M8_$$K2RHA8.R*)LL 4<$@8!5L]#3[+P
MW\.=2TR#4;34X+K3Y[A;2*Z@U^5XI)F8*L:N)L%RQ"A0<DG&*+1[_A_P0YJ_
M\B_\"?\ \B>BVME!9F8P01P&:0RR>6@7>YP"QQU/ Y/I4^?\XKS+1?#OPW\2
M:I>Z;I6JV^IZA9$K=6EGX@EFE@(;:0Z+,2N#P<@<\5N_\*D\,_\ /K>?^#.Z
M_P#CE%H]_P /^"'-7_D7_@3_ /D3L,_7\J,_7\JX_P#X5)X9_P"?6\_\&=U_
M\<H_X5)X9_Y];S_P9W7_ ,<HM'O_ %]X<U?^1?\ @3_^1.PS]?RHS]?RKC_^
M%2>&?^?6\_\ !G=?_'*/^%2>&?\ GUO/_!G=?_'*+1[_ (?\$.:O_(O_  )_
M_(G89^OY49^OY5Q__"I/#/\ SZWG_@SNO_CE ^$OAD$'[+>?^#*Z_P#CE%H]
M_P"OO#FK_P B_P# G_\ (G7@UE3>%-%N=:CUB72+"35XEV1W[VJ&X1?028W
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MAKQKX-T;7#IM[:M?VJ3M"=3NOD)'(!\SD9S@]QBBT>_X?\$.:O\ R+_P)_\
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M;6C_ ,6<^%/3_D'WW_I?/7(Y]Z[+6)6C^%'PTN@1YUU8WCRD@$$B]F48'0<
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MBN*_MWQS_P!"II?_ (.S_P#&*/[=\=?]"II?_@[/_P 8HY'W7WH/K4/Y9?\
M@,O\CM:*XK^W?'/_ $*FE_\ @[/_ ,8I1KOCDD9\*Z6!_P!AL_\ QBCD??\
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M4\K #%=IZ$=0 ".A%)_;GCK_ *%32_\ P=G_ .,4G]N^.O\ H5-+_P#!V?\
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M?[2,=K<?'KQY)J%Q)97K:O.9K>&+SDC;<<@/E=P]\#Z5YO\ 9=)_Z"-Q_P"
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MNCXC]M4\/_\ @5+_ /&Z/;TOYD']C9C_ ,^)?<=-_P $S_\ D:_'?_7E9_\
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M?V[XY_Z%32__  =G_P",4<C[K[T'UJ'\LO\ P&7^1VM%<5_;OCG_ *%32_\
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ML],L[*T1L1WIFF$XN;B"1?N*&3,&5;@\\CGCU2O#](^*UMI6LWVJ:QX6\/\
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M3_K_ (?_ $57V>*^=Q/\61^]</\ _(KH^GZL6BBBN8^A"BBB@ HHHH ****
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MLJW^ OA&WVX34V!C,<X?5[HB[!+$>>/,Q*5+L5W9VY.,5=_X5I<_]#KXG_\
M R+_ .-4?\*RN?\ H=?$_P#X%Q?_ !JBT>XO:U?^?;^]?YF[X9\'Z3X0CN8]
M*MS;+<LCR R,^XI&L:_>)QA$4?AGK5W6=472-*N[UH9K@6\32^5;QF21\#.%
M4<DGT%<K_P *SNO^AT\3_P#@9'_\:J=])3P5X>UF[OO$6L7=LMNTDD]W,KO
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MJJ[B@< $PC/RLI..F:+1[A[6K_S[?WK_ #/4\CU%&1ZBN'_X5E<_]#KXG_\
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MK_S[?WK_ #.XR/449'J*X?\ X5E<_P#0Z^)__ N+_P"-4?\ "LKG_H=?$_\
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MPXO9EP@Z@'&3DGDFN7^VKG_CUM_^^3_C733MRG@YC*3Q,KKM^2*E%6_MJ?\
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M_P"%97/_ $.OB?\ \"XO_C5%H]Q^UJ_\^W]Z_P SN,CU%&1ZBN'_ .%97/\
MT.OB?_P+B_\ C5'_  K*Y_Z'7Q/_ .!<7_QJBT>X>UJ_\^W]Z_S.XR/449'J
M*X?_ (5E<_\ 0Z^)_P#P+B_^-4?\*RN?^AU\3_\ @7%_\:HM'N'M:O\ S[?W
MK_,[C(]11D>HKA_^%97/_0Z^)_\ P+B_^-4?\*RN?^AU\3_^!<7_ ,:HM'N'
MM:O_ #[?WK_,[C(]11D>HKA_^%97/_0Z^)__  +B_P#C5'_"LKG_ *'7Q/\
M^!<7_P :HM'N+VM7_GV_O7^9W&1ZBC(]17#_ /"LKG_H=?$__@7%_P#&J/\
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M_P"A/\8?^"=__BJ]"VCTHVCTHO'L'LZ__/S\/^">??\ "W5_Z$[Q?_X)W_\
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MV\L^FVRHI@ME*E]BO.N\K&Q4*2*=X]B?9U_^?GX?\$]5_P"%OKC_ )$[Q?\
M^"=O_BJ/^%OK_P!"=XO_ /!,W_Q5<E^S]X"U_P (ZEJTFHZ3)H=H]M#%+%)+
M$XOKP22-+=#8[9W!E^9L,V1D?+7MNT>E%X]A^SK_ //S\/\ @GG_ /PM]?\
MH3O%_P#X)F_^*H_X6^O_ $)WB_\ \$S?_%5Z!M'I1M'I1>/8/9U_^?GX?\$\
M_P#^%OK_ -"=XO\ _!,W_P 51_PM]?\ H3O%_P#X)F_^*KT#:/2C:/2B\>P>
MSK_\_/P_X)Y__P +?7_H3O%__@F;_P"*H_X6^O\ T)WB_P#\$S?_ !5>@;1Z
M4;1Z47CV#V=?_GY^'_!//_\ A;Z_]"=XO_\ !,W_ ,51_P +?3OX/\7C_N#M
M_P#%5-\9=&\0>(_ UWHOAM(Q>ZDZ6LEQ,^U+>%CB20X8,<+GA>:\#NOA)XG"
MIIVO?#YO%=Q8:3/H^EZI#):F.$^<KP3*TLPDBPGRY +?N_>B\>P>SK_\_/P_
MX)[M_P +?7_H3O%__@G;_P"*H_X6^O\ T)WB_P#\$S?_ !5>>^!_A_K6A^*K
M-M=\&3:YXCCO4E;QD=0CCC6W\I%(#!S,V"&'D%-ASDGDU] JHQTHO'L'LZ__
M #\_#_@G ?\ "WU_Z$[Q?_X)F_\ BJ/^%OK_ -"=XO\ _!,W_P 57H&T>E&T
M>E%X]@]G7_Y^?A_P3S__ (6^O_0G>+__  3-_P#%4?\ "WU_Z$[Q?_X)F_\
MBJ] VCTHVCTHO'L'LZ__ #\_#_@GG_\ PM]?^A.\7_\ @F;_ .*H_P"%OK_T
M)WB__P $S?\ Q5>@;1Z5XO\ M"?#_P 8?$B32-/\/"UM[+3]VIFXNI6 >[C_
M ./=%".IR&R<M\O/-%X]@]G7_P"?GX?\$ZC_ (6^O_0G>+__  3-_P#%4O\
MPM]?^A.\7_\ @F;_ .*KQ^3PQ\7=5\92:_)8ZE::K;6DTEM%+>VAL 2$*6Z;
M6+98APS,,<@[J;-I/QUEUMXD?5H(9[<K+.+FS:.,MAAY67^4H25YC8G&=V#B
MB\>P>SK_ //S\/\ @GL/_"WU_P"A.\7_ /@F;_XJC_A;Z_\ 0G>+_P#P3-_\
M57FMWI'QAL)A!;SZU>RP13)I]P+BQ,!?<=K7H8JS@KC&P9^G6N4U#PG\:/$/
MA3^S=;37K]9]GEQVKV-L4F$B,_VC=<2%H<!MNULY_A'%%X]@]G7_ .?GX?\
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MH.?N*<UZSM'I1>/8/9U_^?GX?\$\_P#^%OK_ -"=XO\ _!,W_P 51_PM]?\
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MG_H):9_X%C_"N]_:GX_:,^(O_8:N?_0S7EF?>O9C;E1^38B,_;3O+J^AK?\
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MU_Z$[Q?_ ."9O_BJ] VCTHVCTHO'L'LZ_P#S\_#_ ()Y_P#\+?7_ *$[Q?\
M^"9O_BJ/^%OK_P!"=XO_ /!,W_Q5>@;1Z4;1Z47CV#V=?_GY^'_!//\ _A;Z
M_P#0G>+_ /P3-_\ %4?\+?7_ *$[Q?\ ^"9O_BJ] VCTHVCTHO'L'LZ__/S\
M/^">?_\ "WU_Z$[Q?_X)F_\ BJ/^%OK_ -"=XO\ _!,W_P 57H&T>E&T>E%X
M]@]G7_Y^?A_P3S__ (6^O_0G>+__  3-_P#%4?\ "WU_Z$[Q?_X)F_\ BJ]
MVCTHVCTHO'L'LZ__ #\_#_@GG_\ PM]?^A.\7_\ @F;_ .*H_P"%OK_T)WB_
M_P $S?\ Q5>@;1Z4;1Z47CV#V=?_ )^?A_P3S_\ X6^O_0G>+_\ P3-_\51_
MPM]?^A.\7_\ @F;_ .*KT#:/2C:/2B\>P>SK_P#/S\/^"<';?%E;B>.+_A$?
M%D>]@N^32&55R>I.[@45W94>E%*Z[%QA56\_P_X)\J>)+?X(:?XIU;5QX-UO
M588K?4]4OKO2YIFTRUBD5[.^NUM_M"HK.HG1I(HBS8D89W%FM>'?^%*^#]3L
M[671M=M-,T>XU"UT^]U[5;G4+&-K.TN8;E(HY+F5D06WVE<-&JLHXR0E=OX+
M_9C\-Z1=VEQK]C:^(&TN&73]-6\B29%MC=/<H[*R\2AI-I(^4[%( JYJ'[+_
M (*U"]O[UK>6&^U)=5AU&[@6*.:]M[]W>6"5PF65'=6C/WE,:\D%@8.@Y'0-
M0^$7PV\/Z0\WA'6/!L7PZL9=1T>PU&VN#/!:W6^)Y(45Y#)N+LA1R7C+#<J9
M%+XS\+? ^"\N](UC1;E'L+;4_&-T\#WB*B7+H]Z&E1P'$S3*6MP64C&5 "UW
M<'P3>_M]>_X23Q7JGB.]U71Y-"%W)#;VYM[5\[RJQ(%,C$J69@1E%PJC(.IX
MW^#VC^/;26WU&XNEBDT.ZT$K'L(\F<PEGPRD%P8$QGCKD&BX'GO@KQ)\+?A_
MK\^M:/X=U'1]3\1S$ZC-(CR)9A[UU#.3(T<44EU-(<PY4L[NW +#VGPOXGL?
M%^D)J-@S^47DA>.5=LD4L;E)(W7LRLK CVXR,&O*+3]F#2K: 1G6[PQW%P9]
M2@AMX(8;Q?M2W(B5%3$*;UP=F"RLV3N.X>B?#GPK<>$=!GM[R6*6]N[^[U&?
MR,^6KSS/*57/)"[@,GK@GO3 ZJBDR*,BE<!:*3(HR*+@+129%!(Q0 M<)J?P
M2\(:QK4FI7>GSRM+=+?2V7V^X6RFN%QMF>V#^4SC:OS%"<JIZ@5W.<TN:8'G
MUA\!/!.GV;6J:7// ;26P"W6HW,Q2WD54:%2\A*IM50 ,;<<8JT_P4\%R !M
M%4@=/](E_P"?C[3_ '_^>OS?ITXKM\T9%(#RJU_9?^'=G!'#%I5^$5!$<ZS>
MDO$$$8A<F;YH]@"[#E<#I7JD<:Q(J(H5%& JC  ]*7(HR*+@+129%&11<!:*
M3(HR*+@+13<T;J8"TM-#"ER*5P%HI,BC(HN M%)D49%%P%HI,BC(HN M%)D4
M9%%P%HI,BC(HN M%)D49%%P%HI,BC(HN M%)D49%%P%HI,BC(HN M%)D49%%
MP%HI,BC(HN M%)D49%%P%HI,BC(HN M(% HR*,BBX"T4F11D47 6BDR*,BBX
M"T4F11D47 6BDR*,BBX"T4F11D47 6BDR*,BBX"TAZ49%(33 _#W]J?_ ).,
M^(O_ &&KC_T,UY6:]3_:G_Y.,^(O_8:N/_0S7EAKVH?"C\@Q/\:?JPHHHJSF
M"BBB@ HHHH **** "@=:*!U%%P/>M;_Y(Y\*O^P???\ I?/7'UU^M'_BSGPJ
M_P"P???^E\]<A732^%'@9E_O,OE^2"BBBM#RPHHHH ^_O^":/_(H^-/^O^'_
M -%5]GBOB_\ X)I'_BD?&G_80A_]%5]H @5\]B?XLC]ZX?\ ^171]/U8M%)D
M49%<MSZ$6BDR*,BBX"T4F11D47 6BDR*,BBX"T4F11D47 6BDR*,BBX"T4F1
M1D47 6BDR*,BBX"T4F11D47 6BDR*,BBX"T4F11D47 6BDR*,BBX"T4F11D4
M7 6BDR*,BBX"T4F113 \]/P^TM;J6V/BOQ#]IBC$TD)U^7>B'.&(SD+P>3QQ
M4=EX)T346 M/&.NW)+;<0^(9'YP3CANN 3^%?+MM^SG\0=/\1:G:'P3I=YJ=
MPWB:2^\<3SV[3:I#>P7@LHXYC(+E9$,MO"T4B&)40LK9VXS/!W[*7C>Z\'?#
MS1[?PY<^!M<\.ZI#JLVNR1:/!MN8=,GC@;;8<W$0N=@;SP79)FSGYJOGEW.3
MZI0_D1]>)\.=.D,6WQ3XC;S21'C7I3O(SG'/.,'./2E'PWT\XQXH\2$%_+_Y
M#LOW_P"[UZ^W6O /A1^SQXPTC4?@/K6N::;'5M!77D\0QVVJEX+);O[4\8A4
M.5)+S*-ZC=@+DX7CB?$G[*WCFV\(V.C6/A4:XEOXD\22V7VO6QYE@MW?Q2V.
MI-)(Q9VCBC?)R909.A):GSR[A]4H?R(^N$^&%G*Q"^)?$K$=0-<F./UJ3_A5
M5O\ ]#%XG_\ !U-_C7+_  B^%2^&/B9\2O&%]H-AHE[K.HK:V'V$1 36$<:N
M)FV ?O);B2X9RV6.U,G %>OYS1SR[A]4H?R(XC_A55O_ -#%XG_\'4W^-'_"
MJK?_ *&+Q/\ ^#J;_&NXHHYY=P^J4/Y$</\ \*JM_P#H8O$__@ZF_P :/^%5
M6_\ T,7B?_P=3?XUW%%'/+N'U2A_(CA_^%56_P#T,7B?_P '4W^- ^%=N"#_
M ,)%XGX]=:F_QKN**7/+N'U2A_(B..+RXU0,S;0!ECDGZGUKB+WP'IUUK,L3
M^)M>AO)]UP+2+6Y$(7/)6,'A03C@8%=T1D'%?,^L_#3QI:^-[RXTKPKIEWJT
MNO'4X?%%_'#,@MR$509/-2>)XEWHL:HZ-GT+"DI-;&TZ4*B2FKGK_P#PJRU_
MZ&/Q-_X.YO\ &E_X59;9Q_PD?B?/_8;F_P :\)T'P'\=+O3&74->UJWGM[*X
ME0+?0+YNH"*/8<[G+0F4.0I*KCJB@XKH(O ?Q;@UY=3_ +;UB4-<"X>S?4XA
M;@_;SE0NWA/LAQMY&0#C<*?/+N8_5*'\B/4V^&-FKA#XE\2AFZ+_ &Y-DX_&
MI/\ A55O_P!#%XG_ /!U-_C7SE!\._C5<W4=_>)KGVV!9O[/FCUF'?;3R0HN
M)69R7@$R9*CJ,$(!\M?7]HLRVL0N&1[@(/,:,$*6QR0#T&:?/+N'U2A_(CC?
M^%56_P#T,7B?_P '4W^-'_"JK?\ Z&+Q/_X.IO\ &NXHHYY=P^J4/Y$</_PJ
MJW_Z&+Q/_P"#J;_&D_X55;_]#%XG_P#!U-_C7<T4<\NX?5*'\B.'_P"%56__
M $,7B?\ \'4W^-6'\.0^#O#NLSKJ.L7Z_9WD(N]1DD==JD_(QY0^XKL*I:RD
M$FE7:74,EQ;-$PDBB1G=UP<@*O))'8<TG.3ZE1PU&#O&)\J>!/BWI_B-;5]1
M/BIK>\BMFM;KPYXANM2B,DJ,[0RDQQE'C5"SXW* .HX!V-1^*W@S3;BP\_5/
M'UM93AI9[F[U">$00>2\L4Y4MEDD"$*1SGJ >*]+T/Q)X \2>$S<I:7EII/@
M]OLOEZG9W%JUH5@"[-LH!;$3@=_O#O7G21?!N]@DTV3PUX@NA')+#'Y]A>R^
M>T,+*]M'(<AQ'&7 CW8&&V\C-'/+N3]4H?R(A_X6KX--XL4>J^/+O<A;R+2_
MN9;B-E#&0.H.P!50G(<UT?B#6/#_ (:\0:-97>K>-3IFI6!OQJ\>K3&"!"\:
MKYG.5!\T'/0=ZS-%U?X*V=E:ZM-8ZE9/<VD[V\VKP78N+N(D1/L#Y:1F,VT
M DD\#BM#XAWO@;Q0)O#MQ#K.@ZA9:2T#7%QI%R(HM/;RUE!+8C<<H,DL01D
MD4<\NX?5*'\B,V/XB^"I_M9@U3XC7$=O.]OYL<USME*+ND9#GYE5<,2.Q&,Y
MJE=?%?P&LLWV3Q)XRO+>WF\J29=2N<2#9OS$%R6.,8#;,YR"17KT_P #?!E_
MI5K9-IC?9H7\Q##=21L<PK"P+(PRK1HJE>A Z57F_9Y\!W5Z]U/H0FD(V1A[
MB4K"G]R,;L(O ^4<<=*.>7</JE#^1'GG_"?^!8;^QL;OQ)XWTZ_N)3#+:7FH
M3QR6C;E7]\-WR@ETP1G[WUP[Q3XL\->$_'&L>%+K7O%+:K8Z>FII''K=P^Z
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M)_\ P=3?XT?\*JM_^AB\3_\ @ZF_QKN**.>7</JE#^1'#?\ "JK?_H8O$_\
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M>)__  =3?XUW%%'/+N'U2A_(CA_^%56__0Q>)_\ P=3?XT?\*JM_^AB\3_\
M@ZF_QKN**.>7</JE#^1'#_\ "JK?_H8O$_\ X.IO\:/^%56__0Q>)_\ P=3?
MXUW%%'/+N'U2A_(CA_\ A55O_P!#%XG_ /!U-_C1_P *JM_^AB\3_P#@ZF_Q
MKN**.>7</JE#^1'#_P#"JK?_ *&+Q/\ ^#J;_&C_ (55;_\ 0Q>)_P#P=3?X
MUW%%'/+N'U2A_(CA_P#A55O_ -#%XG_\'4W^-'_"JK?_ *&+Q/\ ^#J;_&NX
MHHYY=P^J4/Y$</\ \*JM_P#H8O$__@ZF_P :/^%56_\ T,7B?_P=3?XUW%%'
M/+N'U2A_(CAO^%56_P#T,7B?_P '4W^-+_PJJW_Z&+Q/_P"#J;_&NXHHYY=P
M^J4/Y$</_P *JM_^AB\3_P#@ZF_QH_X55;_]#%XG_P#!U-_C7<44<\NX?5*'
M\B.'_P"%56__ $,7B?\ \'4W^-'_  JJW_Z&+Q/_ .#J;_&NXHHYY=P^J4/Y
M$<5!\+[>":.0>(/$KE&#;7UF8J<=B,\BBNUHI<\NY<</2CHHGR+IG_"S_BOJ
M,7V'5+W2[J;2;R26=]2NK*WTR_\ [1GB4>5%&RS-%&D8\F4J"%&3\Q-2:L_Q
M5TS6-3U+3YM9$]Q=^)(-.<7=S=17,T8N%L8);21!#:H=JR1S*6#&)$)'F\^Z
MVOCNYLFF-O\ #SQ'"9Y#++Y<%JN]R "QQ/R3@<^U3'XDZB?^9"\3_P#?NV_^
M/T<DB/K5+S^Y_P"1XS/>:]>>&O'4/@'7_&K:;;^&6F&IZO'+-=QZFNXB&#[2
MI<2M&")%1"J$Q[<,2*ZCXFR^.=.U>]OM%U/69UE\%7SV^G6ULIBAOD>VV.,(
M6:=@TN Q/ (5>I/??\+)U$?\R%XG_P"_=M_\?I?^%DZC_P!"%XG_ ._=M_\
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M]"'XG_[]VW_Q^C_A96H_]"%XG_[]VW_Q^CDD'UNEY_<_\CNJ*X7_ (65J/\
MT(7B?_OW;?\ Q^C_ (65J/\ T(7B?_OW;?\ Q^CDD'UJEY_<_P#([JBN%_X6
M5J/_ $(7B?\ []VW_P ?H_X65J/_ $(7B?\ []VW_P ?HY)!]:I>?W/_ ".Z
MHKA?^%E:C_T(7B?_ +]VW_Q^C_A96H_]"%XG_P"_=M_\?HY)!]:I>?W/_([J
MBN%_X65J/_0A>)_^_=M_\?H_X65J/_0A>)_^_=M_\?HY)!]:I>?W/_([JBN%
M_P"%E:C_ -"%XG_[]VW_ ,?H_P"%E:C_ -"%XG_[]VW_ ,?HY)!]:I>?W/\
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M !-']B0?]!BP_-__ (FBP>TC_29DT5K?V)!_T%[#\W_^)H_L2#_H,6'YO_\
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M?_'Z/^%E:C_T(7B?_OW;?_'ZY^21[_UJEY_<_P#([JBN%_X65J/_ $(7B?\
M[]VW_P ?H_X65J/_ $(7B?\ []VW_P ?HY)!]:I>?W/_ ".ZHKA?^%E:C_T(
M7B?_ +]VW_Q^C_A96H_]"%XG_P"_=M_\?HY)!]:I>?W/_([JBN%_X65J/_0A
M>)_^_=M_\?H_X65J/_0A>)_^_=M_\?HY)!]:I>?W/_([JBN%_P"%E:C_ -"%
MXG_[]VW_ ,?H_P"%E:C_ -"%XG_[]VW_ ,?HY)!]:I>?W/\ R.ZHKA?^%E:C
M_P!"%XG_ ._=M_\ 'Z/^%E:C_P!"%XG_ ._=M_\ 'Z.20?6J7G]S_P CNJ*X
M7_A96H_]"%XG_P"_=M_\?H_X65J/_0A>)_\ OW;?_'Z.20?6J7G]S_R.ZHKA
M?^%E:C_T(7B?_OW;?_'Z/^%E:C_T(7B?_OW;?_'Z.20?6J7G]S_R.ZHKA?\
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M\B+@R%1@%O4@=ZM[?K7$_P#",^-/^ARM/_!(O_QV@^&?&O\ T.5I_P""1?\
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M_P".T?\ "->-?^ARM/\ P2+_ /':.5=U^/\ D'MY_P#/J7_DO_R1^.7[4_\
MR<9\1?\ L-7'_H9KRLUZW^TC+;6OQY\>17]LU_>IJ\ZS722F%96W'+! "%SZ
M9->;_;=+_P"@7+_X%G_XFO9@ERK4_*,1.3JS]U[OMW]3,HK3^VZ7_P! N7_P
M+/\ \31]MTO_ *!<O_@6?_B:K3N<_,_Y7^'^9F45I_;=+_Z!<O\ X%G_ .)H
M^VZ7_P! N7_P+/\ \33LNX<S_E?X?YF916G]MTO_ *!<O_@6?_B:/MNE_P#0
M+E_\"S_\319=PYG_ "O\/\S,HK3^VZ7_ - N7_P+/_Q-'VW2_P#H%R_^!9_^
M)HLNX<S_ )7^'^9F4#K6G]MTO_H%R_\ @6?_ (FC[;I?_0+E_P# L_\ Q-+3
MN',_Y7^'^9[-K7_)'/A5_P!@^^_]+YJY"NRU=HQ\*OAK(R%K:2PO#!!NP80+
MV8$%OXLG)S@8SBN6\ZU_Y]6_[_'_  KIIKW3Y_,9-XF3<7T[=EYE:BK/G6W_
M #[-_P!_C_A1YUM_S[-_W^/^%:'FW?;\O\RM15GSK;_GV;_O\?\ "@36O_/L
MW_?X_P"% 7?;\O\ ,^]?^":/_(I>-/\ K_A_]%5]GBOA;_@GWIVLZGX6\6G0
M]7BT6-;Z(2)-9BZWGR^""67'TKZS_P"$:\:_]#E:?^"1?_CM>!B(IU9:_F?N
M60UIK+:*5-O3^[W?]X[>BN(_X1GQI_T.5I_X)%_^.T?\(SXT_P"ARM/_  2+
M_P#':YN5=U^/^1[_ +>?_/J7_DO_ ,D=O17$?\(SXT_Z'*T_\$B__':/^$9\
M:?\ 0Y6G_@D7_P".T<J[K\?\@]O/_GU+_P E_P#DCMZ*XC_A&?&G_0Y6G_@D
M7_X[1_PC/C3_ *'*T_\ !(O_ ,=HY5W7X_Y![>?_ #ZE_P"2_P#R1V]%<1_P
MC/C3_H<K3_P2+_\ ':/^$9\:?]#E:?\ @D7_ ..T<J[K\?\ (/;S_P"?4O\
MR7_Y([>BN(_X1GQI_P!#E:?^"1?_ ([1_P (SXT_Z'*T_P#!(O\ \=HY5W7X
M_P"0>WG_ ,^I?^2__)';T5Q'_",^-/\ H<K3_P $B_\ QV@>&?&O_0Y6G_@D
M7_X[1RKNOQ_R#V\_^?4O_)?_ )([>BN(_P"$9\:?]#E:?^"1?_CM!\,^-?\
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M^P???^E\]<A732^%'S^9?[S+Y?D@HHHK0\P**** /O[_ ()H_P#(H^-/^O\
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M'_@MNO\ XU1_PO?P5_T%+C_P6W7_ ,:HHH^K0[L?]O8G^6/W/_,/^%[^"O\
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ML?\ ;V)_EC]S_P P_P"%[^"O^@I<?^"VZ_\ C5'_  O?P5_T%+C_ ,%MU_\
M&J**/JT.[#^WL3_+'[G_ )A_PO?P5_T%+C_P6W7_ ,:H_P"%[^"O^@I<?^"V
MZ_\ C5%%'U:'=A_;V)_EC]S_ ,P_X7OX*_Z"EQ_X+;K_ .-4?\+W\%?]!2X_
M\%MU_P#&J**/JT.[#^WL3_+'[G_F'_"]_!7_ $%+C_P6W7_QJC_A>_@K_H*7
M'_@MNO\ XU111]6AW8O[>Q/\L?N?^8?\+W\%?]!2X_\ !;=?_&J/^%[^"O\
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MCW_H3M;_ / &3_"C_A2WCW_H3M;_ / &3_"BBBP>U?8/^%+>/?\ H3M;_P#
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..[\/FU>K%N45^/^9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>gmab-20241106xex99d1006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &* Z@# 2(  A$! Q$!_\0
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MNM.O;.QN7L+431HUR&,;[@W^K 4[F[>]=]#JUG<SSPQ7<$DT'^MC212T?^\
M>/QH N45R'BCXL>$_!VG6%]JFN6D-M?WL>G6KQ/YOFW#G"QC9GG/7T[U:\/^
M/;#7K&^NY(KG2(;2]DL6.JQBV\QDQ\R;C\R'/![T =+15.XU>RM,>?=P0Y(
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MI;57NM.M/&%E:W'A6XO-(N=11(O%<=A:/%=0NSGY<R,KCSAAB!GO7W[@48%
M'YG>._A=)\&+/P7JGCCPUX7M]!N_$.M7UM\.M8U01Z;IR7-M&D0%RR-;"2(I
M))Y8Z^:PCR0:XKP!\,-2U#P)\"_"&D/%I_B#QUI-WHWB32TC8S+H;7[W2W9!
M'RJ$5T4M@D2CT(K]8KBUANXC%/$DT9P2DBA@?P-+Y$?F^9L7S,;=^.<>F: (
M["R@TVQM[2UA2WMH(UBBAC7:J(HPJ@#H  !BK%%% !5;4KL:?I]S=%#(L,32
M%0<$X!./TJS535K1K_3+NU1@C30O&&(R!E2,_K0!\U_#7]L^[\5W_@B;Q-\-
M-6\&^'/&LGD:'K\VIVMY!-,59DCD6)M\18*V"PZ]<5Z-:_M6?"*^M=<N;;Q]
MHMQ!HDT<.H/%.7$#/)Y:DX'*E_EW#*YX)KQKP)^R/\13I/P^\,>./&7AV?P=
MX'<W&GV_A[3+F"\NIE1TB,\LLS+A?,)PBC..U5_A-^PI>^&-&U;0O%NKZ=K6
ME-X<G\-65S;27S7/DR/NWD33-'#P%_=Q+C<-P(Z4 >^>,/VC_AEX"DUF/Q!X
MSTK2Y='G@M;Z.>4[H9IE+11D $EF52V!DX!)P*S'_:4\(0^-1I3W]HF@_P#"
M,OXG_P"$F:\C^Q"V69(^O_ \YSVQUKP=_P!@_P 40> _"+?\)RFK_$#2=7GU
M74-4NI+JTAU$R0BW"[[=UFCV1)&%(;LP(P:NZK^P=?7_ (6MM(@\1Z=IY@\+
M?V/&8+*5XEO/M\=[YFR21F,1=""I;<<DYH ]OLOVK/A'?^#O^$I@\?:*^@"Z
M6Q:^,Y58YV&5C<$!E)'(W 9[4MY^U5\)-/\ !>F>+;CQ]HL?A_4IVM;6],Y(
MEE7[R!0-P*]2"!@<G KYS^)O[.WQ+AO[?Q1/<:1JWC?Q%XPT.>==%TF8Z780
M6C,%FE0L9'7YB79B,# !XJ6[_8/\8->6WBB'Q;I9\83ZGJ=]J%O"U]9:>%O(
MT1DA>"59AM$:DY;#Y(88H ]R^.'[7/PZ^"&@/<W^OZ?J.KRZ>=2L-'MKM?.O
MHOX2C8*@-GY2>#VS5#XP?M0S?#.R^'_]F>#;CQ-J7C(@6EE_:EO8B(^3YN'E
MF(3IQU'2O*O&/[#OBR72=5T7PIXF\.Z?H^O>&+/0-334--GE>!K<DJ]J1(2J
MMN(VNS;>#DXQ79?M"_LJZU\6M(^&46GS>$[V?P@0TUCXNTN6^T^]/D"+#1*Z
MDC//)]* .R^#G[4_AOXG6%NNJ0?\(AKT^H7>F1Z5>WD-SYTMNBO+Y,\):.10
MK Y![$=J]2\'^--#^(&A0ZUX>U*#5]*F=TCN[8DQN48HVTXYPP(R/2OA#XC_
M ++_ (N^&GPBCTG11-J?CK4_%46J:)9^"=#FAT70V*B*555F<6\31ERQ=@"3
MQ7W%\+_ =E\,?A[X>\*:>H%KI%C%:*P_C*J SGW9MS'W- '3XH  [4M% !11
M10 4444 %%%% 'DG[5?@C7?B+\!_%6@>&K%=3UN[@ MK1IT@$K!@=N]R%7IU
M)KYW\>? _P"+/QQB\1>)=8\%VG@[4+?PJ_AW2M";6H+R>[DD="\LDJ8B1 %X
M&XG/7%?<1&:-H]* /@33OV5_B9I_QNFU'2?#EGI&G7;/+=ZYJ-]8WZ+OM1%N
MMG\E;R";(QMW/$!T-<]\,_V0OBIX(\%>,HH_"%A)K$NBQZ3]CU6_TZ:QUEQ-
MN>40Q0("=N2KW3ELMA@1FOT<Q1B@#\X(_P!DCXE6OPVU+3_^$&N)IH_$[:SI
MUG%J^CI)$DEOY9)@:W-E)@\,A2,8.5)(S2>)OV-OBWK^J>$KK6-"TW4#_85I
MIC0>'KJPL8-$EBG+EP)X)3&"I!+6@!++CI7Z08%&T4 ?-7[3OP7\6_$:7PK_
M &#9)J7]GZ9J=K<237,<9\R6T:*/[Q&<L1R!QU.*\'E_8H\<Z9H%[8>'?#NG
M:,EYX'LM.OH(+N&*/4+^*=7DAE*DYW*&7S"".>M?H;BC:* /@_PU^S/X[EO-
M:O;/X<:9\.[2_P#%.C:K!H^G:G;2I;001NLTG[LA P)!VJ.>,9.:7P=^S;X]
M\,^&?$NFVWPB\(1^)(=,O[0^*]0U-9F\1233%UWP*0""I /VCH0,<5]WXHP*
M /S<T#]CKXAP^%]2%_\ #JQN67Q7I6O6>DW5[IJYAC39<(H@5(8R!V"X(Q\S
M&NHUS]ECQX+S^U=3^'NF_$#25UK69QX1OM4@B0?:EC$%X"Y,1*;2"I^8#E><
M5]]X%&!0!\!+^Q/XNN_#6IVGB'0=-\1:G;>!8]*TJXEO$E6+4!<%PB&0[AY:
M$*)&Q]W@U>T;]F3XC:+^T+X>\26?A*U6S\^QN=2U74[^PU"WQ';K'(8P\(N[
M>8$$ 1.T1ZYYK[OP*,4 "]*6BB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA/';VGV;RR?*MHHH%#N 3'&&SG)ZD5^@>!1@4 ?#OPL_97\2^!/&/PJU>_\
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M29HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T@%HI,T9I@+129HS0
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M !JN[HH]I(/JE+L_O?\ F<)_PK&\_P"AY\4?^!,/_P :H_X5C>?]#SXH_P#
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MQ_Z'+6?^_D7_ ,;K0\/^*O%FJ:]I]G-XRUORIYTC?9)$#@G!P?+KF:V/!O\
MR-NC?]?<?\ZRJX6@J<FH+9]#&MD671IR:I='UE_F>E26>MI(Z_\ "9^(\!B!
M_I$/_P :IOV76_\ H<_$7_@1%_\ &JT[C_7R?[Q_G3*\!0A;X5]Q\XLJP=E[
MG_DTO\S/^RZW_P!#GXB_\"(O_C5'V76_^AS\1?\ @1%_\:K0HI\D/Y5]P_[*
MP?\ )^,O\S/^RZW_ -#GXB_\"(O_ (U1]EUO_H<_$7_@1%_\:K0HHY(?RK[@
M_LG!_P GXR_S,_[+K?\ T.?B+_P(B_\ C5'V76_^AS\1?^!$7_QJM"BCDA_*
MON#^RL'_ "?C+_,J6MMK0NX"WC'Q"Z^8N5:XBP1D<']UTHJ_;?\ 'S#_ -=%
M_F**Y:T(W5D<]3+\-3=H1_%_YGM9&1BO';W]C_X/ZEX_N?&EYX'L;WQ#<WO]
MHSW%S+-+%+<]1*T#2&(L" 02G! (KV.BO$/+/*Y?V7?A=+\0&\;?\(C:1^)V
MU!-6-]#--'_IBC'G[%<)O(X9MN7_ (LT:E^R]\+]7\(>'_"]UX1M'T3P_/+<
MZ7;I+,AM7E9FEV2*X?:Y=MREBK9P01@5ZI10!Y-#^RI\*K>/08T\&V0AT.PN
MM+L(?,E,<=I<;_.@92^)(V\Q_E<,!GC&!5/PY^Q[\(/">FWEAI7@JTM;6\6T
M6=/M%PYD%K.)[<%FD)_=R $<] !]T 5[+10!Y\OP#\!)>O=CPY;BY?Q"/%32
M>9)DZH(S']I^]][82,?=YZ5R^A?L:_!KPR-4&E^!+"Q34K*[TVY2&6<*UK<X
M\^%1YF$1L?=7 7)VXR<^TT4 >;:C^SI\.M6BUN*[\+VLT>M0V%OJ"M)*//CL
MF#6BG#\>60",8SCG-9EI^R=\)[#Q5<^([?P;:0ZS<2W<SW*3SC#72.ESM7S-
MJ"19'W!0 2<XR 1ZY10!YK\+_P!G'X<?!C5+O4?!GA2RT*^NK:.SDGA:1V$"
M8*QKO9MBY 8JN 3R<GFO2:6B@ HHHH **** "BBB@ KD?'_PH\+?$^*Q7Q'I
M8OI+"0S6EQ'/+;SP,1M;9+$RNH(." V".N:ZZB@#SMOV?/AXWANUT#_A%;$:
M/;:=<Z5%:+O""VN&5IT.&R2[(K%B2Q89SDDU?B^#/@V)6!T*&7?YN_SY))3)
MYD"02;BS'<6BC13G.<>N37:T4 >?:=\ ? &DZMH.IVGAFTAO="MK>TTV4-(?
MLT4"R+"J@M@[1+)@D$_,>:=XM^!'@;QSKSZWK6A)=:LWV?\ TQ+F:&0& R&%
ME,;KM9#+(0PP1NZ]*[^B@#&\(^#]'\":!:Z+H-A%INF6VXQP19/+,69B2269
MF)8LQ))))))K9HHH **** "BBB@"*YMHKRWE@F19895*.C#(8$8(->:Z1^S3
M\-] T:[TO3O#4=G:W-Q!=.T5W<"9)(23"8Y?,\R,1Y.T(RA<G &37I]% '#>
M%_@EX*\&3K-H^@PV<HDN)?,$LKL7G55F8EF.2X1=Q/4Y/4DFE_PSS\/O[0M+
MP>&X!);1P1+&)IA#(L!)@\V+?LE\LDE3(K%<\5Z-10!YO;?LZ_#NUM=0M4\,
MP-:7T#VTEO+--)'%$\GF.D*LY$"E\-B()R >H%7-#^!G@CP[>V5[9:&JW]I=
M2WL=Y-<S33M/+$89)'D=V:1C&2F7+8'3&*[RB@#*\,^%]+\&Z+!I.C6B6.G0
M,[1V\9)"EW9VZDGEF8_C6K110 4444 %%%% !1110 4444 %%%% !61XL\)Z
M3XXT"\T37+--0TN[79/;R,RAQG."5(/4=C6I)(J ;F"Y]33/M46/]:G_ 'T*
M!-I'&/\ !'P/)J%[?-X<M#=7M^FIW$A+YEN438LC?-R0O&.GM6/I?[,OPTT=
M+E+7PO"BW$*6[A[F>3$2R"1(UW2'8BN 0JX [#%>E_:8^GF)G_>%)]JBX_>I
M_P!]"G9BYD>4^+OV8?!/B'P[J^F6.FPZ/)J;3/-/$'D&9G5IL(7VC>5&<8YY
MZUNZ=\!? 6EI$(/#ENS1W#77F3R232/(T9B)=W8L_P A*@,2 . !7=?:8N/W
MB'_@0H^TQ#_EJG_?0I#NCDO WP>\(_#>XGN/#VD+8W$T2VYE>>6=UA4DK$C2
M.Q2,$\(N%'I2P?!_PA:WEC=0Z)"EQ8R7,UNX>3]V]PI6<CYOX@2#GUXQ76?:
MHO\ GHG_ 'T*/M4?'[Q.?]H4!==SS;3?@?86?Q*TSQ+)]A%CHFFR:;HUA!9E
M7MEE/[TO*SL7R. N !DYR:FMOV=/AW:&^$?AJ I>120/')/,Z1QN^]TB5G(A
M5F&2(PH)ZUZ&;F/_ )Z)_P!]"C[5%_ST3C_:%%F+F7<X:+X#>!(-=FU=/#\(
MO)3(Y!FE,2NZ;'D6(OY:.R\%U4,?6IY?@IX*F:9GT"W8S:;'I$AWR?-:(P9(
MOO= 5!SUXZUV7VF(G_6+_P!]"D%U%_SU0Y_VA0',C@[/]G_P%I_B*TURWT%8
M]0M+MKZV;[5.8[>=AAY(XC)Y:%N^U1GOFO0ZA%U%_P ]4_[Z%)]JB_YZI_WT
M* YD3T5#]JBSCS$_[Z%'VJ+_ )Z)_P!]"@?,NY-14/VJ+G]XG_?0H^U1=/-3
M_OH4"YEW)J*A%S%_ST4Y_P!H4GVJ+_GJG_?0H#F1/14'VJ+/^M08_P!H4HN8
MO^>J?]]"@=UW)J*A^TQ?\]4_[Z%'VJ+_ )Z)_P!]"@+KN345#]JB_P">B#_@
M0H%U$?\ EHO_ 'T* NNY-14)N8O^>B?]]"D%U%U\Q/\ OH4:A==R>BH?M47_
M #T3C_:%'VF(_P#+1/\ OH46%S(FI#TJ(747_/5/^^A1]IBP?WJ?]]"@.9'.
M_%'_ ))MXK_[!5U_Z*:OP</4_6OW>^*%Q&WPW\5 2+G^RKKC</\ GDU?A$4;
M)^1NO]TU]-D_PS^1]=D<XJ,[OL)12[&_N-^5&QO[C?E7T5SZCVM/^9"44NQO
M[C?E1L;^XWY47#VM/^9"44NQO[C?E1L;^XWY47#VM/\ F0E>@_L^_P#)</ _
M_84C_DU>?[&_N-^5>@?L_*P^-_@<L"H_M2/DC'9JSJ?PY>AC5J0]G+WELSZ$
MU7_D*7G_ %WD_P#0C56K&J.#JE[R/]?)W_VC57</4?G7V5-KD7H??4JM/DC[
MRV74=13=P]1^=&X>H_.M+HU]K3_F7WCJ*;N'J/SHW#U'YT70>UI_S+[QU%-W
M#U'YT;AZC\Z+H/:T_P"9?>=-\-?^2@^'?^OV/^=>IW__ !^W'_71OYUY5\-G
M ^('AWD8^W1]_>O4KZ5/MMQ\Z_ZQOXAZUX.,UQ"]/U/F<PJT_K2]Y?#W\V1T
M4WS4_OK^8H\U/[Z_F*YCB]K3_F7WCJ*;YJ?WU_,4>:G]]?S% >UI_P R^\=1
M3?-3^^OYBCS4_OK^8H#VM/\ F7WCJV/!O_(VZ-_U]Q_SK%\U/[Z_F*U_!TJ#
MQ;HWSK_Q]Q_Q#UK&M_"EZ,PKU:?LI>\MGU/7KC_7R?[Q_G3*2:XC,\G[Q/O'
M^,>M,^T1_P#/2/\ [[%?,K9'RT:D++WE]Y)14?VB/_GI'_WV*/M$?_/2/_OL
M4Q^TA_,OO)**C^T1_P#/2/\ [[%'GQ_\](_^^Q0'M(?S+[R2BH_/C_YZ1_\
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M - NT_[]"C_A%]'_ .@7:?\ ?H5J44<L>P?V;@O^?$/_  %?Y&7_ ,(OH_\
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MX5YX7_Z%[3?_  &6NAHHN^X?4,)_SYC_ . K_(Y[_A7GA?\ Z%[3?_ 9:/\
MA7GA?_H7M-_\!EKH:*+L7U#"?\^8_P#@*_R,2S^'_AF.\MW70-.5EE1@1;KD
M$,,&BM^V_P"/J#_KHO\ ,45QUV[HY:V$P\&N6G%?)'4-\<=!5B#IOB;@XX\.
MWO\ \:I/^%Y:#_T#?$__ (3E[_\ &J]$;@5X6_[7_@^/XE)X$;0?' \2.[;+
M4^$;_#0K-Y)N0WEX-N'('G?<YSFO%O'M^)\S[/$?\_%_X#_P3L/^%Y:#_P!
MSQ-_X3E]_P#&J/\ A>6@_P#0-\3_ /A.7O\ \:KNAJMD9;J(74/F6@#7">8,
MP@C(+C/R@@$\XXH75;)Q.5NX&$#!)2)5/EL0" W/!(8$ ^H]:=X]OQ#V>(_Y
M^+_P'_@G"_\ "\M!_P"@;XG_ /"<O?\ XU1_PO+0?^@9XF_\)R^_^-5VW]N:
M=FV'VZVS<NT< \Y?WK#.57GYB,'(&>E8FA_$[POXE\0>(-%TW6[6[U+0;F*S
MU*!7P;>:1 Z1DG +%2.F>N.H(!>/;\0]GB/^?B_\!_X)B?\ "\M!_P"@;XG_
M /"<O?\ XU1_PO+0?^@;XG_\)R]_^-5V\VM:?;1R/+>V\:1[M[/,JA=HRV23
MQ@<GT[THUFP/G8O;?]RJO+^^7Y%;[I;G@'L3U[47CV_$/9XC_GXO_ ?^"</_
M ,+RT'_H&^)__"<O?_C5'_"\M!_Z!OB?_P )R]_^-5WCZC:1NR-<Q*ZLJE3(
M 03T'7J>U16FM:??O$EM>V]P\L7G1K%,K%X\XWC!Y7/&1Q1>/;\0]GB/^?B_
M\!_X)Q'_  O+0?\ H&^)_P#PG+W_ .-4?\+RT'_H&^)__"<O?_C5:WC7XI^'
M/ ?A>X\0:E?A],M[VWT^62S'VADGFG2!$*IDY\R5 ?3.373V=[;ZA )K6>.X
MA)($D3AU)!((R..""/PHO'M^(>SQ'_/Q?^ _\$X+_A>6@_\ 0,\3?^$Y??\
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M6_42JNIZC'I5A/=RI+)%"A=E@B:1R!_=102Q]@,U;I,5!T.]M#SO_A>6@_\
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M_P#A.7O_ ,:KT3%&*+Q[?B'L\1_S\7_@/_!/._\ A>6@_P#0-\3_ /A.7O\
M\:H_X7EH/_0-\3_^$Y>__&J]$Q1BB\>WXA[/$?\ /Q?^ _\ !/._^%Y:#_T#
M?$__ (3E[_\ &J/^%Y:#_P! WQ/_ .$Y>_\ QJO1,48HO'M^(>SQ'_/Q?^ _
M\$\[_P"%Y:#_ - SQ-_X3E]_\:H_X7EH/_0-\3_^$Y>__&J]$Q1BB\>WXA[/
M$?\ /Q?^ _\ !/._^%Y:#_T#?$__ (3E[_\ &J/^%Y:#_P! WQ-_X3E[_P#&
MJ]$Q1BB\.WXA[/$?\_%_X#_P3&\,>*;3Q9IYO+."]MX@Y3;?V<MK)D?[$B@X
M]\5LBEHK-[Z'5%-)*3NS(\3^);7PIIOVZ[@O)X0P7;8VDES)D_[$:EL>^*Y'
M_A>.@_\ 0-\3?^$Y??\ QJO1:QO%?B-?"FBSZD]AJ.IK%C-MI=JUS.V3CY8U
MY-4FNJ,9PJN5X227I?\ 5')_\+QT'_H&^)__  G+W_XU0?CCH)_YAOB;_P )
MR]_^-5S=G^U7X5OO"LGB%-&\5QZ8+I+*)Y- N%:XG:7R1'$N,NP<$''3!K6N
M_P!H'2=-T$ZI?>'?%M@&O(K""SN-"F6YN99/NB*/JPXY/055X]OQ,_9XC_GX
MO_ ?^"7O^%XZ#_T#?$__ (3E[_\ &J/^%XZ"1C^S?$__ (3E[_\ &JT?AU\6
M-"^)?]HQ::+^RU#39%CO=,U:RELKNW+#*EHI #M8 X89!P<&NSQ2O#M^(>SQ
M'_/Q?^ _\$\7\&>,/!7@0:D=-TSQC+<:E=->7=U?:-J-S-+(?5WC)VJ.%4<*
M. *Z/_A=^@9S_9GB;/K_ ,(Y>_\ QJO1<48IWCV_$/9XC_GXO_ ?^">=?\+P
MT#.?[,\39Z9_X1R]_P#C5 ^-^@ Y&F>)LGJ?^$<O?_C5>BXHQ2O'M^(>SQ'_
M #\7_@/_  3SH?'#0 ,#3/$P'MX<O?\ XU0OQOT!1@:9XF ]O#E[_P#&J]%Q
M1BB\>WXA[/$?\_%_X#_P3SO_ (7EH/\ T#?$_P#X3E[_ /&J/^%Y:#_T#?$_
M_A.7O_QJO1,48IWCV_$/9XC_ )^+_P !_P"">=_\+RT'_H&>)O\ PG+[_P"-
M4?\ "\M!_P"@;XG_ /"<O?\ XU7HF*,47CV_$/9XC_GXO_ ?^">=_P#"\M!_
MZ!OB?_PG+W_XU1_PO+0?^@;XG_\ "<O?_C5>B8HQ1>/;\0]GB/\ GXO_  '_
M ()YW_PO+0?^@;XG_P#"<O?_ (U1_P +RT'_ *!OB?\ \)R]_P#C5>B8HQ1>
M/;\0]GB/^?B_\!_X)YW_ ,+RT'_H&^)__"<O?_C5'_"\M!_Z!OB?_P )R]_^
M-5Z)BC%%X]OQ#V>(_P"?B_\  ?\ @GG?_"\M!_Z!OB?_ ,)R]_\ C5'_  O+
M0?\ H&>)O_"<OO\ XU7HF*,4KQ[?B'L\1_S\7_@/_!/._P#A>6@_] SQ-_X3
ME]_\:H_X7EH/_0-\3_\ A.7O_P :KT3%&*=X]OQ#V>(_Y^+_ ,!_X)YW_P +
MRT'_ *!OB?\ \)R]_P#C5'_"\M!_Z!OB?_PG+W_XU7HF*,47CV_$/9XC_GXO
M_ ?^">=_\+RT'_H&^)__  G+W_XU1_PO+0?^@9XF_P#"<OO_ (U7HF*,47CV
M_$/9XC_GXO\ P'_@GG?_  O+0?\ H&^)_P#PG+W_ .-4?\+RT'_H&>)__"<O
M?_C5>B8H-%X]OQ#V>(_Y^+_P'_@GC?Q"^,NB:AX"\1VL>G^(DDFTZXC5I?#]
MXB F-@"S&,!1[G@5^-Q\.7>3^]L>O_/]%_\ %5^YWQ1_Y)MXK_[!5U_Z*:OP
M<(&3P.M?1Y19QG;R/J\EI8MQGRU4MOL__;&I_P (Y=_\];'_ ,#HO_BJ/^$<
MN_\ GK8_^!T7_P 567@>@HP/05] ?2^QQO\ S^7_ (!_]L:G_".7?_/6Q_\
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M*9_PLS2O^?+7/_!)=?\ QNNPG8^?)R?O'O[U'N/J?SKYM-61\PJ6+LOWJ_\
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MBCFCV#V57_GZ_N7^1Q'_  L>_P#^A%\2_P#?FW_^/4'XD7Y_YD;Q-_WYM_\
MX]7;XHVCT%'-'L'LJO\ S]?W+_(S]!U636=.2ZET^[TMV)!MKU5$JX.,D*S#
MGKUK0/2C&*6H.F*:23=S(\1:Y-H5FD\.DWVKLSA/)L%1G _O'<RC'XUSW_"Q
M[_\ Z$7Q+_WYM_\ X]7;XS1BJ32W1C.G4D[QFU\E_D<1_P +'O\ _H1?$O\
MWYM__CU'_"R+_P#Z$7Q+_P!^;?\ ^/5VYP!G%>%WG[4*V-WXONG\!^(+CPIX
M4U%]-U3Q!:26LJ0NB1R22?9_-$S1JLJL2JDX!P#BG>/8CV57_GX_N7^1WO\
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M>V.DVYN)8+-0TSJ.R D9/M5)I;HRG3G)WC.WR7ZE?_A8]_\ ]"+XE_[\V_\
M\>H_X6/?_P#0B^)?^_-O_P#'JYG4/VFO"-EI6E:M$+J]TO4=&N-:CN;=%.V*
M' >-E)!$@)VD'H00<8JKH?[2$?\ 8NHZKXJ\&:[X0L+>P_M2WNIS!>P7=N2
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MS1[![*K_ ,_7]R_R.(_X6/?_ /0B^)?^_-O_ /'J/^%CW_\ T(OB7_OS;_\
MQZNWQ1BCFCV#V57_ )^/[E_D<1_PL>__ .A%\2_]^;?_ ./4?\+'O_\ H1?$
MO_?FW_\ CU=OBC%'-'L'LJO_ #\?W+_(XC_A8]__ -"+XE_[\V__ ,>H_P"%
MCW__ $(OB7_OS;__ !ZNWQ1BCFCV#V57_GX_N7^1Q'_"Q[__ *$7Q+_WYM__
M (]1_P +'O\ _H1?$O\ WYM__CU=OBC%'-'L'LJO_/U_<O\ (XC_ (6/?_\
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MMR7_ *!&I?\ ?I/_ (NM6BN>S[G']5Q/_00__ 8_Y&5_;DO_ $"-2_[])_\
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M!:*2C- "T44F: %HI,TM !12$XHS0 M%)FC- "T4F:,T +129HS0 M%)FC-
M"TAZ49H[4 <Q\4?^2;>*_P#L%77_ **:OP</4_6OWB^*)_XMMXK_ .P5=?\
MHIJ_!T]3]:^FR?X9_(^NR+X:GR"BBBOHCZH**** "BBB@ KT']GW_DN'@?\
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M_A_D=8=8\2X)'AZT)#X _M,<KG[W^K].<?A0VL^)5#[?#UH2%RH.IXR<=/\
M5\<\5P=O^U/X'N_$L.FQ7-VMF^ES:G)J,UC<1Q0")PCQ2!HP4D!/W6P<\8R1
M6=KO[7?@RPN]$M+"+4KZZU+4O[,D@GTZYM);)S&9%>:.2(.J,!D';@CD9Q1=
M=@]G+^=_A_D>GG5_$@D0#0+4H1EF_M+H<],>7SQS31K/B8JA/AVT#$_,/[3!
MV\?]<^>>*X7P_P#M/>"KRST*/5=7M+35-4C63RK!;B[MH=SLD>^X\E5C#%<
MR!,G(&>M+XD_:5\->"/BAJ/A'Q&SZ6EO;6US'?K#-,A$K%<R[(RL* X&]V R
M>U%UV#V<OYW^'^1W1UCQ+EQ_PCUJ<-A?^)G]X9Z_ZOCCG%']L>)?G_XI^TX3
M*_\ $SZMCI_J^.>,UBK\=_ [>*9?#_\ ;86^CD:%IFMIA:>:J[FB%R4\DR!>
M2@?=CM5"R_:3^'E[;:G<?V\UK!I]O]L>2^LKBV6:#=M\V R1KYZ;OE#1;@20
M.]%UV#V<OYW^'^1U*ZOXDWH&\/VH4GYC_:0^49_ZY\\<TT:UXG\M3_PCEIO)
MY7^U!QQZ^7ZUQ_PX_:$T/XAOXUNXT;3=%\-31QR7MZDL#L&CWL9(98T>,KTV
MD$G- _:B^'":3?:A<:W<V,5G+##+#>Z7=P7&9O\ 4E87B$CK)_"RJ0W8T778
M/9R_G?X?Y'8OK/B52X7P]:, 1M/]I@;AG_KGQQS2G6/$F_CP_:[=N<_VG_%C
MI_J_7C-</KO[4GP^TOP:NO6^L-?B=;@6]E#97)N6DA4F19(1&9(0O 9G0!<\
MU+HG[1?AO_A5OA/QEXDD.@KXBB1K6RA26\D>5@2(HQ'&6D8@< +D^E%UV#V<
MOYW^'^1V2:QXE9HPWA^T ).XC4P=O/'_ "SYXYI#K7B<1DCPY:%QT7^U!@\>
MOE^M<S=?M(?#VTTG2M1.N23VVI1M-"+6PN9Y$C4[7DFC2,M"BGAFD"A3P:3Q
M!^T3X'T34Y=*76%N]56W$T<<4$S0%FC,D4;7"H8T=P,JK,"1R :+KL'LY?SO
M\/\ (ZHZOXDW2 >'[7 ^X?[2^]S_ -<^.*:-8\2_+GP]:<J2?^)F.&QT_P!7
MZ\9K,^''Q9T?XB6:BVD5-3BM8KF^M(]TBVAD&0C2;0N['.WKCG K(A_:8^'$
M[:F$\1#&GKO=FL[@+.-^P_9R8\7'S?+^ZW<\4778/9R_G?X?Y'5+J_B4E,^'
MK0 MAO\ B9YP,]?]7SQSBD;6?$P5R/#MH6!^4?VF.1C_ *Y\<\5Q]S^U'\.+
M/2K:^GUJZB,]S+9K8G2KLWJSQKN>)K81>:K!3G#(..:O7/[1?P]MFT@#Q%'<
MKJD*7,#VEM-.J1.VU9)2B$0J6^7,FT9XHNNP>SE_._P_R.D.K^)/,<?V!:A
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MZH\Z/_GHO_?5?&69\#S+N245'YT?_/1?^^J/.C_YZ+_WU19AS+N245'YT?\
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MAN[.W83%+IUCM$4LT+2R%HXV8EU=Z.>7</JF'_Y]Q^Y'VI_PH'X=?]"CI?\
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MC KT*CGGW#ZIA_\ GW'[D>??\* ^'?\ T*&E_P#?G_Z]'_"@/AW_ -"AI?\
MWY_^O7H-%'/+N'U3#_\ /N/W(\^_X4!\._\ H4-+_P"_/_UZ/^% ?#O_ *%#
M2_\ OS_]>O0:*.>7</JF'_Y]Q^Y'GW_"@/AW_P!"AI?_ 'Y_^O1_PH#X=_\
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MZ#11SR[A]4P__/N/W(\^_P"% ?#O_H4-+_[\_P#UZ/\ A0'P[_Z%#2_^_/\
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M!YIJZ-8(;LK96X-V<W!$2_OCC'S\?-QZYK*_X6%X6_Z&/2/_  .B_P#BJ/\
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M_P"ACTC_ ,#XO_BJ:3>R(E5A!VE)+YFU]@MB^[R(MVX/G8,[O7Z^]0Q:)I\
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MN/T>M_!/A*[@CF@T'1989%#I)'9PLKJ>000O(/K3_P#A ?"__0O:1_X Q?\
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MI=RR.EE$"I$38(.W@U^(1U.]R?\ 3;CK_P ]F_QK]V?BC_R37Q7_ -@JZ_\
M135^#IZGZU]-D[O&=_(^MR/#TI1G>"Z=$6?[3O?^?VY_[_-_C1_:=[_S^W/_
M '^;_&JU%?0GT_U:A_(ON19_M.]_Y_;G_O\ -_C1_:=[_P _MS_W^;_&JU%
M?5:'\B^Y%G^T[W_G]N?^_P W^-']IWO_ #^W/_?YO\:K44!]5H?\^U]R+/\
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M_P# .+_XFM2BG<?U>C_(ON1E_P#"+:+_ - ;3?\ P#B_^)H_X1;1?^@-IO\
MX!Q?_$UJ4478?5Z/\B^Y&7_PBVB_] ;3?_ .+_XFC_A%M%_Z VF_^ <7_P 3
M6I11J'U>C_(ON10M/#&C+=P,NCZ<K"12"+2,$'</]FBM.V_X^8?^NB_S%%<E
M9ZHXZ]&E%JT5]QU;?%>[5B/^$ \7MCC(LX,?^CJ3_A;%W_T3_P 8?^ D'_QZ
MN_*A03@<>U>7^%OVC/!?B2\\:07%\GAU/"FMS:#>7&N30VL4T\4*S.T3%_F0
M(V<G!X)Q@9KQ>:/8^3]C6_Y^_@O\C1_X6Q=_]$_\8?\ @)!_\?K$\9^(]/\
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M6?<NT'EMPQG-*\>P>RK?\_?P7^1RO_"V+O\ Z)_XP_\  2#_ ./T?\+8N_\
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M\/O&'_@';_\ QZC_ (6Q=_\ 1/\ QA_X"0?_ !^NZO)TLK2>X<92)&D8 <X
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M8-PGS2*,L@YY8#J.HKG[CXN^%VM(KK3-4L->M/MRV%Q<:;J%J\=HYZF5C(
MN.0,MZ*:?-'L'L:W_/W\%_D5/^%L7?\ T3_QA_X"0?\ QZC_ (6Q=_\ 1/\
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MX<OK&RU76M-TR\OFV6EO>74<,EPW]V-6(+GV&:.:/8/8UO\ G[^"_P CF/\
MA;%W_P!$^\8?^ =O_P#'J/\ A;%W_P!$^\8?^ =O_P#'JTM:^*?A;15UR/\
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MI./XC_.F8'I7SB:ML?+K#XFR_?O_ ,!B<O\ \)M=_P#0H>)/_ 6+_P".T?\
M";77_0H>)/\ P%B_^.UU&!Z48'I57']7Q/\ S_?_ (#$P;3Q)JE^K&W\$^)Y
M@IP2MK#Q^<U3_P!JZ[_T(?BG_P !8/\ X]7J/PV ,5]P/O+V]J[78/0?E7EU
M<7*$W%):'DUJN+I5'!5=O)?Y'SS_ &KKG_0A^*?_  %@_P#CU']JZY_T(?BG
M_P !8/\ X]7T-L'M^5&P>WY5E]=GV1A]8QG_ #]_!?Y'S_9ZGK;7< ;P-XGC
M4R("[6T.%&X<G]]T%%?0&T>@_*BLY8J4]T)UL3+XJE_D@?YE('7%?'WAW]E/
MQ(?C-+KFO:9I&H>'9/B9JGBMH)Y5FW6DVD-;0,8V7&\3[3M[8SGBOH!E^*63
MM?PACME+O_&DV_%/^_X/_P"^;O\ QKEY/-'!]9_Z=R^X^0/#W[''Q'\"Z'X3
M:#PEX*\:O!X;UCPM+X?\17C"PTPW.JSW<%XF(V\Q/*D1'C0(^$4*WIT7C3]E
M_P"*;^,?'6K:+9:#<6.M>)M&U(0+=107'V>VTS[*[6TLUO.+5UE/!V%S%N4,
M"3GZ=V_%/^_X/_[YN_\ &C;\4_[_ (/_ .^;O_&CD\T+ZU_T[E]Q\@>$_P!C
MOXF> _#'@O/A;P;XYO+'PKJ7A"YT'Q%?$Z=8O/?R7$=_%^Y)D5D*I)&/+D*@
M ,.:Z[Q_^S5\3]3\8^,+72]+\-S>'O$&M>%]>?4$OWMW@.G+:Q36Z6Y1NH@+
MJQ? 7Y>6/'TCM^*?]_P?_P!\W?\ C1M^*?\ ?\'_ /?-W_C1R^:#ZU_T[E]Q
M\U^ _P!C/5]-\8>'=6UWP[X=O!:>//$OB"[DE$4SO:7=O.MIU3YF$K1,5/W=
MH/45Y%J/[#_QNNOA+X;\'RV'ARY^P:!#9":'4H8)(Y8M0DN3'/*;5Y;A-I0Q
M*LD:1MG(/.?O';\4_P"_X/\ ^^;O_&C;\4_[_@__ +YN_P#&CD\T'UK_ *=R
M^X^8X?V5OB!=?%O5+F;PSX5M]'U#XE6_C=?%;7F_5+6VMQ$1;+&(LYDV.H/F
M8422Y!W#/V\.G0UY[M^*?]_P?_WS=_XT;?BG_?\ !_\ WS=_XT<OF@^M?].Y
M?<>A_G1^=>>;?BG_ '_!_P#WS=_XT;?BG_?\'_\ ?-W_ (T<OF@^M?\ 3N7W
M'H?YT<UYYM^*?]_P?_WS=_XT8^*?]_P?_P!\7?\ C1R^:#ZS_P!.Y?<>A@YH
M-9?AO^U_[+C_ +<-D=1RWF'3PXAQGY<;_FZ8S6H:@[(OF2=K!D4?G6+XI_M_
M[ G_  CK::+SS!O_ +3$ACV<YQY?.>GM7+;?BG_?\'_]\W?^-4HW5[G/4K\C
MY>1OT1Z'^=>8_'KP'KOC30-#NO#0M)]9T#6K/6X+*^E,,5YY$FYH#*%;RRRD
M@/M(!QD8JWM^*?\ ?\'_ /?-W_C1M^*?]_P?_P!\W?\ C3Y?-&?UK_IW+[CQ
M?4O@;X^^('BX^--:TG2M"OK_ %O1I)=&BU+[7]GLK'[3EVE\M5>1S<M\BC "
MCG)-<?X5_91\<0Z=HUCJ>DZ3;V^GZ?HVDS+%?AUN([/6!<2R#"# >'+!3SN.
MT^M?3&WXI_W_  ?_ -\W?^-&WXI_W_!__?-W_C1R>:#ZU_T[E]Q\W3?LT_%;
M3Y-+U2RDTNY\0:4=0TC3[QKYD\C3!9RVM@QW!LR#SFD<=S6OXI_9%\4>%])O
M],\(:[=>+M.U7PF_AJ[M?%=W"B1B$;K,KY,"Y7<94?=N.V4G)(KWK;\4_P"_
MX/\ ^^;O_&C;\4_[_@__ +YN_P#&CD\T'UK_ *=R^XP_@KX"US0_%7BSQ+K&
MAZ;X376([.VAT+2+A9H4%NL@,[,J(N]_,"@ <)&F>>!Z_P#G7GFWXI_W_!__
M 'S=_P"-&WXI_P!_P?\ ]\W?^-'+YH/K7_3N7W'H?YT5YYM^*?\ ?\'_ /?-
MW_C6]X4'BT2S_P#"2-HICP/)_LI9@<YYW>8>GTH<;=2X5^>7+R27JCIJ2BJF
MJ&\-A/\ 8/)^V[#Y/VG=Y>[MNV\X^E0=3=E<75K=[O2[R", R2PNBY/&2I K
MY^^#G[)VC>"/AQH8U>QN-2\8V6G/&IU#6;J_M+6X>-T8V\4KF*($.1E$& <#
M%>D!?BGC[_@__OF[_P :-OQ3_O\ @_\ [YN_\:OE\T<7UK_IW+[CYQA_9_\
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MT'UK_IW+[CP[P?\ LO\ B/1-+NWGT_2EU9_$>E:E'<I,"ZP6\*))A]N0<J<
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M="GFMF']D7PG%<O*VI:M*LGC&_\ &CQM)$ US=VTEO+#P@/E!)6VC[P./F-
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MZ 5NT )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10
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M8!,]J\QOOB'X_P#''PET/27\1ZA9>+]4T#P_<?\ "0Z?J%S"[/<:P(0##OV
MD8#.,%@2I^7BCGEW#ZK1_E/M3_A3ME_T,WBW_P ']Q_\51_PIVR/_,S>+?\
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M_<?_ !5=_@48%'/+N'U2C_*<!_PINS_Z&;Q;_P"#^X_^*H_X4W9_]#-XM_\
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MX'_["D?\FK.HO<EZ&57+,(H2:AT[O_,][U&P6/4KM?.N#B9QDS$D_,>IJO\
M8E_YZS_]_36EJO\ R%+S_KO)_P"A&JM?80IPY%IT/NZ>48+DC^[Z+J_\RO\
M8D_YZS_]_31]B3_GK/\ ]_35BBK]E T_LC _\^_Q?^97^Q)_SUG_ ._IH^Q)
M_P ]9_\ OZ:L44>R@']D8'_GW^+_ ,RO]B3_ )ZS_P#?TT?8D_YZS_\ ?TU8
MHH]E#L']D8'_ )]_B_\ ,V/A]I:7?CG086N+N-9+R-=T-PR..>H8<@^XKT:\
M\+P)>3C[=JIQ(W)U"0]_K7"_#7_DH/AW_K^C_G7J=]_Q^W'_ %T;^=>%BXI8
MBR[?J?-X_*L&L2DH?9[OOZF#_P (S!_S^ZI_X'R?XT?\(S!_S^ZI_P"!\G^-
M:]%<_*CC_LO"?R?B_P#,Q_\ A&(/^?[5/_ ^3_&O4?@Y\%] \;6NHOJ=UK+O
M!(JH8]4F3@C/8UPU>[?LV_\ 'CK/_79/_0:\O,I.GAG*#L]#R,UP&'HX24Z<
M;/3J_P#,M_\ #+G@W_GOKO\ X.)_\:/^&7/!O_/?7?\ P<3_ .->OT5\9]:K
M_P [^\^$Y%W?WO\ S/(/^&7/!O\ SWUW_P '$_\ C3K?]F/PE:7$4\-WK\4L
M;!D==9G!4CH1S7KM)BCZU7>CF_O%[-/J_O?^9YD?V?\ 0F))UCQ-D\G_ (GE
MQ_\ %4G_  S]H/\ T&/$W_@\G_QKT^BH]O5_F9'U>GV_%GF'_#/V@_\ 08\3
M?^#R?_&C_AG[0?\ H,>)O_!Y<?XUZ?11[>K_ #,/J]/M^+/.+7X':79!A;Z_
MXJA#<D)KUP,_^/5/_P *<L_^AF\6_P#@_N/_ (JN_P 48J'4F]6R7A:+WC^9
MP'_"G+/_ *&;Q;_X/[C_ .*H_P"%.6?_ $,WBW_P?W'_ ,57?X%&!2YY=Q?5
M*/\ *<%%\(+.&:.0>)/%;%&#!7UZX*G!S@C/(]J*[W%%+F92P]*.R ]*\(^-
M?AK]GN'Q-'XM^)VF^#/[;TQ[6'^T]<AB,L;2%S;HQ(^8GRI"JMG[IQQ7NSYV
MG'7%?$/C?PWXO\47E_;:=(]KXKA^-\$[:@NG_;C8V8L1]EFEB!&8EA,8!9E
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M3CYE:0(><Y8+SD 5"O@;X#?$;XB6E@FB^#-<\8>"XDA@M([>&2XTV.-AM14
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M9>1B6WO+24212H>C*P."*^-/A]8:O\%T&KSZ/J^A66H>$HM#T75K?PW/J_\
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M$SQ/;-?W4VF6]W=PZ<BQ[WD8*=BLV ,GIFM.=]E]QQ_5(?S2_P# I?YG6_\
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MPFFN+*"6X@-K.Z*TD#,&,;$<KD<'!XR.*.=]E]P?58?S2_\  I?YG"?\(_\
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M?_Y)KA?&G[76A>%;]K>WTBYU"!KS[%!J$EY;VEG/((1,R+-,ZJ&VLH56QN+
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MU4YZE=PS],BO1[RSU_[9.&U2P)WMDBP;U_ZZ5POPU_Y*#X=_Z_8_YUZG?_\
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MKPUXZN]7^*WBG5OB!:^*_!4.J^$KXW?VU39VVAZ?#-\A29'(60(7=IAD[Y
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MHV_9E\&#P]JVC"/4/L>J6$&G7.;QF=HXGWJ=Q!.XL22W?->LXH(S0!X]\/\
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M_P!!IO\ P"N/_C==]15>[V_'_@$<N(_G7_@+_P#DC@?^%_>!?^@TW_@%<?\
MQNC_ (7]X%_Z#3?^ 5Q_\;KOJ*/=[?C_ , .7$?SK_P%_P#R1P/_  O[P+_T
M&F_\ KC_ .-T?\+^\"_]!IO_  "N/_C==[2T>[V_'_@!RXC^=?\ @+_^2.!_
MX7]X%_Z#3?\ @%<?_&Z/^%_>!?\ H--_X!7'_P ;KOJ*/=[?C_P Y<1_.O\
MP%__ "1P/_"__ O_ $&F_P# *X_^-UO>%/B+H'C>2XCT:^-V\ #2 P21[0>G
MWU&?PK>).>M.B.2:3Y>B+@JR?O237HU^K)*JZGJ=OH]A/>W;^5;0(9)'VEMJ
MCDG !)_"K1Z4T_=-0=#O;0\_'Q_\"$?\AIO_  "N/_C='_"_O O_ $&F_P#
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M_P#&Z/\ A?W@7_H--_X!7'_QNN^HH]WM^/\ P Y<1_.O_ 7_ /)' _\ "_O
MO_0:;_P"N/\ XW1_PO[P+_T&F_\  *X_^-UWU%'N]OQ_X <N(_G7_@+_ /DC
M@?\ A?W@7_H--_X!7'_QNC_A?W@7_H--_P" 5Q_\;KO:6CW>WX_\ .7$?SK_
M ,!?_P D<#_PO[P+_P!!IO\ P"N/_C='_"_O O\ T&F_\ KC_P"-UWU%'N]O
MQ_X <N(_G7_@+_\ DC@?^%_>!?\ H--_X!7'_P ;H_X7]X%_Z#3?^ 5Q_P#&
MZ[ZBCW>WX_\  #EQ'\Z_\!?_ ,D<#_PO[P+_ -!IO_ *X_\ C='_  O[P+_T
M&F_\ KC_ .-UWU%'N]OQ_P" '+B/YU_X"_\ Y(X'_A?W@7_H--_X!7'_ ,;H
M_P"%_>!?^@TW_@%<?_&Z[ZBCW>WX_P# #EQ'\Z_\!?\ \D<#_P +^\"_]!IO
M_ *X_P#C='_"_O O_0:;_P  KC_XW7?44>[V_'_@!RXC^=?^ O\ ^2.!_P"%
M_>!?^@TW_@%<?_&Z/^%_>!?^@TW_ (!7'_QNN^HH]WM^/_ #EQ'\Z_\  7_\
MD<#_ ,+^\"_]!IO_  "N/_C='_"_O O_ $&F_P# *X_^-UWU)1[O;\?^ '+B
M/YU_X"__ )(X+_A?W@7_ *#3?^ 5Q_\ &Z/^%_\ @7_H--_X!7'_ ,;KOJ0F
MCW>WX_\  #EQ'\Z_\!?_ ,D>1>/_ (V^#=7\"^(K&TU9YKJYTZXABC6RN,N[
M1L !^[[DBOR"/PH\9Y/_ !2NK_\ @&_^%?NP2>.:5>E=^%QOU5-1C>_F>EA,
M;C,&FH2B[_W7_P#)'X3?\*H\:?\ 0JZO_P" ;_X4?\*H\:?]"KJ__@&_^%?N
MU17=_:\_Y%]YW_VUC^\?_ 7_ /)'X2_\*H\:?]"KJ_\ X!O_ (4?\*H\:?\
M0JZO_P" ;_X5^[5%']KS_D7WC_MK']X_^ O_ .2/PE_X51XS_P"A5U?_ , W
M_P *3_A5'C/_ *%75_\ P#?_  K]VZ*/[7G_ "+[P_MK']X_^ O_ .2/PD_X
M51XS_P"A5U?_ , W_P *[7X*^ ?$OA[XM>$M3U/P_JEEI]IJ"2SW$MG)MC0
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MKVMN<%;B',:]3VDN2]K?"_\ Y(^%/^$@LO\ IY_\ I__ (BC_A(++_IY_P#
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M;H_X7]X%_P"@TW_@%<?_ !NN^HH]WM^/_ #EQ'\Z_P# 7_\ )' _\+^\"_\
M0:;_ , KC_XW1_PO[P+_ -!IO_ *X_\ C==]11[O;\?^ '+B/YU_X"__ )(X
M'_A?W@7_ *#3?^ 5Q_\ &Z/^%_>!?^@TW_@%<?\ QNN^HH]WM^/_   Y<1_.
MO_ 7_P#)' _\+^\"_P#0:;_P"N/_ (W1_P +^\"_]!IO_ *X_P#C==[2T>[V
M_'_@!RXC^=?^ O\ ^2.$A^//@>XFCBCUEF>1@BC[%<#))P/^6?K17=9.112]
..WL5&-;K)?<__ )(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>gmab-20241106xex99d1007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !* )T# 2(  A$! Q$!_\0
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,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>gmab-20241106xex99d1008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !! *H# 2(  A$! Q$!_\0
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HB@ HHHH **** "BBB@ HHHH **** &KUI?2BB@!:*** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gmab-20241106xex99d1009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  V % # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z2EIK4
M1W%Y!:J#--'$#TWL%S^=4?\ A)=.)8+.92H)/E1L_0X[#UJ./0HK2YGN83'Y
MTKF1GN(P[ GL&X('H.U++K20$@W=@S#^'S]I]>G/:J23 LOJT("$17+AAD;;
M=S^?'%207\<RJPBG0'^_$RG]15*WU^*<<)YG&X>2V_(_(4K^)+&)L2F:(\<M
M ^.??&*.5]@-)KA%4LQ( ]0:<)%;&&!R,UEGQ-IIW".Z6:1?^64 ,C_]\@$T
MVQU":62:6>&54)'DQ"$[T7'.X^I/;MQ0XM;H#8HJE_:8S@6UR?\ MD1_.I+:
M]-RS#[/-#@9S*N ?IS2L!8-8&KZ7J]YJJ2P:@(].$04VBYB8R9.6,@R<8(&.
M.G7FN@HH3L!R,]E_9<7GW.D6LD2@F66:^:3:.Q^=><UDZAXOU/3'2"W\+RV;
M3*7@(:$;\8&"20L?48!R<?P\&NWU/>D*RI"9_*8.T:C+,!_='<]Q]*R[SQG8
M6]HDT"76HR,_E_9K*!I)E;!/S+U3IU;%:QE?I<#G(=<U6Y:,7L-W&D@Y6SMV
MN0I]"^0O'LN*UK+5[.)/,>UULG.TB6RD7_QU5 _'%-7Q'XEU,'['X:>P3/$F
MI7"!L?[B$_SJH]QK>H3^0MS;7<JG#QV[N(UZYW,H7!Z<%C]*MJ^C5OF!J1:O
MX>U+S4"IO5PD@:W='1L9 ;Y00<<\U*)XE ;3M:C7)P(;IA(A/IR0P_/\*U-(
ML!I^GPP^3# X4&1;<'9OQ\Q&>3SW/-6V0/\ > ;ZC-8.0&''XG6U4'48TMT)
M"B[B?S+=B>/OC[O_  ( >];B,KH&4AE89!'<4S[+"BD+$B@C! 4=*YJ*#_A&
MO$=C96;'^SM0\W-D3E;9D7=OC_NH>A7H"RXQDY5D]@.KHI&(522<#UK#FUNY
MU!FBT6%+D@[6NYR5@0^Q'+GV7CU(H2N!L7%Q%;1-)-(D42C+.Y  'N:Y2^O+
M/Q-*#I^D#57'RB_DS!$OTEQN8?[@(]ZT(?",,]PESJLTFL7*G*?: !#&?]B(
M?*/J<GWK?  IIJ('(_\ "$7-S&1=:Y?$$<6T4F8%XX!#[F;_ ($WX5?AT?5K
M01I;:I (4)Q%)8J!C' &UACGVKH**'.3W P)8O$JQJ([C2W?^(O#*H_ !S44
M:>+/,3S)='V9^?:DV<>W-=)12OY 8+Z?KMRQ$NKV]O&<@?9;3Y@,\'+LPSCV
MJSI/AVUTJ>2Y#2W5[(NQ[NZ??(RYSMST49[* /:M2EHNP(KBWCNHC'*@DC/5
D6Z'ZT]$$:A5 "@8  P ***0#J*** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gmab-20241106xex99d1010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H (H# 2(  A$! Q$!_\0
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M/:SH$T5S<S-EHK2ZA*RQRD'EX6P&&>2K$<,#CG8/B)H'B'4+?[3X/:;Q5-&
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E&.()\D=Y"568@XP#)&\;$>L1/5C7HIHHK2?1D1ZCJ***S+/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gmab-20241106xex99d1011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  J ,P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**0G%
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M ,O)?B3%2LTM"#P9X\N/$6M7NC3Z<4NM,MH'O;R$_P"C+<2#<85R=VY1@D$
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J@HHHH 3 I:** $P*6BB@!*6BB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gmab-20241106xex99d1012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O *,# 2(  A$! Q$!_\0
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MUO7=S'96TMQ,XCBB0N[L<  #))KA=%AEGNK07A!>>:34KL'/!7&P<]E)0?\
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&BEHI ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gmab-20241106xex99d1013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  X '0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@! ,4M%<SXN\0WFFFRT[288KC6]19EMA/GRHE4 R328()505X!!8LH!&20
M)7=A-V1IZWK^G>';!KS4[R&QM@<>9,P7)[ =R3V R:QSXGU/5/\ D#:#--&2
M0MUJ4GV.(^X4AI"/0[!GL>]/T/P19Z9?+J5Y+)K&N;=K:E>X+J#U6-1\L2\_
M=0#/&<G).EXA\06GAC2I-0O3)Y",B;88R[LSL%4!1R<E@,5>FR5V3K\C'DT;
MQ7J#QF?Q#;:7&,[HM-L0S'_MI*6'Y(*DE\$"ZW"ZUW7+@,0<+?&#&#D8,00X
M['GD<'-0ZQ\0;6UU!]+T>VG\0ZRA^>TL<%(#_P!-I20D7T)W'LIJLGAGQ'XE
M99/$6L#3K7=G^R] D:-6&3Q)<D"1N#_ (_QIZVN]!:-Z&7XAL?#]E>365C)K
MFJ^(&0)]AT[6KOS$!Z&1O-VPKWW-C@<9. >N\'Z;J.D>&["TUB\^WZBBGSIM
MQ;)))"AB 6"@A0Q +!<GDFH](_X1SPS=0^'M.-CI]TRF9;"$JLCCNY'4DX))
M.2<$\X-<O\<=7GT71/#]S!OPNOV+S[6QB%9-\A/!R %/ [X[9JE>;4$+2/O'
M<ZQK=KHBVANB_P#I5S':1!%W$R.<#/MP23V -:&<UYI\8KZ2"[\&);S".9-=
MMKN1"FXO K")P,\#FX3GWXYYKMM:\/VNOBQ^T^:LEE<I>6\D,A1DD7(!R.H(
M+*0<@AB#4.-DF^I2=VS6R**!THJ"P/2D/ KGO$'BIM.O(M,TZT;5-:F3S$M5
M;8D<><>9-)@B-,@@<%F((4'!Q1C\&7.N1[O$^I/J>[!.GVN;>S4CG;M!W2#/
M7>Q!Q]T=*=M-17+%[\1M!L[N:TBO&U*^B^_::9"]U*G.,,L8;:?]['K4$_BW
M7KF%'TWPA>2;QD?VC=0VH'U +L/^^<\CWQTUEIUKIENMO:6\5K;K]R&",(B_
M0  "LOP[XACU;PS#JLX%E&4=I?.; CV%E8DG& -I.3CBJ5ELKDZF0-9\<+"T
MK^&-(/\ =MTUIS(>?4VX7/?K^-);16WQ*T?2=?M)K[1+^'SA!/$R&2(DE)48
M$,DB%HP>A!VJ0>AK.FU2_P#BI$UKH<\VF>%7.V?60I2:^3(W1VH."J$9!G..
M/]7G(<)\3-?E\!^%+'3/#OE:?>S@VFGHL0?:50^7&B'@EF\M!G@!B3TK7ENT
MDM2+V5V]#7MM&\96;9_X2;3K]<L=MUI)5B,?*-R3 #'<[3GT%<)\:)/&7_",
M:?%=:?:W6D#5[%]1N-&N)$NA;BX3<L<9 ;<3MP4?<!D 9YKV6WW^5'YNTR[1
MO*],XYQ^M<M\6;9KCX;>(_+7?+#9O<HO7+1CS%'YH/?TI4YVFKCE&\="72M8
M\+>&_!PO=/FL]/\ #UH"N85V)&0VTJ5 R'W<%2-VXXQDXHTOXD>']4MM1E;4
M$L'TUD6^@U#_ $>6T+C*"1&P5W#!7/4$$5Q?Q"@CT_6?"?B&SM[B[T>^U**>
M_LK.(.TTH@E:VF51U;>(U)R,_NR3\M9=GX&UR\U36;C4-"N/[:U/43?I>+>*
MEC'&(?+A67:_F,R(3&RJ &*D@J&!%J$'K)D.4EHD5=(U@>,/#VJ>*[.5/L&G
M3W^L'4V^=)[A(Y8H$B<<-%%%C<PR"V%'(<"/^Q=4U;X>^$-'NGDO-5MO#M]J
M#0R$O/N:$10J<Y);$Q7DG)4]2,C=M/@YJB_#S_A"+FYL$\/6=K)!;QV:,C7K
M$,4,RD!8U#,&**6#$#D+E3UWP_T?41]HUO6[(V.JW<4-LML\JRM!!$"%4LO&
MYF:1S@D?,HR<5<IQC=Q)46VKGE=[X6UC6)=0U_29]:O=$U._MK:QMI5W3V40
MN8WFF E!81,ZD@<% BG!4D+Z)K%EJ7A[Q1X5^S:]J=_-?W[07$%V\9C>W6WE
M=SL5%"D,J$, #D@9P<5Z'BH)+."2XBN'B1YXE98Y2H+(&QN /49P,_05C*LY
M:-&BIVV+(Z44=**P-CF=8\*7%SJ<VIZ5JLVCZA-$D,KK"DT4JH6*;D8=1N;E
M2IY.<\8H3>'O&[8\KQCI\?KNT/=_[7%=IMHVU:FU_P ,B.5,\PU[QKXL\#S0
MVLVG#QO=O$91;Z+826LNP<%BSNT0Y_A+JQ!^4,1@YGAC2;7Q#X.M/$GC/5[.
M7P]$CW$.F+(5TZ!-Y(:9I,&=A@8WA5'9 0#7L)'%?-<5]!<:9K7A^;5&M-.@
MU/69X9#'NQ*VQH$521YA62[+*@QEE7TS712M--)6[LQG[K3;OY'O-_XOT32+
M*UO+G4K:*SNB5@N X,;X1G)##(VA48D] %))KQS4_&,7CSQE9>*[*2W30]-T
M/4IM%N[J%@PN!)!%)<LK %5 ?"J0"1N8X#+3OAY\-]>\"^!_!_VW0H[AM"@F
M@N-&M)(Y6E2X4F8H&(0;6"@(#RN_DE@*Z.7X<ZKXJN-3UIFCT&?5C);OIUY%
MYXCM'A2)MX1P!*WEQM@$JNU0<D$U25.G)V?S_KR$^>:6EBUX8U_7;3Q!I6CS
M7_\ :5O]KO;5A-$&G>WA) N7E! !#F.,@+@EB>#P/3+B".ZMY(95#Q2*493T
M((((_*N:\$?#_2_ EC';V+7-U*D*P&[OI?,F9%)(!; ZL68X RS$G))-=5U%
M<TY)RO$WBFEJ>,^&I-0U4^%O!UW:SK?^'+SS=1N3;LL(@MPRVS*Y&UC+F)@
M20!)G!%>R@ BC;S2YXJ93YM@C&PM%%%26%%%% !1110 4444 -/2O+O@MX7G
ML]+U^XUG3O)O9O$NH74"7,)W1()3'$R%L\%%!##C#8'%%%:)M0:1FU>2/4Z*
:**S- HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gmab-20241106xex99d1014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  Y ,\# 2(  A$! Q$!_\0
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)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gmab-20241106xex99d1015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  W '4# 2(  A$! Q$!_\0
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M7CT.^LIE0M]EMY9(XTSR[;408'7)/Z&JOAC27TR?0M-G)-S''-J-R>G[QSM
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AE^:?FDVYS@L<D\\]:**3G)JS86-(<4M%%0,**** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>gmab-20241106xex99d1016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O /,# 2(  A$! Q$!_\0
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MQ)%XTNI+2RO]4TYX[B?5M\EW;RRRB261;=<(I? 4)N&P(N[<<BN^G^%VL_\
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H*0@GH:<3@4 _E0 P#!&>34E,W<\CO1NPV*>X]Q2N3132XS118+'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>gmab-20241106xex99d1017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmab-20241106xex99d1017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !1 #T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**SI];
MMK;5[?3I6,=Q.C/%N&%?;]X ]"0.<=<<]J %U;6K?1Q:FX+*MQ<);*P4D!V.
M%R>P)P,^I%7P<UE>*-*;6M!O+-'$<LD9\N0KG8XY5L>S '\*B\&:]_PDWAC3
MM2*E))X@94(P4D'RNN.V&#"@#;HHHH **** "LW7=&BUNQ:"0M'("'BF3&^)
MQ]UU]Q^O3O6E10!B>']8EO$FM+U%AU*TPLZ+]UL_=D7_ &6_0@CM7/?#^4Z7
MXC\6: [ ^1>C4(!C'[JX&X\>TBR<^]:OC&VN[2*/6-+M'O-3M2%%M$0IN(BP
MWH22!T^8$]"/<UY]KFK7MM\7= UK0C/?0:KH\T4]H8P(V6%PX 8X(D^:0 =,
MC!QF@#VBBJ.CZO:ZWI\-Y:2^;#(,@]"#W!'8CH0>AJ]0 4444 %%%% "$9%>
M/?%G3YO".H:+XALXGDMK;5H;EUC.#'O.R8>ZR(W0\!E![U[%7-?$6QM=1\)7
MD%['YMHYC$J9QE=ZYH UM+L+.W$MQ:*JK=MY[E/NNQ &['J0!SWJ_7FWP@UZ
M:&&^\)ZA([W^@R?95ED0KY\( V.,]>",GUS7I- !1110 4444 %<W\103X,U
M7 R1#N'X$&NC/2N3\;W<A\':[]IC$"*C)&V\'S%P/FXZ<DC'M0!S_CW1[JT\
M46NL:6#_ &FL9EBC!P+@Q\O"?]^-FQ[H#7>>'M<M?$FCVFIV3^9:W,8DC)&#
M@]B.Q'(([$51\80.NEB]ASY]A*MTH7^(*?G7\5+#\:PM%E3PGXJ^Q1-_Q)->
M9KJR;/RQ7!&Z2,>@<?.!ZA_6@#O**04M !1110 5GZUH5CXAL'LM0@%Q:N5+
M1DD9(((/'N!6A10 QT#1E6Y!&#FN$_LDZEHFI>'LK%?Z;(LMA+)R%7.^!^.<
M*1L_X ?6N^KF?%-G<65W;:W8Q&::U4I<0(,M/ 3E@!W92-R_0CO0!>\*Z\OB
M'1H+HIY,_P T<\!.3%*IPZ'Z,#^E;%</X:NY)-7M]5L+2X_LC78?.F21-IMI
GU& S#MO48/NJ^M=N.E "T444 %%%% !3'Z_A110 A^_4E%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
